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Summary 
 
The infection of a eukaryotic host cell by a bacterial pathogen is one of the most intimate 
examples of cross-kingdom interactions in biology. Infection processes are highly relevant from 
both a basic research as well as a clinical point of view. Sophisticated mechanisms have evolved 
in the pathogen to manipulate the host response and vice versa host cells have developed a wide 
range of anti-microbial defense strategies to combat bacterial invasion and clear infections. 
However, it is this diversity and complexity that makes infection research so challenging to 
technically address as common approaches have either been optimized for bacterial or 
eukaryotic organisms. Instead, methods are required that are able to deal with the often 
dramatic discrepancy between host and pathogen with respect to various cellular properties and 
processes. One class of cellular macromolecules that exemplify this host-pathogen heterogeneity 
is given by their transcriptomes: Bacterial transcripts differ from their eukaryotic counterparts 
in many aspects that involve both quantitative and qualitative traits. The entity of RNA 
transcripts present in a cell is of paramount interest as it reflects the cell’s physiological state 
under the given condition. Genome-wide transcriptomic techniques such as RNA-seq have 
therefore been used for single-organism analyses for several years, but their applicability has 
been limited for infection studies. 
The present work describes the establishment of a novel transcriptomic approach for infection 
biology which we have termed “Dual RNA-seq”. Using this technology, it was intended to shed 
light particularly on the contribution of non-protein-encoding transcripts to virulence, as these 
classes have mostly evaded previous infection studies due to the lack of suitable methods. The 
performance of Dual RNA-seq was evaluated in an in vitro infection model based on the 
important facultative intracellular pathogen Salmonella enterica serovar Typhimurium and 
different human cell lines. Dual RNA-seq was found to be capable of capturing all major bacterial 
and human transcript classes and proved reproducible. During the course of these experiments, 
a previously largely uncharacterized bacterial small non-coding RNA (sRNA), referred to as 
STnc440, was identified as one of the most strongly induced genes in intracellular Salmonella. 
Interestingly, while inhibition of STnc440 expression has been previously shown to cause a 
virulence defect in different animal models of Salmonellosis, the underlying molecular 
mechanisms have remained obscure. Here, classical genetics, transcriptomics and biochemical 
assays proposed a complex model of Salmonella gene expression control that is orchestrated by 
this sRNA. In particular, STnc440 was found to be involved in the regulation of multiple bacterial 
target mRNAs by direct base pair interaction with consequences for Salmonella virulence and 
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implications for the host’s immune response. These findings exemplify the scope of Dual RNA-
seq for the identification and characterization of novel bacterial virulence factors during host 
infection. 
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Zusammenfassung 
 
Die Infektion einer eukaryontischen Wirtszelle mit einem bakteriellen Pathogen ist eines der 
komplexesten Beispiele einer Domänen-überschreitenden Wechselwirkung zweier Organismen. 
Infektionsprozesse sind in höchstem Maße relevant, sowohl in der Grundforschung als auch von 
einem klinischen Blickwinkel aus betrachtet. Im Laufe der Evolution entstanden komplizierte 
Mechanismen, die es einem Pathogen erlauben, die Wirtsantwort zu manipulieren. Umgekehrt 
haben potentielle Wirtszellen eine Reihe von anti-mikrobiellen Verteidigungsstrategien 
entwickelt, um bakterielle Infektionen zu bekämpfen und letztlich zu beseitigen. Es sind jedoch 
genau diese Verschiedenheit und Komplexität, welche die Infektionsforschung so anspruchsvoll 
und technisch schwer analysierbar machen. Gängige Analysemethoden wurden zumeist 
entweder für bakterielle oder aber eukaryontische Organismen entwickelt. Dagegen werden 
Techniken benötigt, welche es erlauben, mit den mitunter extremen Unterschieden zwischen 
Wirt und Pathogen umzugehen, die sich in etlichen zellulären Eigenschaften und Prozessen 
manifestieren. Eine Klasse zellulärer Makromoleküle, die diese Heterogenität zwischen Wirt und 
Pathogen widerspiegelt, sind ihre jeweiligen Transkriptome: Bakterielle Transkripte unter-
scheiden sich von ihren eukaryontischen Pendants in vielerlei Hinsicht, was sowohl quantitative 
als auch qualitative Aspekte miteinschließt. Die Gesamtheit zellulärer Transkripte ist von 
größter Bedeutung, da sie den physiologischen Zustand der jeweiligen Zelle unter den 
gegebenen Bedingungen reflektiert. Aus diesem Grund werden Genom-weite Transkriptom-
techniken wie etwa die RNA-Sequenzierung seit etlichen Jahren erfolgreich angewandt, um 
biologische Prozesse zu untersuchen – jedoch ist deren Eignung für Infektionsstudien in starkem 
Maße limitiert. 
Die vorliegende Arbeit beschreibt die Etablierung eines neuartigen Ansatzes, „Duale RNA-
Sequenzierung“ genannt, der Transkriptomstudien mit der Infektionsbiologie kompatibel macht. 
Mithilfe dieser Technologie wurde hier im Besonderen versucht, die Rolle nicht-
proteinkodierender RNA-Moleküle für die Virulenz zu beleuchten, da die Charakterisierung 
dieser RNA-Klassen bisherigen Infektionsstudien weitgehend verwehrt blieb. Die Anwendbar-
keit der Dualen RNA-Sequenzierung wurde innerhalb eines In-vitro-Infektionsmodells getestet, 
welches auf dem wichtigen, fakultativ intrazellulären Pathogen Salmonella enterica serovar 
Tyhimurium und verschiedenen humanen Zelllinien basiert. Die Duale RNA-Sequenzierung 
zeigte sich dabei in der Lage alle wesentlichen bakteriellen sowie humanen Transkriptklassen zu 
erfassen und erwies sich als reproduzierbar. Im Zuge dieser Experimente wurde ein Gen für eine 
zuvor kaum beschriebene kleine nicht-kodierende RNA (STnc440) als eines der am stärksten 
induzierten Gene intrazellulärer Salmonellen identifiziert. Interessanterweise hatten vorherige 
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Studien gezeigt, dass die Inaktivierung dieses Gens zu einem Virulenzdefizit innerhalb 
unterschiedlicher Tiermodelle für Salmonellose führt. Die zugrunde liegenden molekularen 
Mechanismen blieben jedoch unbekannt. In der vorliegenden Arbeit wurden genetische, 
Transkriptom- sowie biochemische Analysen eingesetzt um das komplexe Regulationsnetzwerk 
dieser kleinen RNA erstmals näher zu beleuchten. Im Einzelnen konnte gezeigt werden, dass 
STnc440 die Expression mehrerer bakterieller mRNAs durch das Ausbilden zwischen-
molekularer Basenpaarungen reguliert, was weitreichende Konsequenzen sowohl für die 
Virulenz des Pathogens als auch die Immunantwort des Wirts hat. Diese Ergebnisse 
veranschaulichen das Potential der Dualen RNA-Sequenzierung für das Auffinden und 
Charakterisieren neuer bakterieller Virulenzfaktoren während der Wirtsinfektion.  
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1. Introduction 
 
1.1  The transcriptome as a snapshot of an infected cell’s physiological state 
Currently, several possibilities exist to globally analyze biological processes within bacterial or 
eukaryotic cells and these can be grouped into four fundamentally differing approaches: (1) 
Genomics addresses the genetic material (i.e. the genomic DNA) of an organism, while (2) 
transcriptomics focusses on the transcribed proportion of the genome (i.e. RNA) and (3) 
proteomics assesses the proteinaceous fraction of cells (i.e. what is translated from RNA into 
protein). Finally, (4) metabolomics detects cellular metabolites to describe the distinct biological 
processes of a cell or organism. All these approaches have been shown to yield invaluable 
information regarding the physiological state of cells or their responses to external 
perturbations and changing environments. During the past decade, however, it became 
increasingly clear that the traditional dogma of gene expression – which assigns effector 
functions only to proteins – is obsolete. Instead diverse classes of RNA transcripts are now 
known to fulfill important functions that go far beyond serving as simple messengers for protein 
synthesis or as house-keeping molecules. In bacteria diverse non-coding RNA elements have 
been identified, including anti-sense RNAs (Thomason and Storz, 2010), riboswitches (Winkler 
and Breaker, 2005) or small RNAs (sRNAs; see below). In higher eukaryotes, as demonstrated by 
the Encyclopedia of DNA elements (ENCODE) project, protein-coding genes constitute only a 
very minor fraction (~3%) of the genome and are outnumbered by non-coding genes (Dunham 
et al., 2012). Together, this collective body of work has provided a compendium of non-coding 
transcripts (see Tab. 1.1) of which the most relevant classes for the present study will be 
introduced in detail in the following sections. 
1.1.1 Bacterial sRNAs 
Bacteria possess diverse non-coding RNAs (see Tab. 1.1). Among them the class of sRNAs 
constitutes the largest and best-studied cohort, with representatives in all studied bacterial 
species (both Gram-negative and -positive) (Gottesman and Storz, 2011; Storz et al., 2011). 
Many sRNA genes show signs of horizontal transfer, but conservation studies are generally 
difficult as sequence constraints are limited and often the secondary structure defines 
functionality (Gottesman and Storz, 2011). In Salmonella, the most recent transcriptome-wide 
analysis has predicted the presence of close to 300 different sRNAs (Kroger et al., 2013). sRNA 
biogenesis is heterogenic but generally it can be broadly classified into two mechanisms: 
Classically, sRNA genes are transcribed independently of the neighboring genes from their own 
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promoters. Others, however, have recently been reported to be processed from the untranslated 
regions (UTRs) of coding genes (Chao et al., 2012). 
sRNAs are defined as short transcripts (generally between 50 and 500 nt) that lack coding 
potential. Rather, these transcripts are well known to have effector functions themselves, e.g. by 
post-transcriptionally regulating (in most known cases repressing) the expression of target 
mRNAs in cis or trans. Typically regulation is mediated by base-pairing between the so-called 
seed region of the sRNA and critical sites in the mRNA target – in the classical scenario the 
ribosome binding site, thereby preventing translation initiation and inducing mRNA decay. For 
this to occur, many sRNAs rely on a chaperone protein, referred to as Hfq (host factor of the RNA 
bacteriophage Qβ) (Vogel and Luisi, 2011). Hfq facilitates inter-molecular RNA-RNA interactions, 
recruits specific ribonucleases for target mRNA degradation and protects the bound sRNA from 
being nucleolytically attacked, thereby increasing its stability (Wagner, 2013). Accordingly, this 
sub-class of transcripts has been termed Hfq-dependent sRNAs. Recently, the RNA chaperone 
ProQ has emerged as a second global sRNA binder, with Hfq and ProQ dependence not being 
mutually exclusive (Smirnov et al., unpublished). Finally, instead of direct base-pairing with 
target mRNAs, other members of the class of sRNAs have been demonstrated to function as 
titrators by binding and sequestering proteinaceous regulators of gene expression. The best-
studied representatives of this sub-class are two sRNAs referred to as CsrB and CsrC, which both 
bind to the translational regulator CsrA (Carbon storage regulator A), thereby modulating the 
activity of this protein (Babitzke and Romeo, 2007; Romeo et al., 2013). 
Irrespective of their precise mode of action, sRNAs seem to generally fine-tune and/or time 
target gene expression, rather than mediating strict on/off switches as typically done by 
transcription factors. sRNAs often help bacteria to rapidly adapt to changing environmental cues 
and they have been implicated in cellular responses to diverse stress conditions (Benjamin et al., 
2010; Bobrovskyy and Vanderpool, 2014; Repoila et al., 2003; Vogel and Papenfort, 2006). 
Consequently, they often act within complex regulatory circuits (Hoe et al., 2013; Vogel and 
Papenfort, 2006) including virulence programs (see section 1.1.4.).  
1.1.2 Eukaryotic microRNAs (miRNAs) 
Initially discovered in worms, miRNAs are meanwhile known to be present in a wide range of 
eukaryotic organisms, from flies and plants to mammals. In humans, there are currently close to 
2,000 mature miRNAs annotated (miRBase; as of October 2014). Dependent on the organism, 
miRNAs are about 21-25 nt in length. They are typically transcribed as long, polyadenylated 
primary transcripts (pri-miRNAs) and processed in the nucleus into precursor stem-loops (pre-
miRNAs), which are subsequently exported into the cytosol (Krol et al., 2010). Here further 
processing occurs by the RNase III-type endonuclease Dicer and results in a double-stranded 
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(ds) miRNA duplex. The mature guide strand is eventually loaded together with a member of the 
Argonaut protein family into the RNA-induced silencing complex (RISC). As part of RISC, the 
guide miRNA scans transcripts and recruits the complex to the respective target mRNAs to 
cleave and degrade, translationally inhibit and/or deadenylate them (He and Hannon, 2004). 
Thus, several differences notwithstanding, by acting in concert with defined protein chaperones 
and ribonucleases as post-transcriptional regulators of mRNA translation and stability, 
eukaryotic miRNAs appear functionally analogous to bacterial sRNAs. 
1.1.3 Eukaryotic long non-coding RNAs (lncRNAs) 
Recently, lncRNAs have emerged as an additional eukaryotic non-coding transcript class with 
regulatory capacity. Unlike miRNAs, lncRNAs constitute a heterogenic class of molecules. By 
definition, all transcripts >200 nt that lack coding potential are referred to as lncRNAs. Current 
predictions for human transcriptomes indicate that there might be >10,000 individual 
representatives (Derrien et al., 2012). For practical reasons, the class of lncRNAs is therefore 
typically further sub-divided into long intergenic non-coding RNAs (lincRNAs) as well as sense 
and anti-sense lncRNAs that overlap with protein-coding loci. Individual candidates may or may 
not be polyadenylated or spliced and localize to the nucleus and/or the cytosol. Likewise, the 
reported modes of action for this transcript class differ substantially: An emerging theme in 
lncRNA-mediated control of gene expression, however, seems to be the recruitment of histone-
modifying complexes to specific loci in the genome to epigenetically regulate target gene 
transcription (Mercer and Mattick, 2013; Rinn, 2014). For several further lncRNAs, however, 
other functions have been reported: Some representatives act as decoys by titrating 
transcription factors and thus, indirectly regulate target gene transcription (Hung et al., 2011). 
Others guide protein complexes to their correct sub-cellular destination (Huarte et al., 2010) or 
play structural roles by forming a scaffold for the assembly of cellular sub-compartments 
(Souquere et al., 2010). In some cases, not even the product but rather the act of transcription 
itself provides functionality: For instance, deep-sequencing has identified the existence of a class 
of divergent lncRNAs that are transcribed anti-sense to the promoters of coding genes and 
provide directionality of coding gene transcription (Almada et al., 2013). The resulting lncRNA 
products might simply represent byproducts of transcription and are typically rapidly degraded 
after synthesis (Clark et al., 2012).  
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Table 1.1|Properties and functions of RNA classes that constitute the bacterial and mammalian transcriptome.   
  
transcript 
class 
approximate proportion of 
total RNA 
size range biogenesis 
nature of 
5’/3'end 
major reported function(s) 
Infection-relevant 
representative(s)1 
reference(s) 
bacteria rRNA 
~60-90% (depending on 
metabolic state) 
120 nt (5S); 
~1,500 nt 
(16S); ~3,000 
nt (23S) 
transcribed as longer precursor followed by 
extensive modifications, the cleavage and 
maturation of both ends 
5'-mono-
phosphate; 3'-
hydroxyl 
component of ribosomes (mRNA 
translation) 
- 
 
 
tRNA ~5-15% ~70 nt 
transcribed as longer precursor followed by 
extensive modifications and the maturation of 
both ends; a specific amino acid is attached 
to each tRNA 
5'-mono-
phosphate; 3' 
CCA + hydroxyl 
group 
anti-codon adapter molecule for mRNA 
translation 
initiator tRNA cleavage by 
virulence-associated VapC 
protein 
(Winther and Gerdes, 2011) 
 
mRNA ~5% 
varies (100’s to 
10,000’s of nt) 
primary transcripts (mono- or polycistronic) 
5'-triphosphate; 
3'-hydroxyl 
template for protein synthesis - 
 
 
tmRNA ~1% ~360 nt 
transcribed as a larger precursor and 
processed into mature tmRNA (similar to 
tRNA biogenesis) 
processed and 
aminoacylated 
(similar to tRNAs) 
rescues and recycles stalled 
ribosomes; mRNA/protein quality 
control ("trans-translation") 
- (Himeno et al., 2014) 
 6S RNA ~1% ~200 nt 
transcribed from own promoter; further 
processed on either end 
5'-mono-
phosphate; 3'-
hydroxyl 
global regulator of transcription by 
interacting with the σ70 RNA 
polymerase holo-enzyme 
Legionella pneumophila 6S 
RNA was shown to impact 
on intra-macrophage 
replication 
(Cavanagh and Wassarman, 
2014; Faucher et al., 2010) 
 
sRNA ~5% ~50-500 nt 
either transcribed from own promoter or 
processed form UTRs of mRNAs 
diverse 5' ends 
(tri- or 
monophos-
phorylated 
dependend on 
biosynthesis as 
primary transcript 
or processing 
product); 3'-
hydroxyl 
gene regulation by direct (imperfect) 
base-pair interaction with mRNAs or  
titration of RNA-binding proteins 
e.g. S. Typhimurium: IsrM, 
IsrJ, IsrI, IsrH-1, OxyS, 
InvR, DapZ, SgrS, RyhB, 
IsrE; E. coli: MgrR; 
Staphylococcus aureus: 
SprD; Vibrio cholerae: 
TarA/B, VrrA; Listeria 
monocytogenes: SreA; 
Chlamydia trachomatis: 
IhtA 
(Albrecht et al., 2010, 2011; 
Chabelskaya et al., 2014; Chao 
et al., 2012; Gong et al., 2011; 
Grieshaber et al., 2006; Mann et 
al., 2012; Moon et al., 2013; 
Ortega et al., 2012; Padalon-
Brauch et al., 2008; Pfeiffer et al., 
2007) 
 
crRNA, 
(tracrRNA) 
species-dependent (only some 
bacteria have a functional 
CRISPR/Cas system) 
~24-48 nt 
(crRNAs); 
~30-100 nt 
(tracrRNA) 
crRNA synthesis very diverse and dependent 
on CRISPR type (e.g. processed from longer 
precursor or separately transcribed from 
intrinsic promoters); tracrRNA transcribed 
from own promoter 
for crRNAs 
dependent on 
mode of 
biogenesis; 
tracrRNA with 5’-
triphosphate, 3’-
hydroxyl 
genome defense; regulation of 
endogenous gene expression 
CRISPR/Cas-mediated 
regulation of bacterial 
lipoprotein expression in 
Francisella novicida 
(Bhaya et al., 2011; Heidrich and 
Vogel, 2013; Sampson et al., 
2013; van der Oost et al., 2014) 
 
cis-asRNA 
under debate (often depends 
on technological aspects but 
also species-specific 
differences) 
from tens to 
thousands nt 
independently transcribed 
5'-triphosphate; 
3'-hydroxyl 
under debate (gene regulation by 
antisense mechanisms, "excludon" 
concept, role in genome evolution as 
asRNAs tend to be enriched in genomic 
regions of foreign origin, source of 
nanoRNAs?, transcriptional noise?) 
e.g. S. Typhimurium  
AmgR, IsrC, IesR-1; 
Shigella flexneri RnaG 
(Georg and Hess, 2011; 
Giangrossi et al., 2010; Gonzalo-
Asensio et al., 2013; Gottesman 
and Storz, 2011; Lasa et al., 
2011; Lee and Groisman, 2010; 
Padalon-Brauch et al., 2008; 
Sesto et al., 2013) 
 
circRNAs rare varies 
arise from the 3'-5' ligation of both ends of 
linear RNA molecules 
n. a. - - 
(Doose et al., 2013; Vicens and 
Cech, 2009) 
 
nanoRNA unknown ~2-4 nt unknown 5'-hydroxyl 
priming transcription initiation 
(incorporated into nascent mRNA) 
- (Nickels, 2012) 
  
bacterial 
lncRNAs 
unknown 
several 
hundred nt 
independently transcribed 
5'-triphosphate; 
3'-hydroxyl 
regulation of gene expression from 
opposite strand (excludon concept)? 
enzymatic activity?  
- 
(Conway et al., 2014; Weinberg 
et al., 2009) 
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Table 1.1|continued.   
  
transcript 
class 
sub-
class  
approximate proportion of 
total RNA 
sub-cellular 
localization 
size range biogenesis 
nature of 
5’/3'end 
major reported function(s) 
Infection-relevant 
representative(s)1 
reference(s) 
mammals rRNA n. a. 
~60-90% (depending on 
metabolic state) 
mitochondria + 
cytoplasm 
121 nt (5S); 
156 nt (5.8S); 
~1,900 nt 
(18S); ~5,000 
nt (28S); 
mitochondrial: 
~1,000 nt 
(12S) and 
~1,600 nt 
(16S) 
pre-rRNAs transcribed by RNA Pol I; 
extensively processed and modified into 
mature rRNAs 
5'-mono-
phosphate; 3'-
hydroxyl 
component of ribosomes 
(mRNA translation) 
- 
 
  tRNA n. a. ~5-15% 
mitochondria + 
cytoplasm 
~70-90 nt 
pre-tRNAs transcribed by RNA Pol III; 
extensively processed and modified into 
mature tRNAs; a specific amino acid is 
attached to each tRNA 
5'-mono-
phosphate; 3' 
CCA + hydroxyl 
group 
anti-codon adapter molecule 
for (cytoplasmic) mRNA 
translation 
tRNA cleavage 
products 
(Angiogenin-
mediated 
processing) might 
be involved in gene 
regulation 
(Li et al., 2012b) 
 
mRNA n. a. ~5% 
translated in 
cytoplasm; 
may be 
shuttled into P-
bodies to 
pause 
translation or 
degrade 
mRNA 
varies (10’s to 
100,000 nt) 
RNA Pol II transcripts as pre-mRNAs; co-
transcriptionally 5'-capped, spliced and 3'-
polyadenylated 
5'-capped (7-
methylguanylate); 
3'-poly(A) tail and 
-hydroxyl group 
template for protein synthesis - 
 
 
snRNA n. a. 
together <5% 
nucleus (within 
"splicing 
speckles") 
~150 nt 
transcribed by RNA Pol II as 5'-capped pre-
snRNAs, exported into the cytoplams for 
extensive modification e.g. hypermethylation 
of 5' cap (except for U6 snRNA which is 
transcribed by PolIII and does not enter the 
cytoplasm), nuclear re-import and further 
modifications (pseudouridylation, methylation) 5'-capped (2,2,7,-
methylguanylate); 
3'-hydroxyl 
pre-mRNA processing/splicing - 
 
 
snoRNA 
C/D box nucleolus ~70–120 nt 
typically spliced from intronic regions of 
coding transcripts that are transcribed via 
RNA Pol II and further processed 
(exonucleolytic trimming), but also 
independently transcribed representatives 
r/tRNA maturation (guide 
methylation) 
- 
 
 
H/ACA 
box 
nucleolus ~150-200 nt 
r/tRNA maturation (guide 
pseudouridylation) 
- 
 
 
scaRNA n. a. 
Cajal bodies 
(nuclear 
organelle) 
~150-200 nt 
guide modifications 
(methylation and 
pseudouridylation) of 
spliceosomal RNAs 
- 
 
 
scRNA n. a. ~1-2% cytosol 
diverse, but 
generally <300 
nt 
diverse diverse 
diverse; typically associate 
with cytoplasmic proteins to 
form RNP complexes involved 
in regulation of the last step of 
gene expression 
- 
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Table 1.1|continued.   
  
transcript 
class 
sub-
class  
approximate proportion of 
total RNA 
sub-cellular 
localization  
size range biogenesis 
nature of 
5’/3'end 
major reported function(s) 
Infection-relevant 
representative(s)1 
reference(s) 
 
miRNA n. a. 
typically ~0.1-2% (in 
exceptions up to 10%) 
cytosol, 
nucleus, 
mitochondria 
21-22 nt 
transcribed as a primary transcript (pri-
miRNA) in the nucleus (in exceptions, spliced 
out of a coding transcript: "Mirtron"), cleaved 
into pre-miRNA, exported into the cytosol, 
cleaved into miRNA duplex and mature guide 
miRNA loaded into RISC 
5'-mono-
phosphate; 3'-
hydroxyl 
gene regulation by direct 
(imperfect) base-pairing with 
RNA transcripts 
miR-146, miR-155, 
let-7, miR-15, miR-
21, miR-371-3, miR-
29, miR-125a/b, 
miR-149 
(Eulalio et al., 2012) 
 
endo-siRNA n. a. unknown nucleus <30 nt 
endogenous dsRNA substrates are chopped 
into smaller fragments 
5'-mono-
phosphate; 3'-
terminally 
modified 
silence transposable elements 
in  germ  and somatic cells; 
role in heterochromatin 
formation; much better 
characterized in plants than in 
mammals 
- (Nilsen, 2008) 
 
piRNA n. a. cell type-specific nucleus ~26-30 nt 
primary piRNA as a product of long single 
stranded precursor molecules; secondary 
piRNAs generated via "Ping Pong" 
mechanism 
5'-mono-
phosphate; 2'-O-
methyl 
modification at 
the 3' end 
genome defense (transposon 
silencing) in the germ line 
- (Aravin et al., 2007) 
 
l(i)ncRNA 
poly(A)+ 
~5% (but precise fraction 
unclear) 
nucleus, 
cytoplasm, 
cellular sub-
compartments 
(P-bodies, 
paraspeckles, 
etc.) 
extremely 
heterogenic 
(<0.5 kb to 
>100 kb) 
independently transcribed; might or might not 
be spliced and polyadenylated 
5'-capped (7-
methylguanylate); 
3'-hydroxyl 
diverse (gene regulation by 
interacting with chromosomal 
DNA or RNA transcripts, 
components of RNP 
complexes, structural 
components of sub-cellular 
compartments, etc.) 
NeST, Lethe, 
lincRNA-Cox2, 
THRIL, NEAT1, 
IL1β-RBT46 
(Carpenter et al., 
2013; Gomez et al., 
2013; Iiott et al., 
2014; Imamura et 
al., 2014; Li et al., 
2014; Rapicavoli et 
al., 2013) 
 
poly(A)- - 
 
 
cis-NATs n. a. 
under debate (often depends 
on technological aspects) 
nucleus, 
cytoplasm 
varies typical RNA Pol II-dependent transcripts 
5'-capped (7-
methylguanylate); 
3'-hydroxyl 
transcriptional interference, 
RNAi 
- 
 
 
circRNAs n. a. unknown 
predominantly 
in the 
cytoplasm 
varies 
arise from the 3'-5' ligation of both ends of 
linear RNA molecules 
n. a. "sponge" for miRNAs - 
(Jeck and Sharpless, 
2014; Memczak et 
al., 2013) 
           
 
1: in the given context of bacterial infection of eukaryotic   
   host cells 
crRNA: CRISPR-associated RNA 
tracrRNA: trans-activating crRNA 
asRNA: anti-sense RNA 
circRNA: circular RNA 
scaRNA: small Cajal body RNA 
scRNA: small cytoplasmic RNA 
endo-siRNA: endogenous small interfering RNA 
piRNA: PIWI-associated RNA 
NATs: natural anti-sense transcripts  
n.a.: not applicable 
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1.1.4 Non-coding RNAs involved in virulence, infection and immunity. 
Representatives from each of these classes of non-coding RNAs are emerging as important 
regulators in infection processes (Tab. 1.1): For instance, in bacterial pathogens a wealth of 
sRNAs have been found to play profound regulatory roles not only in physiology but also 
pathogenicity (reviewed in Caldelari et al., 2013; Gripenland et al., 2010; Hebrard et al., 2012; 
Papenfort and Vogel, 2010, 2014; Toledo-Arana et al., 2007). In Salmonella, genome-wide 
expression analyses under various infection-related conditions have begun to identify potential 
virulence-related sRNAs. For instance, the FUR-regulated sRNAs RyhB and IsrE have been found 
to be highly induced in a fibroblast model of Salmonella infection (Ortega et al., 2012). Many 
pathogenicity island-encoded sRNAs (Isr genes) are activated inside macrophages (Gong et al., 
2011; Padalon-Brauch et al., 2008) and numerous additional sRNAs undergo strong expression 
changes during growth over a range of infection-mimicking in vitro conditions (Kroger et al., 
2013). Moreover, in vitro studies with Salmonella and pathogenic E. coli suggest various sRNAs 
that contribute to pathogenicity. These include the Salmonella pathogenicity island 1 (SPI-1)-
associated InvR (Pfeiffer et al., 2007) and DapZ (Chao et al., 2012) sRNAs, the lipopolysaccharide 
(LPS) synthesis-controlling MgrR (Moon et al., 2013), or the virulence effector-targeting SgrS 
sRNA (Papenfort et al., 2013). However, inhibition of many of these well characterized sRNA 
genes by transposon insertions did not lead to a pronounced growth defect in in vivo models of 
infection (Barquist et al., 2013; Chaudhuri et al., 2013). Rather, these global transposon 
mutagenesis screens suggest that several additional, so-far under-characterized sRNAs 
compromise Salmonella virulence when deleted – with one such example being Salmonella 
Typhimurium non-coding RNA 440 (STnc440).  
Also in the eukaryotic cell many non-coding transcripts are known to fulfill regulatory functions, 
and this includes the orchestration of the immune response upon pathogenic attack: In various 
cell types representatives of the miRNA family have been shown to regulate among others the 
expression of key immune genes, cell-cycle genes or enzymes involved in oxidative stress 
(reviewed in Eulalio et al., 2012). For instance, the conserved miR-146 and miR-155, whose 
expression is induced upon Toll-like receptor 4 (TLR4) stimulation by bacterial LPS (Taganov et 
al., 2006), feedback to regulate TLR4 signaling in a non-redundant manner (Schulte et al., 2013). 
The let-7 miRNA family was shown to regulate cytokine gene expression after Salmonella 
infection of murine macrophages (Schulte et al., 2011). In addition, members of the miR-15 
family have recently been reported to be suppressed in epithelial cells by invading Salmonella, 
thereby making host cells more susceptible to infection (Maudet et al., 2014). 
Representatives of the heterogenic class of lncRNAs are now emerging as crucial regulators for a 
variety of cellular processes, with a few reported examples of immunity-associated lncRNAs. 
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Pioneering studies reported individual lncRNAs to regulate immunity processes by means of 
interacting with key transcription factors such as nuclear factor-kappa B (NFκB) (Rapicavoli et 
al., 2013) or heterogeneous nuclear ribonucleoproteins (hnRNPs) (Carpenter et al., 2013; Li et 
al., 2014). Recently, the application of global RNA-seq to LPS-stimulated monocytic cells was 
used to compile a catalogue of immune-relevant lncRNA candidates and revealed that in some 
cases the identified lncRNAs affect the expression of important immune genes in cis (Iiott et al., 
2014). 
These studies notwithstanding, compared to their protein-encoding counterparts, non-coding 
transcripts are still under-characterized in the context of infection. The previous findings, 
however, demonstrate infection to be reflected not only in the coding transcriptome but also in 
the non-coding RNA expression profile of both a eukaryotic host cell and a pathogenic 
bacterium. Therefore, the steady-state composition of all cellular RNAs would represent an 
invaluable proxy for the physiological state of both a given bacterial and eukaryotic cell and 
thus, unbiased transcriptomic approaches promise unprecedented access to a global 
understanding of host-pathogen interplay. 
 
1.2  Transcriptomics: then and now 
Traditional methods to measure the cellular expression of individual transcripts were based on 
gene-specific DNA probes used for detection by hybridization (e.g. Northern blot) or by 
amplification (e.g. quantitative real-time PCR (qRT-PCR)). However, such approaches were 
limited to the analysis of a small number of pre-selected target genes. Global quantitative 
transcriptomics became possible upon the development of microarrays. These made use of 
numerous DNA probes that had been immobilized in parallel on glass slides or membranes 
(Fodor et al., 1993; Schena et al., 1995). Fluorescently labeled RNA (or corresponding cDNA) 
samples were subsequently hybridized to the microchip and after washing, the abundance of 
any given transcript in the input sample could be inferred from the fluorescent signal intensity 
of the spot corresponding to the respective gene probe. This led to a shift from hypothesis-
driven to discovery-driven science. While microarrays allowed the study of expression states of 
multiple genes simultaneously, they were still limited to the detection of known RNA molecules 
(often mRNAs) and therefore failed to discover novel transcripts. This was in part overcome by 
the introduction of high-resolution tiling arrays (Bertone et al., 2004; Selinger et al., 2003). 
These relied on the same working principle as microarrays but instead of spotting DNA probes 
for defined transcripts, stretches of genomic DNA were immobilized on the chip surface, thereby 
not only allowing for the detection of known transcripts but also for the identification of novel 
gene products. However, despite their great potential, the high costs associated with tiling 
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arrays – especially when analyzing gene expression in organisms with large genomes such as 
higher eukaryotes – restricted their application to a few specialized laboratories. Additionally, 
since expression states are deduced from fluorescent signal intensities that have both a lower 
(sensitivity) and an upper limit (saturation), both microarrays and tiling arrays have a low 
dynamic range and are often restricted to the analysis of the most abundant cellular transcripts 
(typically mRNAs) (Wang et al., 2009). 
Alternatives to probe-dependent methods that are occasionally employed for eukaryotic 
transcriptomes are tag-based techniques. The original approach, termed serial analysis of gene 
expression (SAGE) (Velculescu et al., 1995), combined 3’-primed reverse transcription of cellular 
RNAs with the identification of the resulting cDNA fragments (‘tags’) by Sanger sequencing. 
These short (13-15 nt) cDNA tags corresponding to a transcript’s 3’end were then assigned to 
their respective source gene and enumerated to inform about its expression state. A 
modification of the technique to selectively sequence tags from the 5’cap of eukaryotic mRNAs 
referred to as cap analysis of gene expression (CAGE) (Kodzius et al., 2006) was introduced later 
in order to identify transcription start sites (TSSs) in eukaryotic genomes on a global scale. More 
recently, the problem associated with unequivocally assigning short tags to their specific locus in 
the genome has been partially overcome with the improvement of SAGE to SuperSAGE 
(Matsumura et al., 2003) and massive amplification of cDNA ends (MACE) (Asmann et al., 2009) 
which generate longer tags (25-94 nt) than the former approaches. Whereas tag-based 
approaches, by counting individual sequence tags, entail a much increased dynamic range as 
compared to fluorescence-dependent protocols, they still suffer from rather low sensitivity (e.g. 
they are unsuitable to profile a whole transcriptome including diverse non-coding transcripts). 
Noteworthy, all currently available tag-based approaches are restricted to the detection of either 
the 3’ (SAGE, SuperSAGE, MACE) or 5’end (CAGE) of input RNA molecules, thereby preventing 
the full-length coverage of cellular transcripts and failing to discriminate between different 
transcript isoforms. 
The above-described transcriptomic approaches have been widely applied to various 
experimental systems including infection models. For instance, the first genome-wide 
transcriptomic studies of several important bacterial pathogens such as Vibrio cholerae (Merrell 
et al., 2002), Borrelia burgdorferi (Revel et al., 2002), Chlamydia trachomatis (Belland et al., 
2003), C. pneumonia (Maurer et al., 2007) and S. Typhimurium (Eriksson et al., 2003) were 
performed with the help of microarrays and revealed gene expression patterns that suggested 
strategies used by these microbes to adapt to their host cells. Likewise, tiling arrays were 
applied to both in vitro and in vivo grown Listeria monocytogenes (Toledo-Arana et al., 2009) and 
used to identify sRNAs or novel virulence genes in streptococci (Kumar et al., 2010; Perez et al., 
2009; Zheng et al., 2011). In turn, microarrays yielded important insights into the global 
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response of potential mammalian hosts upon cytokine (Zhu et al., 1998) or pathogen-associated 
molecular pattern (PAMP) stimulation (Hedges et al., 2005; Kerns et al., 2009; Tross et al., 2009), 
as well as towards diverse bacterial (reviewed in Rappuoli, 2000) or viral infections (Der et al., 
1998). Recently, two microarray-based studies reported the response of human epithelial cells 
to S. Typhimurium infection and found that by secreting effector proteins Salmonella induces 
pervasive transcriptional reprogramming in the host (Bruno et al., 2009; Hannemann et al., 
2013). Less frequently, tag-based approaches have been applied to the field of infection biology, 
e.g. to profile gene expression in eukaryotic parasites (reviewed in Kronstad, 2006) or in group 
A Streptococcus pyogenes-infected human epithelial cells that, in combination with microarray 
analysis, revealed the induction of a set of apoptosis-related mRNAs in invaded host cells 
(Nakagawa et al., 2004).  
In summary, even though these diverse transcriptomic approaches provided novel insights into 
the infection process of eukaryotic cells with diverse pathogens, they all suffer from the high 
amounts of input RNA required as well as the rather low sensitivity and/or dynamic range. Most 
importantly, the inherent characteristic of the described approaches to be mRNA-centric 
prevented the performance of “whole”-transcriptome studies (i.e. to profile both coding and 
non-coding gene expression in an unbiased fashion). 
Next-generation sequencing (NGS) technologies have recently revolutionized biology. 
Illumina/Solexa, Roche/454 (a.k.a. Pyrosequencing) or ABI/SOLiD were the first NGS 
technologies to enter the market. Even though these systems have very different working 
principles they all share a dramatic increase in speed as compared to conventional Sanger-
sequencing: Long DNA stretches or even entire genomes could be sequenced within several 
hours (Metzker, 2010). Initially applied to genomics, since ~2008 NGS technologies have been 
adapted for the massively parallel sequencing of cDNA, which is referred to as RNA-seq. The 
advent of RNA-seq enabled the high-throughput profiling of entire transcriptomes and has 
heralded a new era in the field of transcriptomics (reviewed in Wang et al., 2009). Compared to 
traditional approaches, the digital nature of RNA-seq (Fig. 1.1) makes it highly sensitive and 
provides a wide dynamic range. In addition, RNA-seq does not (necessarily) require prior 
annotation of the corresponding genome (even though it benefits from it), it is organism-
independent and bears the potential to capture all (coding and non-coding) cellular transcripts. 
Importantly, not only can quantitative information about gene expression (i.e. differential 
expression) be obtained, but also qualitative information: RNA-seq allows for the refinement of 
transcript boundaries, the identification of UTRs, processing sites, splice isoforms in eukaryotes 
or bacterial operon structures, respectively, the screening for TSSs as well as the identification of 
novel (e.g. non-coding) genes. All these features have readily rendered RNA-seq the method of 
choice for transcriptomic studies irrespective of the organism of interest. 
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Figure 1.1|Fundamental differences between probe-dependent and probe-independent approaches to 
gene expression analysis. Probe-dependent methods such as microarrays rely on fluorophore labeling of 
RNA or cDNA, which allows for an analogue quantification of gene expression that is limited by a narrow 
dynamic range and a lower and upper detection threshold. In contrast, sequencing of cDNA molecules 
enables the digital enumeration of reads and increases both sensitivity and dynamic range.  Figure taken 
from Westermann et al., 2012. 
 
1.3  RNA-seq: variation of a theme 
RNA-seq is based on the simple principle that by sequencing cDNA molecules on NGS platforms 
the expression state of any cellular RNA transcript can be inferred from the read count mapped 
to it. The “standard” RNA-seq protocol thus starts with extracting cellular RNA from a biological 
sample. Total RNA is next reverse transcribed into cDNA, amplified and then adapter or linker 
sequences are added to either end of each cDNA molecule to render it compatible with the 
respective sequencing technology. Sequencing of the final cDNA library results in the generation 
of “sequencing reads”, which are sequence stretches of a defined length (depending on the NGS 
technology they can vary between ~50 and a few hundreds of nucleotides) that correspond to 
the input cDNA. In a last step, sequencing reads are usually mapped to the reference genome 
sequence of the respective organism (if available). Thus, by enumerating the mapped reads per 
annotated gene its relative expression state under the sampled condition can be determined. 
Several additional steps have been introduced to improve the basic protocol and increase the 
information obtained from RNA-seq data. Some of the most important concepts will be outlined 
below. 
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RNA enrichment/depletion: Ribosomal transcripts usually comprise the majority of RNA 
molecules (up to 90%) in both bacterial and eukaryotic cells. However, due to their house-
keeping role in cellular protein synthesis they are typically constitutively expressed and thus 
their expression state is of low informative value. Consequently, protocols were developed to 
either deplete rRNA or selectively enrich the mRNA fraction prior to sequencing, thereby 
minimizing sequence reads derived from unwanted transcripts and maximizing those from the 
desired RNA classes. Depletion/enrichment can either be achieved on the RNA level or – upon 
reverse transcription – on the cDNA level. For instance, the commercial RiboMinus, Ribo-Zero 
and MICROBExpress kits are based on DNA oligonucleotides with sequence complementarity to 
rRNA that were immobilized on magnetic beads for the efficient removal of ribosomal 
transcripts from total RNA samples (reviewed in Sultan et al., 2014). Likewise, enzymatic 
treatment (e.g. exonuclease digestion for bacterial transcriptomes) can be used to specifically 
deplete processed transcripts, including the abundant mature rRNA and tRNA molecules, while 
primary transcripts remain (Sharma et al., 2010). Alternatively, instead of their active removal 
rRNAs can passively be depleted during cDNA synthesis by the use of ‘not-so-random’ primers 
which represent a mixture of all possible but ribosomal sequences to prime reverse 
transcription (Armour et al., 2009). 
Rather than depleting rRNA (and tRNA), eukaryotic transcriptomes can be enriched for 
polyadenylated mRNAs and lncRNAs. Thus, kits based on a similar principle to the described 
rRNA depletion technique but using oligo(dT)-coupled magnetic beads have been used to 
capture and enrich poly(A)+ RNAs. In contrast, studies investigating short RNA species (e.g. 
bacterial sRNAs or eukaryotic miRNAs) often involve a size-fractionation of total RNA on a gel or 
column to exclude longer RNA molecules (including the larger ribosomal transcripts) from 
reverse transcription. 
All these techniques substantially lower the required sequencing depth (see below). On the 
other hand, the enzymes or kits are expensive, the required amounts of starting material is 
increased compared to total RNA-seq and it is often unclear if or to what extent technical biases 
are introduced during the additional steps (The Sequencing Quality Control Consortium, 2014). 
Consequently, several studies deliberately refrain from depletion/enrichment but sequence total 
RNA. 
Fragmentation: Without prior treatment, RNA/cDNA molecules can usually not be covered over 
the entire transcript body using the common deep-sequencing technologies that are based on 
short reads. Thus, to ensure homogeneous coverage and to eliminate length biases during PCR 
amplification, nucleic acids may be fragmented prior to sequencing. Different fragmentation 
methods exist that shear either the original RNA or the corresponding cDNA molecules into 
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smaller, uniform fragments. Generally, these can be divided into three principle approaches: (1) 
to mechanically fragment the sample (e.g. via sonication), (2) to enzymatically cleave nucleic 
acids, or (3) to incubate them in a buffer that induces their chemical fragmentation. In practice, 
the deep-sequencing technology used determines the best-suited fragmentation strategy of a 
sample. However a general observation seems to be that transcript coverage is more 
homogeneous when fragmentation is performed on the RNA level, whereas cDNA shearing 
introduces a bias towards a transcript’s 3’ end (Wang et al., 2009). 
Strand-specificity: In the earliest RNA-seq protocols information on the strand-specificity of the 
original RNA molecules was lost as a consequence of cDNA amplification. Upon first strand 
synthesis, the single-stranded (ss) cDNA had to be amplified to match the input amount 
requirements and thus was used as a template for PCR. This resulted in ds cDNA products that 
were then sequenced. The obtained sequencing reads could be mapped to a specific locus in the 
genome, but not assigned to one of the two strands. This is problematic because prokaryotic 
genomes are typically very densely staggered with genes on both the leading and lagging strand 
which frequently overlap one another. Likewise, anti-sense transcription is widespread in 
animals (Dunham et al., 2012). Therefore, current protocols rely on different techniques to 
maintain strand-specificity during cDNA library generation and sequencing (reviewed in Levin 
et al., 2010). Of these, the most common protocols involve the selective labeling of second strand 
cDNA that allows for its specific degradation after the library amplification. Alternatively, 
adapters may be ligated to the input RNA molecules to maintain information about their 
orientation during cDNA synthesis and amplification.  
Depth requirements: The first RNA-seq studies in mammals were performed on the 
polyadenylated fraction of cellular transcripts and the resulting libraries were sequenced to 
~10-50 M reads (Mortazavi et al., 2008; Sultan et al., 2008). The first studies in prokaryotes 
reported the sequencing of rRNA-depleted samples to ~1-7 M reads/library (Oliver et al., 2009; 
Perkins et al., 2009; Yoder-Himes et al., 2009). This was sufficient to infer differential mRNA 
expression. However, an increased depth is required for RNA-seq to provide information on the 
expression levels of low abundant RNAs, transcript boundaries, splice isoforms or operon 
structures. In fact, to deduce both quantitative and qualitative aspects of gene expression by 
RNA-seq, depth recommendations for an exhaustive profiling of bacterial or mammalian rRNA-
depleted transcriptomes suggest 1-10 M or ~100 M reads/library, respectively (Haas et al., 
2013; Toung et al., 2011). Obviously, when refraining from depletion/enrichment of individual 
RNA classes but sequencing total RNA instead, a greater depth will be required to reach the 
same coverage. 
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In 2008 the first studies reported RNA-seq-based transcriptomics for murine (Mortazavi et al., 
2008) and human cells (Sultan et al., 2008), and thus for potential host organisms of bacterial 
infections. These early studies focused on coding gene expression as reverse transcription was 
primed using oligo(dT) primers to selectively sequence only polyadenylated transcripts (mRNAs 
or polyadenylated lncRNAs). These works uncovered the sheer complexity of mammalian 
genome expression, including pervasiveness of transcription, a multitude of lncRNAs as well as 
the prevalence of alternative splicing and isoform variation. Meanwhile, RNA-seq has been 
coupled to diverse upstream methods to give rise to tailored techniques for answering specific 
scientific questions: For instance, combining it with the pull-down of RNA-binding proteins by 
means of co-immunoprecipitation (co-IP) or in vivo cross-linking and immunoprecipitation 
(CLIP) allows for the global detection of transcript binding partners of cellular RNA-binding 
proteins (RBPs) or the identification of novel RBPs (e.g. Castello et al., 2012). A modification of 
this approach to specifically pull-down nascent ribosomes or RNA polymerase molecules 
provides a snapshot of translating mRNAs (Ingolia et al., 2009) or nascent transcripts 
(Churchman and Weissman, 2011), respectively, at a given time point in the cell. Finally, even 
the secondary structure of cellular transcripts can be investigated with the help of deep-
sequencing, namely by analyzing RNA samples that were treated with different structure-
specific enzymes (Kertesz et al., 2010). 
RNA-seq technology was subsequently adapted to bacterial transcriptomes, essentially by 
circumventing the need for polyadenylated transcripts as substrates for reverse transcription 
and by decreasing RNA input material requirements. Many of the pioneering studies were 
performed using pathogenic bacteria, including S. Typhi (Perkins et al., 2009), Bacillus anthracis 
(Passalacqua et al., 2009), Burkholderia cenocepacia (Yoder-Himes et al., 2009), Helicobacter 
pylori (Sharma et al., 2010) or Chlamydia trachomatis (Albrecht et al., 2010), and identified a 
plethora of novel genes including many new sRNAs (for reviews see (Croucher and Thomson, 
2010; Guell et al., 2011; Sorek and Cossart, 2010). The original RNA-seq protocol has since been 
further modified to increase the informational output: For instance, the usage of a specific 
exonuclease in a method referred to as differential RNA-seq (dRNA-seq) allowed the selective 
degradation of processed RNA molecules leaving only primary transcripts, thereby enabling the 
identification of TSSs on a genome-wide scale (Sharma et al., 2010). The transcript interactome 
of specific RNA-binding proteins could be analyzed on global scale by combining co-IP with RNA-
seq. For instance, studies with S. Typhimurium reported the sRNA interactome of the important 
bacterial RNA chaperone Hfq over growth in vitro (Chao et al., 2012; Sittka et al., 2008). 
Collectively, these works have changed our concept of bacterial transcriptomes which turn out 
to be much more complex and flexible than previously anticipated. For example, many genes 
have more than just a single TSS and often external stimuli dictate which TSS will be used. Also 
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operon compositions are highly diverse, i.e. a given gene might be transcribed both as a 
monocistrone and as part of a larger operon. 
 
1.4  Towards a joint analysis of pathogen and host transcriptomes 
During infection, bacterial pathogens are in intimate contact with their eukaryotic host cell. 
Thus, in order to be close to their natural niche, pioneering microarray studies aimed to analyze 
infection within joint host-pathogen models rather than in pure isolation (reviewed in Rappuoli, 
2000). These studies however, came with their own intrinsic problems: In order to prevent 
cross-hybridization, chips were either designed to exclude probes with a high risk of detecting 
transcripts from both organisms or the data derived from such probes were later excluded from 
the data analysis. Cross-hybridization was particularly an issue when analyzing pathogen gene 
expression as the bacterial RNA is typically overwhelmed by the host transcriptome background. 
Consequently, protocols were developed to physically separate host and pathogen from one 
another and to enrich for bacterial RNA after infection had taken place but prior to detection 
(reviewed in Hinton et al., 2004). These enrichment techniques, which are still commonly used 
nowadays, either rely on the separation of bacterial from eukaryotic cells or transcripts. In the 
former case, if the model system is based on extracellular pathogens, the host-pathogen 
interaction is disrupted and differential centrifugation results in the selective sedimentation of 
host cells while the bacterial cells remain in the supernatant fraction. In case of invading 
pathogens, host cells can be selectively lysed (e.g. by detergent treatment). In such a scenario, 
differential centrifugation will pellet intact bacterial cells while the host lysate remains in the 
supernatant. Preparing RNA from the pellet or supernatant fraction, respectively, will result in 
an enrichment of pathogen RNA. Alternatively, discrimination between host and pathogen can 
be achieved on the transcript level. Methods such as the MICROBEnrich kit make use of the 
different characteristics of eukaryotic and bacterial RNA species. That is, similar to the rRNA 
removal method described above, oligonucleotides that are specific to the most abundant 
eukaryotic transcripts (18S rRNA, 28S rRNA, polyadenylated mRNAs) might be coupled to 
magnetic beads to capture and pull out a substantial fraction of host RNA from a mixed 
transcriptome sample. Finally, depletion of host material may be achieved on cDNA level via the 
selective capture of pathogen-derived cDNAs by means of hybridization using biotinylated DNA 
probes derived from the respective bacterial chromosome (Bent et al., 2013; Morrow et al., 
1999). 
In the context of their natural niche, transcriptomic analyses unraveled pathogen gene 
expression patterns that differed from bacteria grown in vitro (Mandlik et al., 2011). Likewise 
the host response to live bacterial challenge was found to be more complex than that towards 
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individual PAMPs (e.g. Hannemann et al., 2013). However, separation and enrichment are labor-
intensive, error-prone as additional steps in the protocol are considered potential sources of 
bias, and usually are incompatible with low amounts of starting material. In contrast the high 
resolution of RNA-seq, down to the single-nucleotide level, achieves a high discriminatory 
power. In theory, this renders RNA-seq the ideal method to study host and pathogen gene 
expression without the need to physically separate the cells. 
 
1.5  Salmonella as a model organism for host-pathogen interaction studies 
Salmonella represents a genus of Gram-negative enterobacteria that comprises two species (S. 
enterica and S. bongori) with more than 2,500 individual serovars. The complete ~5 Mb genome 
sequence from various Salmonella strains is available (Parkhill et al., 2001). Salmonella spp. 
typically infect their hosts by the oral ingestion of contaminated food or drinking water. 
Salmonella are facultative intracellular pathogens and several serovars exhibit a relevant disease 
potential for humans. For instance, infection with primate-specific S. enterica serovar Typhi (S. 
Typhi) or S. Paratyphi can lead to lethal typhoid fever while S. Typhimurium has a broader host 
range including poultry and cattle, and infected humans may suffer from non-typhoid, self-
limiting gastroenteritis. In the mouse model, however, S. Typhimurium causes systemic 
infections, thereby mimicking human typhoidal fever upon S. Typhi infection. Due to the ease of 
cultivation under standard laboratory conditions and its genetic similarity, but lower risk 
potential for human health as compared to other serovars, S. Typhimurium is amongst the best-
studied Gram-negative model organisms. This includes diverse genetic and biochemical tools 
which are routinely applicable for the study of this organism. 
Salmonella pathogenicity is mediated by effector proteins that are directly secreted via a 
specialized multi-component apparatus referred to as the type-three secretion system (T3SS) 
into the host’s cytoplasm. Upon translocation, these effectors substantially manipulate 
important host cellular processes to the bacterium’s benefit, including cytoskeletal 
rearrangements, membrane trafficking and signal transduction pathways (reviewed in Haraga et 
al., 2008). Two distinct T3SSs were acquired by Salmonella and are known to be essential for 
infection and host colonization: The T3SS of SPI-1 (T3SS-1) translocates bacterial effectors 
across the plasma membrane of the target cell to mediate invasion upon host contact. A complex 
regulatory circuit ensures precise expression of T3SS-1 by integrating various environmental 
parameters of the small intestine into the regulation cascade that converges on the level of the 
AraC-like transcriptional activator HilD (Ellermeier and Slauch, 2007) (Fig. 1.2). Upon its 
stimulation, HilD transcriptionally activates two further regulators, HilC and RtsA, which amplify 
the signal, leading to the rapid induction of the entire SPI-1 locus. 
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Figure 1.2|Current model for the regulation of SPI-1 and SPI-2. Regulatory network compiled from Choi 
and Groisman, 2013, Ellermeier and Slauch, 2007, and Fass and Groisman, 2009. Solid lines represent direct 
regulations and dashed lines represent indirect effects. See main text for details. 
 
In contrast, the T3SS-2 routes effectors across the vacuolar membrane of Salmonella’s 
intracellular replication niche, the so-called Salmonella-containing vacuole (SCV). Thus, 
expression of SPI-2 has to be tightly controlled to ensure its activation only within the host cell 
environment. This precision is mediated by various upstream positive and negative regulators, 
including the two-component systems OmpR/EnvZ and PhoQ/PhoP, that sense environmental 
factors and feed into the regulatory network (Fass and Groisman, 2009) (Fig. 1.2). A third two-
component system, SsrA/B, acts as a hub by integrating the activating or inhibiting stimuli and 
upon activation the response regulator protein SsrB binds directly to the promoters of SPI-2 
genes to activate their transcription. 
The two pathogenicity islands, however, do not operate independently (Fig. 1.2). For example, 
HilD, the master activator of SPI-1 genes has been shown to regulate transcription of the ssrA/B 
operon, encoding the key regulator of SPI-2 (Bustamante et al., 2008; Martinez et al., 2014). 
Conversely, the PhoP/Q system that activates SPI-2 expression is known to shut down SPI-1 
activity (Bajaj et al., 1996; Behlau and Miller, 1993). These and similar mechanisms are 
considered to coordinate the cross-talk between the different SPIs, with huge impact on 
Salmonella virulence (Fabrega and Vila, 2013). 
Conversely, mammalian cells possess diverse anti-microbial defense strategies to antagonize 
bacterial invasion which are based on the innate and adaptive branch of immunity (reviewed in 
Abdullah and Knolle, 2014; de Jong et al., 2012). Conserved PAMP motifs on the surface of 
pathogens are sensed by extra- or intracellular pattern recognition receptors (PRRs) of the host. 
Paradigm examples in this context represent the detection of bacterial LPS by TLR4, that of 
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flagellin by TLR5 or that of bacterial peptidoglycans by NOD-like receptors (NLRs). 
Consequently various intracellular pathogens, including Salmonella, have evolved strategies to 
minimize sensing by host PRRs, e.g. by down-regulating flagellin expression (Winter et al., 2008) 
or modifying LPS (Guo et al., 1997; Matsuura et al., 2012) after host cell invasion. Triggered by 
PAMP detection, both non-professional (i.e. epithelial cells) and professional immune cells 
(macrophages) undergo defined gene expression programs orchestrated by key transcription 
factors of immunity, such as activator protein-1 (AP-1) or NFκB. This may lead to the secretion 
of cytokines to activate defense programs in neighboring cells, to recruit phago- and 
granulocytes to the site of infection or to activate the adaptive immune response and generate 
immunological memory. Evolved as a host defense mechanism to clear infection, inflammation 
can be manipulated by certain pathogenic species including Salmonella that have evolved 
mechanisms to dampen or augment the host’s inflammatory response. That is, in contrast to the 
host induction of an immune response by PRR-mediated PAMP sensing, these pathogens 
translocate effectors into their host cell to actively elicit a classical response. The pathogen may 
profit from the resulting environmental alterations, e.g. by inducing release of nutrients not 
present in non-inflamed tissues. For instance, effector proteins of S. Typhimurium can induce 
gut tissue inflammation, allowing the pathogen to tap host nutrients and outcompete members 
of the commensal microbiota that often lack the capability to utilize these compounds 
(Thiennimitr et al., 2012).  
 
 
Figure 1.3|Schematic of host-pathogen interplay based on the model system of mammalian epithelial 
cells infected by S. Typhimurium. Inflammation was considered both a host defense mechanism as well as a 
strategy employed by the pathogen for successful colonization. See main text for further details. 
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S. Typhimurium appears to be an ideal choice as a model organism for the establishment of a 
novel host-pathogen transcriptomic approach. A wealth of previous data outlines a paradigm 
example for the adaptivity of cross-kingdom interaction processes (Fig. 1.3). As infection 
involves a tight interplay between two active opponents many aspects of the underlying 
biological processes may only be fully appreciated when analyzing the two partners jointly. This 
would potentially allow for the identification of novel host-pathogen interaction nodes and for a 
better understanding of the behavioral repertoire of the two counter-players during infection.  
 
1.6  Dual RNA-seq: a thought experiment 
A single-step protocol for the simultaneous profiling of host and pathogen transcriptomes is 
very attractive for several reasons: Omitting the physical separation of host and pathogen cells 
or of their endogenous transcripts would substantially speed up sample preparation (Fig. 1.4). 
Likewise, the fewer steps in the experimental workflow from sample acquisition to analysis 
would minimize the sources of technical bias. Most importantly, however, profiling pathogen 
gene expression within its host cell niche, together with the corresponding host response 
without disrupting this tight interaction would provide an unprecedented and unperturbed view 
of the infection process. Directly relating gene expression changes in one organism to responses 
in the respective counter-player might reveal novel mechanisms of how these organisms 
interact. For such an experiment, that would allow for the simultaneous analysis of two 
unrelated transcriptomes, we coined the term “Dual RNA-seq” (Westermann et al., 2012). 
Transcriptomic heterogeneity anti-correlates with the relative ease of performing multi-
organism RNA-seq. Such heterogeneity nowhere is more extreme than in the context of bacterial 
infections of mammalian host cells. It manifests itself in both quantitative and qualitative traits: 
A prototypical mammalian cell contains in the range of 10-20 pg of total RNA. This is >100 fold 
more when compared to a prototypical prokaryotic cell which harbors ~100 fg of RNA. In 
practical terms, this means that in order to capture gene expression changes in both organisms, 
an optimal proportion of bacterial to host cells should be present in the sample. Ideally both 
genomes should eventually be covered to a similar degree, in order to prevent from the hyper-
profiling of one and the hypo-profiling of the other partner. A bacterial genome may be around 
1-5 Mb in size, while that of humans contains around 3,000 Mb. Thus, to reach an equal coverage 
of both genomes, human reads should theoretically be in ~1,000 fold excess over the bacterial 
reads. However, bacterial genomes are usually densely packed with genes and – unlike their 
eukaryotic counterparts – there is little non-transcribed space, which makes the discrepancy 
less dramatic. 
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For infections with extracellular pathogens, the infectious dose should be adjusted in a way that 
allows for the parallel investigation of both infection partners. In the case of intracellular 
bacterial species, selecting for invaded and against non-infected bystander cells would probably 
facilitate the adjustment of a suitable host-to-pathogen proportion in the sample. This would 
further differentiate between the specific immune responses of infected host cells and non-
infected – yet extracellularly stimulated – bystanders. 
 
 
Figure 1.4|A new approach to host-pathogen transcriptomics. Traditional approaches for host pathogen 
transcriptomics (left) depended on the physical separation of host and pathogen prior to their analysis. 
Instead, Dual RNA-seq omits a separation step and analyzes the two organisms together (right). 
Discrimination between host and pathogen gene expression thus only occurs in silico, by mapping RNA-seq 
reads to the respective reference genomes. Figure taken from Westermann et al., 2012. 
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Quantitative differences are accompanied by qualitative heterogeneity between bacterial and 
mammalian transcriptomes. Even though house-keeping transcripts (rRNA, tRNA) are common 
in bacteria and eukaryotes, their specific properties may differ. Importantly, mRNAs show 
fundamentally different characteristics between the two kingdoms: Whereas bacterial mRNAs 
harbor a 5’ triphosphate group, the 5’ end of eukaryotic messengers is protected by a cap 
structure (7-methylguanosine). Additionally, although polyadenylation of messengers exists in 
bacteria and eukaryotes, the average number of adenines (A’s) per mRNA molecule and 
importantly the fate of the corresponding transcript differ substantially (Dreyfus and Regnier, 
2002): In eukaryotes, with the exception of histone mRNAs all messengers are co-
transcriptionally polyadenylated. Mammalian mRNAs contain ~250 A’s at their 3’ end and this 
poly(A)-tail mediates stability of the transcript. In stark contrast, bacterial mRNAs are not 
routinely polyadenylated, but if they are, the poly(A)-stretch is short (~50 A’s) and marks the 
respective transcript for degradation. Consequently, selection of the polyadenylated fraction 
would isolate transcripts with contrasting fates in the different organisms and therefore, 
enrichment for specific RNA classes is not recommended for Dual RNA-seq. Transcriptome 
heterogeneity further increases as there are several RNA classes that are exclusive to either 
bacterial or mammalian transcriptomes (Tab. 1.1). Furthermore, whereas polycistrons are 
common in bacteria, eukaryotic mRNAs are expressed as monocistrons. Splicing, RNA 
processing and editing or sub-cellular localization further add to the qualitative heterogeneity 
between bacterial and eukaryotic transcriptomes. 
The intra- and inter-organism transcriptome heterogeneity notwithstanding, the conceptual 
idea of simultaneously profiling host and pathogen gene expression would be relevant for 
bacterial/mammalian infection models. Yet additional considerations would have to be taken for 
the experimental protocol to capture gene expression in both counter-players. For example, to 
account for the transcriptomic heterogeneity described above, one would refrain from the 
enrichment and/or depletion of certain RNA classes, but sequence total RNA instead. The RNA 
extraction protocol should efficiently isolate both bacterial and eukaryotic transcripts, at best 
irrespective of their size. During cDNA library construction it is essential to include a 
fragmentation step in order to shear the diverse RNA molecules into more homogenous 
fragments. Importantly, strand-specificity should be guaranteed to be able to assess expression 
of anti-sense transcripts in both organisms. Moreover, as an internal quality control, biological 
samples should be supplemented with artificially synthesized RNA molecules (spike-in RNAs) 
(Jiang et al., 2011). The primary sequence of any such spike-in RNA must be confirmed 
bioinformatically to be absent from all the genomes under investigation. Features such as spike-
in RNA length, GC content or concentration have to be empirically optimized for any assay 
system. Lastly, the required sequencing depth should be estimated for each infection model. 
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Figure 1.5|Estimation of the minimal sequencing depth requirements for Dual RNA-seq. a, Common 
infection models of bacterial pathogens were screened for reported numbers of individual pathogens per host 
cell. In these, a given host cell typically interacted with approximately ten bacterial cells (dashed line). b, 
Total cellular RNA content of a prototypical HeLa cell exceeds that of a prototypical bacterial pathogen by 
approximately a factor of 200. Based on the assumption that on average each host cell would be populated by 
ten bacterial cells (see panel a), this number decreases to factor 20 (= 5%). Informative RNA classes (mRNAs 
and regulatory non-coding RNAs) account for ~5% of both a mammalian and a bacterial transcriptome. 
Thus, only 5% of 5% (= 0.25%) of the total RNA isolated from an infected cell are expected to represent 
bacterial mRNAs and sRNAs and 5% of 95% (= 4.75%) to account for host mRNAs, lncRNAs and miRNAs. c, 
Based on these fractions and current sequencing depth recommendations for single-organism RNA-seq (see 
main text), the required depth for Dual RNA-seq was extrapolated. Figure taken from Westermann et al., 
2012. 
 
To assess the feasibility of Dual RNA-seq in a “standard” infection model of mammalian cells and 
bacterial pathogens, the average numbers of bacteria per infected host cell were compiled from 
the literature (Fig. 1.5a). Based on the above mentioned total RNA content of an average 
eukaryotic or prokaryotic cell, the relative proportion of bacterial transcripts in a mixed host-
pathogen RNA sample was estimated to be around 5% (Fig. 1.5b). Of these, again only ~5% are 
expected to reflect informative transcript classes such as mRNAs or sRNAs. Aiming at the 
suggested minimum of 1 M non-rRNA reads for bacterial RNA-seq (Haas et al., 2013), a total of 
400 M reads would be needed for a Dual RNA-seq experiment based on total RNA to capture 
pathogen gene expression (Fig. 1.5c). Likewise, ~95% of the sampled RNA would be eukaryotic 
and rRNA would again dominate. Calculating with 5% non-rRNA transcripts and aiming at the 
recommended sequencing depth for mammalian RNA-seq of ~100 M (Toung et al., 2011), one 
ends up with 2,000 M reads being required for a Dual RNA-seq experiment to capture host gene 
expression (Fig. 1.5c). This indicates that counter-intuitively the host would be the limiting 
factor in the given setting. Note, however, that the predicted proportions of non-rRNA molecules 
b a 
c 
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in the sample might not accurately reflect the actual proportion of reads derived from these 
classes in the final cDNA library. It is thus concluded that – even though the precise sequencing 
depth would have to be defined empirically – Dual RNA-seq for an infection model based on 
mammalian cells challenged with bacterial pathogens appears feasible using current technology 
(e.g. by Illumina sequencing). 
 
1.7  Aim of the study 
The present study was sought to establish the Dual RNA-seq approach – i.e. the simultaneous 
analysis of host and pathogen gene expression during infection – for the model system of human 
cell lines and intracellular S. Typhimurium. To this end, an experimental protocol might be based 
on the infection of host cells with constitutively green fluorescent protein (GFP)-expressing 
Salmonella to be able to distinguish invaded host cells from non-infected ones. Infected cells 
should be fixed, invaded cells and non-infected bystanders be separated via fluorescence-
activated cell sorting (FACS), total RNA extracted and cDNA libraries constructed. These would 
subsequently be analyzed by Illumina sequencing. From the resulting data, novel Salmonella 
virulence genes may be identified and their biological role in the adaptation of the pathogen to 
its intracellular lifestyle and corresponding consequences in host gene expression be unraveled. 
The overall goal was to develop a tool that would allow infection biologists to assess the global 
picture of an infection event and ultimately, to link given virulence phenotypes to the underlying 
molecular mechanisms. 
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2. Implementation of the Dual RNA-seq approach 
 
This chapter describes a detailed protocol for Dual RNA-seq of two very different interaction 
partners, the bacterial pathogen S. Typhimurium and human epithelial or monocyte-like cells. 
Therefore, the present study may be considered a generic description of the application of Dual 
RNA-seq to virtually any organisms – irrespective of kingdom affiliation – which are amenable to 
also conventional RNA-seq. Note however, that the relative proportion of host to pathogen reads 
may differ for other model systems and the required sequencing depth itself largely depends on 
the respective scope of a study. 
 
2.1  Choice of the infection model and optimization of infection conditions 
In order to evaluate the general applicability of Dual RNA-seq for bacterial/mammalian host-
pathogen interactions we established an in vitro infection model based on human cervical 
carcinoma HeLa-S3 cells and S. Typhimurium strain SL1344. This model represents a robust, 
widely accepted and long studied assay system (Kihlstrom, 1977). Infection of epithelial cells 
involves SPI-1-dependent invasion which is followed by a phase of SPI-2-dependent intracellular 
replication (Galan and Curtiss, 1989; Garcia-del Portillo et al., 1993). Furthermore, the HeLa-S3 
cell clone has recently been suggested by the ENCODE consortium as a preferred model cell line 
for various experimental setups and specific culture conditions were proposed to ensure 
comparability between different studies (Birney et al., 2007; Dunham et al., 2012). Its selection 
will therefore enable a direct comparison of our infection data with a wealth of additional 
experimental conditions. To discriminate between invaded host cells and non-infected 
bystanders a constitutively GFP-expressing Salmonella strain (Papenfort et al., 2009) is used. In 
this strain the coding sequence of gfp is placed downstream of the constitutive ptet promoter and 
integrated into the put locus within the Salmonella chromosome. 
A scheme of the experimental pipeline from the infection assay to RNA-seq is given in Figure 2.1: 
HeLa-S3 cells are cultured according to the ENCODE guidelines and infected with S. 
Typhimurium following a previously published protocol from our group (Schulte et al., 2011). 
That is, cells which were seeded 2 d in advance are challenged with defined doses of S. 
Typhimurim that were grown to an OD600 of 2. Subsequently, the cells are centrifuged briefly to 
mediate pathogen/host cell contact and synchronize the infection event. After incubation for 30 
min at 37°C to allow invasion to occur, the remaining extracellular pathogens are killed by the 
addition of gentamicin. Invaded bacteria, however, are protected due to the host membrane 
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impermeability for the antibiotic. Samples are taken at defined time points after infection and 
fixed (see below). FACS-sorting is used to separate invaded and bystander cells, leading to the 
enrichment of Salmonella-infected cells and the resolution of the specific responses of extra- and 
intracellularly stimulated hosts. For a pilot experiment, RNA standards at a fixed concentration 
are added to the biological sample as an internal quality control (‘spike-in RNA’; see page 40). A 
sonication-based shearing step, that fragments RNAs into near uniform-length sizes in the range 
of 200-400 bp, is included to avoid transcript length biases during the downstream PCR 
amplification. Ligating RNA adapters to the fragmented transcripts in a defined orientation 
ensures that the resulting cDNA libraries are strand-specific. The barcode sequences used for 
multiplexing are introduced during PCR. The final cDNA libraries are sequenced on Illumina’s 
HiSeq 2000 platform (100 cycles; single-end mode) yielding ~100-150 M reads per lane. 
 
 
Figure 2.1|Experimental workflow established 
for the simultaneous transcriptome analysis of 
Salmonella-infected mammalian cells. HeLa-S3 
cells are infected with constitutively GFP-
expressing S. Typhimurium. At a given time point 
after infection, cells are fixed to preserve their 
transcriptome and sorted into the sub-populations 
of invaded (GFP-positive) and non-infected 
bystander cells (GFP-negative). From the resulting 
samples, total RNA is extracted and used to 
construct cDNA libraries. 
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Initially, HeLa-S3 cells were infected with a multiplicity of infection (m.o.i.) of 10, an infectious 
dose frequently used in the literature (e.g. Sittka et al., 2007). A thus infected HeLa culture was 
visualized by confocal laser scanning microscopy (CLSM) at 4 h post-infection (p.i.) (Fig. 2.2). 
This revealed that challenging HeLa-S3 with S. Typhimurium gives rise to a mixed population of 
infected (GFP-positive) and non-infected (GFP-negative) host cells, with the former usually 
containing more than just a single pathogen presumably reflecting multiple infection events. As 
predicted, gentamicin selectively killed extracellular pathogens (highlighted in the control by 
white arrows) whereas intracellular bacteria were unaffected. 
 
 
Figure 2.2|Fluorescence microscopy of HeLa-S3 infected with GFP-expressing S. Typhimurium. 
Cultures of HeLa-S3 cells were either infected with wild-type Salmonella (m.o.i. 10) or left uninfected. At 4 h 
p.i., chromosomal DNA was stained with the Hoechst dye and the cells were visualized by CLSM. The scale bar 
indicates 25 µm. 
 
To obtain detailed information on the respective fates of host and pathogen after infection, 
HeLa-S3 infectivity and cell death were monitored over a range of increasing bacterial doses 
(Fig. 2.3) and intracellular replication of invaded pathogens was traced over time (Fig. 2.4). On 
the host side, the infection rate largely depended on the m.o.i. as revealed by GFP-based flow 
cytometric analysis (Fig. 2.3a). When comparing the rate of infected HeLa-S3 cells for discrete 
m.o.i. values between 4 and 24 h p.i., a reduction in the relative amount of infected cells over 
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time was observed; in particular if high bacterial doses had been applied (m.o.i. ≥10). This 
discrepancy can be explained by an increase in cellular stress resulting in apoptosis (Fig. 2.3b) 
and necrosis (Fig. 2.3c). For the purpose of analyzing infection-associated gene expression 
patterns, unspecific processes (such as necrosis) should be avoided. As a consequence, a m.o.i. of 
5 was selected for further assays, thereby mostly preventing the induction of cell death upon 
infection. 
 
 
Figure 2.3|Measuring bacterial dose effects on host cell infectivity, apoptosis and cytotoxicity. HeLa-
S3 cells were infected with increasing doses of GFP-expressing S. Typhimurium (m.o.i. 0.05-100) for 4 h or 24 
h. a, The infectivity rate was determined by flow cytometry based on a positive GFP signal for infected cells. b, 
The rate of apoptotic cells was measured after Annexin V/propidium iodide staining by flow cytometry. c, 
Host cell cytotoxicity was determined by measuring the release of the cytosolic enzyme lactate dehydro-
genase (LDH) into the culture medium as a proxy for cell death. The maximum amount of cytotoxicity was 
defined by treating the cell culture with lysis buffer prior to the analysis. *: p <0.05; ***: p <0.001 (as 
compared to non-infected cells; one-tailed Student‘s t-test). The data reflect the mean +/- SD from biological 
triplicates. 
 
To trace intracellular replication, we developed a novel protocol for the rapid quantification of 
bacterial growth inside mammalian host cells (Fig. 2.4a): Briefly, infected host cells were 
analyzed by flow cytometry as described above, except that GFP intensity (rather than the 
relative proportion of GFP+ cells) was quantified in the invaded sub-population over time and 
compared to that immediately after infection (t = 0 h). In particular, the geometric mean in the 
histogram (GFP channel) for the GFP+ fraction was normalized against that of the non-infected 
fraction. The increase in normalized GFP intensity over time was used as a proxy for bacterial 
proliferation (see Methods section for further details). As shown in Figure 2.4b, the obtained 
kinetics matched well to those obtained from conventional plating assays. If infection was 
carried out at a m.o.i. of 5, intracellular replication of invaded bacteria was initially observed 
from ~4 h p.i. and reached its plateau around 20 h p.i. The subsequent decrease might be due to 
active killing by the host or – at least to some extent – reflect residual traces of host cell death 
even at this low bacterial dosage as indicated in the cytotoxicity measurements (Fig. 2.3c). 
a b c 
28 
 
Finally, based on the determined infection rate (Fig. 2.3a) with a m.o.i. of 5 at 4 h (5.48%) or 24 h 
p.i. (2.17%), respectively, and the amount of colony-forming units (c.f.u.) recovered from lysed 
host cells (Fig. 2.4b, inset), the average number of intracellular bacteria per HeLa cell at these 
two time points was estimated: 4 h p.i., i.e. at the time when intracellular replication is about to 
start, there were on average ten bacteria within each invaded cell. This number increases to ~75 
bacteria per infected cell at 24 h p.i. 
 
 
 
 
 
Figure 2.4|Tracking proliferation of intracellular S. Typhimurium using diverse methods. a, Flow 
cytometry was used to profile intracellular replication. To this end, gates for uninfected (blue) or invaded 
host cells (yellow) were defined in a dot plot of GFP vs. R-phycoerythrin (PE) channels (left panel), where GFP 
intensity reflects the amount of intracellular bacteria and PE is used as a proxy for a cell’s autofluorescence 
level. From the histogram in the GFP channel the geometric mean for each sub-population (x1, x2) was 
deduced. Normalizing the geometic mean of the invaded fraction (x2), that will increase over time as the 
bacteria replicate, to that of the uninfected cells (x1), that represents a constant, corrects for systematic 
technical errors and thus, smooths the curve of the replication kinetics (right panel). b, The normalized 
replication profile from the flow cytometry-based approach described in panel a was compared to the 
proliferation kinetics inferred from traditional plating assays. The inset illustrates the relative amount of 
intracellular bacteria at 4 h or 24 h p.i. compared to the amount of input bacteria. The data reflect the mean 
+/- SD from biological triplicates. 
a 
b 
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Together, the in vitro infection model of ENCODE-compatible HeLa-S3 cells and constitutively 
GFP-expressing S. Typhimurium was characterized into great detail and demonstrated to 
generate very reproducible results. Moreover, as a consequence of the fluorescent Salmonella 
strain used, gene expression changes in the two sub-populations of invaded and bystander host 
cells can be separately monitored. Finally, due to the selection of a relatively mild infectious dose 
and the resulting minimization of host cell death, the model reflects physiological conditions. It 
should therefore enable the identification of infection-associated gene expression programs in 
both organisms and consequently, shed light on the intimate interplay between host and 
pathogen on the transcriptomic level. 
 
2.2  Transcriptome fixation 
Infection under the conditions used above results in a rather small proportion of invaded (GFP-
positive) cells. GFP-based FACS can be applied to enrich this sub-population. As sorting is a time-
consuming process, however, cells should be fixed beforehand to freeze the transcriptomes at 
the time when the samples are taken. 
A suitable preservative for the given objective would meet two criteria. First, fixation should not 
affect RNA integrity/quality as a prerequisite for downstream analysis by RNA-seq and second, 
it should not interfere with GFP fluorescence as this parameter is the basis for FACS-based 
discrimination of host populations. Here, seven commonly used fixation methods were tested 
with regard to these two parameters (Fig. 2.5): Fixation with different concentrations of ethanol 
(EtOH) (Gillespie et al., 2002), the addition of ‘stop solution’ (i.e. 95% EtOH/5% phenol) 
(Eriksson et al., 2003), using the (NH4)2SO4-based reagent RNAlater (Qiagen), or different 
concentrations of paraformaldehyde (PFA) with or without 2% sucrose (W.-D. Hardt, personal 
communication). RNA quality of samples derived from these fixed cells was judged by capillary 
electrophoresis and compared to an unfixed control (Fig. 2.5a). Interestingly, the majority of 
fixation methods resulted in a characteristic fragmentation pattern of total RNA in accordance 
with previous findings (Cox et al., 2006). For instance, EtOH-mediated fixation led to a 
concentration-dependent increase in the fragmentation of the major eukaryotic ribosomal 
transcripts. In the given experimental setup, this would not necessarily be disadvantageous as 
the RNA samples are subsequently further fragmented prior to library generation. However, in 
addition to the concentration-dependency a time-dependent effect on fragmentation was 
observed (Fig. 2.5b). Due to this high degree of variability, we refrained from EtOH fixation. PFA 
treatment on the other hand, induces unspecific cross-linking of cellular RNA, DNA and protein. 
As a consequence, without reversal of the cross-link no RNA could be extracted (Fig. 2.5a). In 
contrast, when cross-linking was reverted by heating the samples for 15 min to 70°C as 
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proposed previously (Hamatani et al., 2006; Kuramochi et al., 2006), normal amounts of RNA 
could be isolated, however, the quality of such samples was severely impaired (Fig. 2.5a). 
Treatment with stop solution – which was developed for prokaryotic transcriptomes (Udekwu 
et al., 2005) – also negatively affected RNA quality. The only preservative that did not affect RNA 
integrity was RNAlater. 
 
 
Figure 2.5|Evaluation of different transcriptome fixation techniques. HeLa-S3 cells were infected with S. 
Typhimurium (m.o.i. 5) and cell samples were taken 4 h p.i. and analyzed. a, The influence of various 
preservatives on RNA integrity was evaluated using capillary electrophoresis for RNA samples extracted from 
differentially fixed samples. EtOH: ethanol; PFA: paraformaldehyde; sucr.: sucrose (2%). For PFA-fixed 
samples, the induced cross-link either was (+) or was not (-) reversed by heating the samples for 15 min at 
70°C before RNA extraction. In all cases fixation was performed overnight. Note that only eukaryotic rRNA 
bands are visible as the bacterial ones were too faint within the host background. b, Influence of the fixation 
period on RNA integrity. Cell samples were fixed in either EtOH or RNAlater for the indicated periods and 
RNA was analyzed as in panel a. c, The influence of fixation on GFP fluorescence was evaluated by 
determining the relative fraction of GFP-positive cells at different time points upon fixation (compared to 
unfixed samples). d, Increasing concentrations of RNAlater (diluted in PBS) reduce the amount of viable 
bacteria (black curve). The relative fraction of detectable GFP-positive cells is concentration-independent 
(grey). The data represent the mean from biological triplicates and error bars indicate +/- SD. 
 
a 
c 
b 
d 
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Furthermore, in contrast to a recently published report (Zaitoun et al., 2010), RNAlater did not 
seem to interfere with GFP fluorescence (Fig. 2.5c). In our hands, even when storing the cell 
samples for one week in RNAlater, the relative amount of detectable GFP-positive cells was 
unchanged. This does not hold for other fixation reagents which led to a decrease in the fraction 
of GFP-positive cells over time, such as EtOH (time- and concentration-dependent quenching in 
accordance to previous findings (Becker et al., 2012)) or stop solution (time-dependent 
quenching; likely due to the phenol contained in the mixture). 
To assess whether different fixation protocols influence the relative representation of major 
(pro- and eukaryotic) transcript classes, RNA samples analyzed in Figure 2.5a were converted 
into cDNA and sequenced. Indeed, the relative proportion of individual transcript classes was 
dependent on the fixation method used (Fig. 2.6), especially for the bacterial transcriptome 
(upper panel). EtOH treatment for instance, led to a marked reduction in the representation of 
bacterial ribosomal transcripts, while tRNAs accumulated upon fixation. Also mRNAs were 
slightly depleted upon both EtOH and PFA fixation. Surprisingly, despite the striking effects of 
most of the fixatives on human rRNA (in Fig. 2.5a,b bacterial ribosomal bands are not visible due 
the huge host background), the resulting human RNA-seq profiles were much more uniform 
than their bacterial counterparts. In summary, RNAlater again performed best as both the 
human and the bacterial RNA-seq profiles were virtually identical to those from the unfixed 
control.  
 
 
Figure 2.6|Global profile of RNAlater-fixed transcriptomes highly resembles those from unfixed cells. 
RNA samples derived from infected and differentially fixed HeLa-S3 cells (analyzed in Fig. 2.5a) were 
sequenced on Illumina’s HiSeq 2000 platform to ~10 M reads/sample. 
 
It was further determined if RNAlater treatment of infected host cells would also fix intracellular 
bacteria. As a proxy for effective fixation of invaded pathogens, the concentration of RNAlater 
that sterilized the sample was determined. Apparently a concentration of ≥80% was sufficient to 
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abolish growth of bacteria recovered upon host cell lysis (black graph in Fig. 2.5d). This 
indicates that when using RNAlater in this or higher concentration, the reagent perfuses the host 
cell and fixes the intracellular bacteria. In parallel, the potential influence of the RNAlater 
concentration on the detectable fraction of GFP-positive cells was evaluated (grey line in Fig. 
2.5d), but virtually no effect on this parameter was found. Together, for Dual RNA-seq analyses – 
at least in the context of the described infection model – RNAlater appears to be the best suited 
preservative as it was found to neither affect GFP fluorescence (Fig. 2.5c) nor RNA quality (Fig. 
2.5a,b) and is compatible with RNA-seq (Fig. 2.6). Note however, that RNAlater fixation is not 
necessarily the optimal choice for any infection model. With other cell types (especially certain 
primary cells or tissue samples), RNAlater treatment might be too harsh and eventually cause 
cell lysis. Thus, it is recommended to evaluate further fixation protocols in the future, especially 
in the context of systems based on primary cells and in vivo models. Note further that RNAlater-
fixed cells tend to clump. Thus, filtering the samples prior to sorting is essential in order to 
prevent from clogging the cell sorter. 
 
2.3  FACS-based enrichment of infected cells 
The fixed samples consisting of invaded (GFP-positive) and non-infected bystander cells (GFP-
negative) were subjected to FACS analysis. A typical FACS plot is depicted in Figure 2.7a (panel 
‘pre-sort’). In order to prevent cross-contamination, a conservative gating strategy was selected 
(i.e. leaving a gap between the two gates). To evaluate the purity of the thus sorted fractions, the 
resulting samples were re-analyzed using the same settings as prior to the sort (Fig. 2.7a, panel 
‘re-analysis’ and 2.7b). This revealed that the GFP-positive fraction also contained a small 
fraction of GFP-negative cells (~10-15%). Contaminations might be due to cell duplets 
consisting of GFP-positive and -negative cells that – as a consequence of the GFP signal detected 
– are sorted in the GFP-positive collection tube. Duplet discrimination, however, in this case is 
not useful as cell shape, size and granularity are heterogeneous and largely depend on the 
bacterial load per host cell and thereby singlets may not be easily distinguishable from duplets. 
Alternatively, GFP-negative cells in the GFP-positive fraction might have initially (i.e. pre-sort) 
contained intracellular bacteria but due to the mechanical forces applied during sorting, the 
plasma membrane might have been ruptured and the bacterial load been released. This is likely 
to be the case especially for the 24 h time point, when infected cells are densely packed with 
about 75 individual bacteria (see above) and are thus fragile. Consequently, at least some of such 
cells might not even be considered true contaminations at all. 
The GFP-negative sub-population on the other hand appeared highly pure (Fig. 2.7a, panel ‘re-
analysis’). To test whether this fraction indeed represents non-infected bystander cells, the ratio 
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of bacterial rfaH mRNA vs. human β-actin mRNA was quantified in sorted sub-populations (24 h 
p.i.) by qRT-PCR analysis (Fig. 2.7c). Indeed rfaH mRNA was hardly detectable in GFP-negative 
cells. As inferred from these data, GFP-positive samples are enriched for bacterial RNA by 
approximately 500 fold as compared to GFP-negative cells. Taken together, as supported by two 
independent methods, GFP-based cell sorting results in highly enriched sub-fractions of invaded 
and non-infected host cells, originating from the same starting culture. 
 
 
Figure 2.7|GFP-based separation of infected from non-infected HeLa-S3 cells by cell sorting results in 
a high enrichment of the sub-populations. a, Representative FACS plots of Salmonella-infected HeLa-S3 at 
4 h or 24 h p.i. (m.o.i. of 5). The percentage values indicate the relative proportion of GFP+ and GFP- cells 
prior to and after sorting. b, Representative fluorescence microscopy images of HeLa-S3 cultures infected for 
4 h prior to or after FACS enrichment. c, The purity of sorted cell populations was further assessed by qRT-
PCR on extracted total RNA samples from cells that had been infected for 24 h and were FACS-enriched. 
Salmonella rfaH mRNA serves as a proxy for the bacterial and β-actin mRNA for the human transcriptome. 
The mean +/- SD from biological triplicates is shown. 
 
a b 
c 
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The relative proportion of the bacterial transcriptome within the host background at distinct 
time points after infection was determined either prior to or after FACS-based enrichment of 
invaded cells (Fig. 2.8). For this purpose rfaH and β-actin mRNAs were again used as a proxy for 
the bacterial or human transcriptome, respectively. Because it was unknown whether these two 
transcripts are being expressed to a similar level in the context of their respective 
transcriptome, a dilution series of separately isolated S. Typhimurium and human total RNA was 
prepared (Fig. 2.8a). From the resulting trend-line equation the relative proportion of bacterial 
RNA within an infectious sample at different time points p.i. could be deduced (Fig. 2.8b, blue 
bars). Based on this estimation the relative proportion of the Salmonella transcriptome 
increases by ~7 fold from 4 h to 24 h p.i. (both for sorted and unsorted samples), reflecting 
intracellular replication kinetics (Fig. 2.4). In sorted fractions, bacterial RNA constitutes an 
estimated proportion of between ~0.3% (4 h p.i.) and ~2% (24 h p.i.) of the total RNA sample.  
 
 
Figure 2.8|Estimation of the fraction of bacterial RNA in the mixed host-pathogen transcriptome 
samples. a, A serial dilution of separately isolated Salmonella to HeLa-S3 total RNA was prepared and 
bacterial rfaH (relative to human β-actin) mRNA was quantified by qRT-PCR. b, The resulting trend-line 
equation from panel a was used to deduce the percentage of the Salmonella transcriptome within mixed total 
RNA samples from infected HeLa-S3 cells at different time points and with or without FACS-based enrichment 
of the invaded cells. Depicted is the mean +/-SD from three biological replicates. 
 
2.4  Computational challenges 
cDNA libraries were supposed to be sequenced on the Illumina HiSeq 2000 platform with ~100 
cyles in the single-end mode. A bioinformatics pipeline, based on the recently published 
READemption tool (Förstner et al., 2014), was compiled to meet the requirements of Dual RNA-
seq (Fig. 2.9). That is, raw reads were first quality-filtered and reads <20 nt were removed. The 
b a 
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remaining reads were next mapped simultaneously to the Salmonella and human reference 
genomes or the spike-in RNA sequence. Reads that could not be mapped to either reference 
sequence with an accuracy ≥90% were considered ‘not mappable’ and discarded. Likewise, 
reads that could be mapped to more than one reference genome were defined as ‘cross-
mappings’ and removed. The remaining reads mapped to only one reference sequence. Note 
however, that also these reads might map to multiple loci (but within the same genome). If a 
given read was mapped to n positions in the same genome, each of the annotated n genes to 
which a read was aligned was attributed with 1/n reads. The aligned reads can next be used to 
(1) calculate coverage plots that are visualized using the Integrated Genome Browser (IGB) 
(Nicol et al., 2009), (2) identify alternative splice patterns as well as circular transcripts (Doose 
et al., 2013), and (3) to call differential gene expression. In case of the latter, gene-wise read 
quantifications are calculated and used as input data for the DEseq tool (Anders and Huber, 
2010) to reveal gene expression changes between two conditions. Only transcripts that had been 
detected above a certain Reads per kilobase transcript per million mapped reads (RPKM) cut-off 
(see page 43) were included in the expression analyses. If applicable, differentially expressed 
genes can be put into a functional context via gene ontology (GO)-term analyses by analyzing 
KEGG (Kyoto Encyclopedia of Genes and Genomes) signaling pathways (Kanehisa et al., 2014) or 
using the Signal Pathway Impact Analysis (SPIA) tool (Tarca et al., 2009). 
 
 
Figure 2.9|Computational work-flow for Dual RNA-seq. Most steps in the mapping pipeline are based on 
the READemption tool (Förstner et al., 2014). File types are given in brackets. Note that spike-in RNA 
standards were included only for pilot Dual RNA-seq. 
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2.5  Defining the minimal material requirements for a Dual RNA-seq experiment 
The limiting steps in the Dual RNA-seq pipeline (Fig. 2.1) are prior to or during cDNA library 
generation. Due to the mild infectious dose and the resulting low infection rate (Fig. 2.3), 
collecting sufficient infected cells by cell sorting can be time-consuming. In order to be able to 
handle several samples in parallel the protocol had to be stream-lined. Therefore the minimal 
RNA amount required for Dual RNA-seq was empirically determined. GFP-positive cells were 
collected by FACS in decreasing amounts from 5x105 to 1x103, total RNA was isolated and 
subjected to the standard Dual RNA-seq protocol (Fig. 2.1). As expected, a positive linear 
relationship between the input number of cells and the RNA output was observed (Fig. 2.10a, 
blue line). In contrast, the relative proportion of mappable reads followed a switch-like curve 
(red graph in Fig. 2.10a): Whereas for an input cell number of 104 ~75% of the raw reads could 
be mapped, this fraction sharply declined with lower input amounts. Starting from only 103 cells 
resulted in >70% of non-mappable reads. Irrespective of the initial RNA amount, all cDNA 
libraries were adjusted to the same concentration prior to sequencing. This means that samples 
derived from low input RNAs were more extensively amplified by increasing the number of PCR 
cycles. As a result, the cDNA libraries for these samples were biased towards smaller fragments 
(Fig. 2.10b). The smallest fragments ran at a height of ~100 nt. Note however, that these 
fragments already contained the poly(A) stretch that had been ligated prior to reverse 
transcription. 
The quality of reads derived from low input samples decreased markedly at their 3’ end (Fig. 
2.10c). This might be an indication for homo-polymers, which are considered to hamper the 
Illumina sequencing reaction. In fact, the relative adenine content in the raw sequencing data 
(i.e. prior to poly(A) trimming) describes a similar switch-like curve as – although it anti-
correlates with – the proportion of mapped reads (grey line in Fig. 2.10a): For samples derived 
from ≥104 cells the relative fraction of adenines is around the expected 25% but it rapidly 
increases to up to 50% in less input samples. Hence, it seems as if for samples with <100 ng of 
input RNA the increasing numbers of PCR cycles would bias towards the smallest fragments of 
~100 nt of which a considerable fraction represents 3’ oligo(A) stretches. Despite poly(A) 
stretches being clipped computationally prior to the mapping process, many of the remaining 
sequences are presumed too short (i.e. <20 nt) to pass the length filter and thus, discarded (Fig. 
2.9). Based on these findings, a minimal RNA amount of ~100 ng (corresponding to ~1x104 
infected HeLa-S3 cells) would be needed for Dual RNA-seq. These requirements should allow for 
the parallel processing of multiple samples. 
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Figure 2.10|Minimal material requirements for Dual RNA-seq. Salmonella-infected HeLa-S3 cells were 
harvested at 4 h p.i. in decreasing amounts from 5x105 to 1x103. Total RNA was extracted and the amount 
measured (blue graph in panel a; logarithmic scale). RNA was reverse transcribed and the resulting cDNA 
samples were PCR-amplified to the same amount (b). The resulting cDNA libraries were analyzed by capillary 
electrophoresis and pooled in an equimolar ratio prior to sequencing on Illumina’s HiSeq 2000 (~20-30 M 
reads/library). The proportion of reads that could be mapped to the human or Salmonella reference genome 
as well as the proportion of adenine (A) nucleotides were determined for each sample (panel a; red or grey 
graph, respectively; linear scale). The red dotted line denotes 1x104 cells. c, Sequencing quality depends on 
the amount of input cells. For each sample, phred scores (as a measure of sequencing quality) were plotted on 
the y-axis and the relative position of the respective base within the 100 bp read is plotted on the x-axis. The 
decrease in phred scores at the 3’ end anti-correlates with the proportion of A nucleotides (grey line in panel 
a) suggesting homo-polymers might hamper Illumina sequencing.  
 
 
a b 
c 
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2.6  A proof-of-principle experiment 
Three independent biological replicates from two defined time points after HeLa-S3 infection 
with S. Typhimurium (m.o.i. 5) were sequenced to moderate depth (i.e. ~20-35 M 
reads/sample). Each experiment was comprised of eight individual samples (Fig. 2.11; Tab. 2.1). 
These included two in vitro grown Salmonella reference controls from rich medium without 
(‘LB’) or upon medium shift from LB into the host cell medium and incubation therein for 
another 15 min at room temperature (‘DMEM’). This was done as previous studies indicated that 
shifting bacterial cultures from LB to the host cell medium in which the infection assay will take 
place, affects global gene expression in the bacterium (e.g. Blair et al., 2013; Hautefort et al., 
2008). For instance, due to the low iron content of mammalian cell culture media such as DMEM, 
numerous bacterial iron transporter genes are typically induced in tissue culture medium 
(Hautefort et al., 2008). Therefore, in order to be able to distinguish between gene expression 
changes associated with different culture conditions and true infection- and intracellular 
lifestyle-specific gene expression programs, both medium controls were included in the analysis. 
A previous comparative study indicated that following common column-based extraction 
methods (e.g. via the RNeasy kit) short RNA species tend to become lost, whereas phenol-based 
reagents (e.g. TRIzol) bias against longer transcripts (Stead et al., 2012). TRIzol extraction has 
further been reported to deliver RNA in low yield for some bacterial species (Jahn et al., 2008). 
Thus, these methods seemed non-ideal for Dual RNA-seq experiments. Rather total cellular RNA 
was isolated using the mirVana RNA isolation kit – a procedure optimized to recover all types of 
RNA, including small and large RNA species. 
Since the mirVana isolation protocol was optimized for mammalian cells it was necessary to 
prevent potential biases when extracting RNA from bacteria. Therefore, rather than isolating 
RNA from pure Salmonella samples, the ratio of bacteria to human cells was maintained by 
supplementing the Salmonella lysates with lysates from HeLa-S3 cells before RNA extraction 
(see Methods section). Early (4 h p.i.) and late infection time points (24 h p.i.) were taken, each 
of which was split into invaded cells and non-infected bystanders via FACS. As a reference 
control for the host side mock-infected HeLa cells were included for each time point and sorted 
for the GFP-negative fraction to ensure equal treatment between infected and naïve cells. Early 
time points were sequenced to an overall greater depth (~35 M reads/library) than the later 
ones (~25 M reads/library) to account for the expected lower fraction of Salmonella RNA in the 
early samples. 
 
39 
 
 
 
 
Table 2.1|cDNA libraries analyzed in the Dual RNA-seq pilot experiment.  
# library name Salmonella strain host cell type time point total reads replicates 
 1 0 h WT LB  WT HeLa-S3 (as carrier RNA)  0 h  ~25 M  3 
 2 0 h WT DMEM  WT HeLa-S3 (as carrier RNA)  0 h  ~25 M  3 
 3 4 h mock GFP-  - HeLa-S3  4 h  ~25 M  3 
 4 4 h WT GFP+  WT HeLa-S3  4 h  ~25 M  3 
 5 4 h WT GFP-  WT HeLa-S3  4 h  ~25 M  3 
 6 24 h mock GFP-  - HeLa-S3  24 h  ~25 M  3 
 7 24 h WT GFP+  WT HeLa-S3  24 h  ~25 M  3 
 8 24 h WT GFP-  WT HeLa-S3  24 h  ~25 M  3 
 9 0 h WT LB  WT THP-1 (as carrier RNA)  0 h  ~25 M  1 
10 0 h WT DMEM  WT THP-1 (as carrier RNA)  0 h  ~25 M  1 
11 4 h mock GFP-  - THP-1  4 h  ~25 M  1 
12 4 h WT GFP+  WT THP-1  4 h  ~25 M  1 
13 4 h WT GFP-  WT THP-1  4 h  ~25 M  1 
14 24 h mock GFP-  - THP-1  24 h  ~25 M  1 
15 24 h WT GFP+  WT THP-1  24 h  ~25 M  1 
16 24 h WT GFP-  WT THP-1  24 h  ~25 M  1 
 
 
Even though technical reproducibility for RNA-seq was initially claimed to be high (e.g. Marioni 
et al., 2008; Mortazavi et al., 2008) more recent studies recommend the use of internal 
references that allow for inter-experimental comparison (e.g. McIntyre et al., 2011). For that 
reason biological samples were supplemented with synthetic spike-in RNAs (Jiang et al., 2011). 
In particular, two distinct spike-in RNAs with equal length but different GC-content (spike #1 
and #2; see Methods section), were evaluated for their suitability in the Dual RNA-seq approach 
(Fig. 2.12). Both sequences were computationally tested to be absent from both the Salmonella 
and human genome. Both standards behaved linear within the tested range, i.e. an increased 
input concentration of spike-in RNA resulted in a higher read number mapped to the spike-in 
Figure 2.11|Experimental overview of pilot 
Dual RNA-seq. Two time points after Salmonella 
infection of HeLa-S3 cells were sampled. Infected 
host cells were separated from non-infected cells 
from the same culture by FACS. Mock-treated 
control cells at both time points sorted for the GFP-
negative fraction served as a host reference. As 
pathogen controls, extracellular Salmonella were 
grown in LB to an OD600 of 2 and either were or 
were not shifted to host cell DMEM medium. 
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sequence (Fig. 2.12). Importantly however, spike #1 (but not spike #2) sequestered only a 
minor fraction of the total sequencing reads meaning that the vast majority of reads was still 
mapped to the biologically relevant sequences (i.e. the two genomes). The relatively high 
occurrence of spike #2 might be due to the identity of its first nucleotide (a cytosine; see 
Methods) which has been considered a preferred substrate for the T4 RNA ligase that is used for 
library construction (Romaniuk and Uhlenbeck, 1983; Stark et al., 2006). In conclusion, spike-in 
#1 appears to be well suited for the given assay system and thus, was added to each of the RNA 
samples of the pilot experiment (see Fig. 2.1). 
 
 
Figure 2.12|Spike-in RNA standards are used as an internal quality measure of Dual RNA-seq. 
Mapping statistics for total RNA samples that had been supplemented with different concentrations of 20 nt-
long synthetic RNA standards (spike #1 and #2; see Methods section for details). Right panel: Magnification 
of the obtained read distribution for spike #1. 
 
With a median length of ~96 nt (Fig. 2.13a), sequencing reads came close to the maximum of 
100 nt. The quality-filtered sequencing reads from the two time points after infection were 
simultaneously mapped against the human (hg19 – hs37d5 annotation) and Salmonella 
(NC_016810.1) reference genomes, the three Salmonella virulence plasmids (NC_017718.1, 
NC_017719.1, NC_017720.1), as well as against the spike-in RNA sequence (spike-in #1). Only a 
minor fraction of reads could be mapped to both genome sequences and their fraction decreased 
with increasing mapping stringency (Fig. 2.13b). Based on these findings, an accuracy threshold 
of ≥90% was applied and the ‘cross-mapped’ reads below that criterion were discarded and not 
included in the downstream analyses. 
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Figure 2.13|Read length distribution and cross-mapping reads. a, Mean and median length of raw 
sequencing reads. b, A minor fraction of reads could be mapped to both reference genomes. Their relative 
amount compared to the total mapped reads is shown for different accuracy cut-offs. Data from the three 
replicates are shown. 
 
As shown in Fig. 2.14 for representative libraries, by using these settings the discriminatory 
power of Dual RNA-seq was very high. That is, reads that could be mapped against the 
Salmonella genome (green fractions in Fig. 2.14) were almost exclusively detectable in libraries 
derived from invaded HeLa-S3 cells while being almost undetected in those derived from non-
infected bystander or uninfected control cells. This highlights the stringency of parallel read 
mapping for the Salmonella/human model system. Furthermore, in line with intracellular 
bacteria undergoing replication over time, a higher proportion of Salmonella-derived reads were 
detected in the 24 h samples compared to the 4 h samples (~2% Salmonella reads at 4 h p.i. and 
~10% at 24 h p.i.; Fig. 2.14). In particular, between 0.5 M and 3 M Salmonella-mapped reads 
were obtained. With a median read length of 96 nt (Fig. 2.13a), this corresponds to 10-58x 
genome coverage. The increase in Salmonella reads over time matched the relative increase of 
Salmonella RNA in the mixed samples as predicted from qRT-PCR measurements (7 fold 
increase from 4 h to 24 h p.i.; Fig. 2.8b). On the other hand, the relative fractions of Salmonella to 
human reads in the GFP-positive samples (Fig. 2.14) were slightly higher than predicted (Fig. 
2.8b). This suggests either a marginal preference for bacterial over human RNA fragments 
during cDNA library generation or that the qRT-PCR-based estimation slightly underestimates 
the relative fraction of Salmonella RNA. Nevertheless, even in libraries derived from infected 
cells (Fig. 2.14) the vast majority (~90-99%; i.e. ~20-35 M reads summing up to ~0.6-1.1x 
genome coverage) of mapped reads corresponds to the human transcriptome. The fraction of 
reads that mapped to the spike-in sequence was relatively constant in all samples indicating 
uniform sequencing (Fig. 2.14). 
 
a b 
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Figure 2.14|Overview of Dual RNA-seq mapping statistics. Upper: Sequencing reads can be stringently 
assigned to their respective genome or the spike-in sequence. Lower: Dual RNA-seq captures all major RNA 
classes of bacterial and mammalian organisms. Representative results from one out of the three biological 
replicates are shown. 
 
Most importantly, all of the major bacterial and human transcript classes were detected in the 
Dual RNA-seq data (Fig. 2.14, lower part). In the case of the Salmonella data subset, the majority 
of mapped reads (61% in the 4 h sample; dark grey in Fig. 2.14) accounted for ribosomal 
transcripts. As ribosomal RNA has not been actively depleted, this indicates that in accordance 
with previous studies (e.g. Sharma et al., 2010) rRNA has a lower conversion efficiency than less 
structured RNA classes such as mRNAs (9-17%; blue in Fig. 2.14) and sRNAs (3-6%; red), which 
were readily detectable in the libraries. Strikingly, at 24 h p.i. the vast majority of bacterial reads 
were mapped to tRNAs, while only a minor proportion were rRNA-derived. This might reflect 
the reduction in metabolic activity of intracellular Salmonella at the late time point (see also Fig. 
2.4b). In agreement with previous studies (e.g. Kroger et al., 2012), reads derived from 
Salmonella anti-sense transcripts (yellow) and intergenic regions (white) were lowly abundant. 
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On the host side, again fewer than expected reads were derived from ribosomal transcripts 
(~40%; dark grey in Fig. 2.14) and almost no reads mapped to tRNAs. This indicates that the 
human counterparts of these house-keeping transcripts also have lower conversion rates into 
cDNA than mRNAs and regulatory non-coding RNA species. Of note, in the present context such 
under-representation is considered beneficial as it favors sequencing without prior rRNA 
depletion (as proposed in Westermann et al., 2012). In contrast, more informative human RNA 
classes such as mRNAs (12-18%; blue in Fig. 2.14), lncRNAs (11-13%; red) and to lesser extent 
miRNAs (0.1-0.2%; orange) were well covered in the datasets. In conclusion, Dual RNA-seq is 
able to discriminate between host-pathogen transcriptomes and captures all relevant RNA 
classes – both coding and non-coding – from two organisms with radically different 
transcriptome structures. 
In order to find the best suited cut-offs for differential gene expression analyses, RPKM values 
for the individual Salmonella and human transcript classes were calculated (Fig. 2.15). On the 
bacterial side, the average RPKM of mRNAs was ~20 and that of sRNAs >100. Human mRNAs as 
well as miRNAs were detected with an average RPKM of ~1, while that of lncRNAs was markedly 
lower, in agreement with previous studies describing that coding genes are generally higher 
expressed than lncRNA genes (Dunham et al., 2012). The classes of snRNAs and snoRNAs gave 
rise to an average RPKM of ~0.1 or 10, respectively. Based on these values, we defined the 
following thresholds for individual RNA classes: For Salmonella mRNAs or sRNAs, candidates 
that exceed a RPKM of 10 or 20, respectively, were considered expressed. For human mRNAs 
and miRNAs a RPKM cut-off of 0.5 and for lncRNAs a cut-off of 0.1 was set. 
 
 
Figure 2.15|RPKM distribution. For the relevant bacterial (a) or human (b) transcript classes, respectively, 
RPKM distributions are depicted. The end lines of the box plot indicate the 25 and 75 percent quantiles and 
the vertical line denotes the median RPKM. 
a b 
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Reproducibility of the Dual RNA-seq method was evaluated by comparing sequencing data 
between triplicate experiments. Normalized read counts for detected Salmonella (mRNA and 
sRNA) or human transcripts (mRNA, lncRNA, miRNA), respectively, were plotted pair-wise 
between all biological replicates (Fig. 2.16). Reproducibility of individual transcript detection 
was found to be high, both for the Salmonella (r = 0.91-0.99) and human datasets (r = 0.94-0.98). 
Given this high reproducibility, the data from the three replicates were pooled. In doing so, ~1.5-
9 M mapped Salmonella reads (30-180x genome coverage) and ~60-100 M mapped human 
reads (2-3x genome coverage) were obtained. 
 
 
Figure 2.16|Reproducibility of Dual RNA-seq. For the 4 h time point and the respective controls the 
normalized read counts for each detected transcript (mRNA, lncRNA, miRNA, sRNA) were plotted between 
biological replicates (log2 scale). 
 
2.7  Salmonella gene expression changes revealed by Dual RNA-seq 
2.7.1 Impact of culture medium on Salmonella gene expression 
To perform differential gene expression analyses in intracellular vs. extracellular Salmonella we 
first sought a relevant reference control. In particular, RNA was collected from extracellular 
bacteria either in rich LB medium or in host cell DMEM (Fig. 2.11). When comparing gene 
expression levels in the two media substantial differences were observed (Fig. 2.17). For 
instance, according to previous studies (e.g. Hautefort et al., 2008) iron transporter genes (e.g. 
fepD (Tsolis et al., 1995)) were strongly activated upon medium transfer to DMEM as were the 
cold-shock-induced genes lpxP (Carty et al., 1999) and cspA (Jeffreys et al., 1998). Likewise, 
expression levels of sRNAs were strongly affected by the medium shift. Note however, that while 
several sRNAs that were subsequently identified to be up-regulated inside the host cell (MicL, 
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RyhB, IsrE, RybB) were already induced in DMEM itself, STnc440 was in fact down-regulated 
indicating that its high induction upon host cell entry (see below) is not related to the infection 
medium. Together, based on these findings extracellular Salmonella in DMEM were chosen as 
reference control for all further comparisons. If the LB sample would be used instead, one would 
have to dissect two overlaying gene expression programs – one triggered in response to metal 
ion limitation in the host cell medium and the one to the adaptation to an intracellular lifestyle. 
 
 
Figure 2.17|Influence of the medium shift on Salmonella gene expression. Salmonella was grown in LB 
to an OD600 of 2 and then transferred to DMEM. RNA-seq was performed on samples either before or after the 
transfer. The ten most strongly induced or repressed mRNAs (a) or sRNAs (b) in DMEM compared to LB are 
shown. Biological triplicates were considered. 
 
In vivo, Salmonella invades two major cell types, epithelial cells and monocytes/macrophages. To 
assess the differences and similarities in Salmonella expression programs triggered during the 
infection of these fundamentally different cell types, the analysis was extended to a second 
human model cell line. In addition to the infection of epithelial HeLa-S3 cells (biological 
triplicates) we included samples taken 4 h or 24 h after infection of monocyte-like, non-
differentiated THP-1 cells (single replicate) (Fig. 2.18). 
 
 
a b 
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Figure 2.18|Pathogen dose effects on infectivity and cell death of human THP-1. Analogous to Fig. 2.3. 
For all further experiments with THP-1 cells, a m.o.i. of 10 was used for infection. 
 
2.7.2 Virulence gene expression during infection 
During infection of HeLa-S3 cells Salmonella show a biphasic pattern of virulence gene 
expression (Schlumberger and Hardt, 2006): As invasion of non-phagocytic cell types such as 
epithelial HeLa-S3 is T3SS-1-mediated, SPI-1 genes should be induced early during the process, 
i.e. already in extracellular Salmonella. For example, previous work reports SPI-1 activation 
when Salmonella were grown to late exponential/early stationary phase in vitro (Kroger et al., 
2012, 2013). In contrast, the T3SS-2 is required to establish the intracellular lifestyle and 
consequently SPI-2 genes are activated only after host cell invasion at a time when SPI-1 is 
already repressed to basal levels. Here, relative expression levels of SPI genes were monitored at 
the two time points after HeLa-S3 invasion (Fig. 2.19a). Indeed, while SPI-2 genes were strongly 
induced inside the host cell niche at both time points, SPI-1 genes were down-regulated 
compared to their extracellular levels, especially at 24 h p.i. Interestingly, similar expression 
patterns of SPI genes were found after infection of monocytic THP-1 cells (Fig. 2.19b): Again SPI-
2 genes were generally induced post-invasion and SPI-1 genes suppressed. However, full de-
activation of SPI-1 was already observed at the early time point, suggesting either a fast shut-off 
of invasion genes after host cell internalization or that Salmonella may invade this cell type in a 
T3SS-1-independent manner. A second major difference between the two infections concerned 
the avrA gene, whose expression was rapidly down-regulated upon invasion of HeLa-S3 but 
induced upon THP-1 invasion. Since avrA encodes a translocated effector acetyltransferase with 
immune-suppressive functions (Hardt and Galan, 1997), its differential expression between 
epithelial and monocytic cells might reflect distinct requirements for interfering with cell type-
specific host defense mechanisms. 
 
a b c 
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Figure 2.19|Salmonella virulence gene expression patterns in different host cell types. Relative gene 
expression changes of the detected SPI-1 or SPI-2 genes at different time points after infection of HeLa-S3 (a) 
or THP-1 cells (b) compared to the extracellular reference control (‘DMEM’). 
 
Three further pathogenicity islands of S. Typhimurium (SPI-3/-4/-5) are known to be involved 
in virulence (Fabrega and Vila, 2013). However, these have been studied in much less detail than 
SPI-1 and -2. For example, only little is known about their intracellular expression status. Here 
inside both cell types SPI-5 seemed to follow similar kinetics as SPI-2 (Fig. 2.20), i.e. genes from 
both islands were intracellularly induced. In agreement with previous findings that reported a 
co-regulation of SPI-4 with invasion genes (Gerlach et al., 2007), SPI-4 expression was rapidly 
shut off after invasion, thereby resembling the expression kinetics of SPI-1 factors. Genes from 
SPI-3 displayed a bipartite expression pattern: The mgt operon was strongly activated inside 
both cell types according to previous reports (BlancPotard and Groisman, 1997; Hautefort et al., 
2008), whereas other SPI-3 genes were repressed. In summary, characteristic expression 
signatures of virulence genes fit the dogma of SPI-1 genes being required for host cell invasion 
and SPI-2 genes for intracellular survival and replication, thereby providing proof-of-principle 
for Dual RNA-seq to reliably capture Salmonella’s intracellular gene expression changes. 
Moreover, the approach yielded insights into the intracellular expression levels of the under-
studied SPI-3, -4 and -5 loci.  
 
a b 
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Figure 2.20|Expression of genes from pathogenicity islands SPI-3 to SPI-5. Analogous to Fig. 2.19. Grey 
shaded boxes mean that the respective transcript was not detected in at least one of the three time points. 
 
Another hallmark of bacterial invasion is the frequent modification of cell wall LPS to counter-
act PAMP sensing by host PRRs (e.g. Guo et al., 1997; Matsuura et al., 2012; Paciello et al., 2013). 
This occurs because in such cases the intracellular LPS form is hardly sensed by host receptors 
and thus the modification facilitates the evasion of the host’s immune response and becomes 
important predominantly in the context of chronic infections. Besides LPS, lipoproteins 
represent a second integral component of the outer membrane of Gram-negative bacteria. 
Salmonella carries two functional copies of the lipoprotein gene in its chromosome (lppA and 
lppB). Interestingly, Dual RNA-seq reports a switch from lppA to lppB expression during the 
course of infection of HeLa-S3 cells (Fig. 2.21). It is therefore tempting to speculate that in 
addition to the modification of the LPS component lipid A (Guo et al., 1997; Matsuura et al., 
2012), Salmonella has evolved mechanisms to ensure contextual expression of its different 
lipoprotein variants during infection what might further contribute to the evasion from host 
recognition. Note that due to the lower sequencing depth, lpp expression was not detected in 
THP-1 infections. 
 
        
Figure 2.21|A switch in lpp expression upon HeLa-
S3 invasion. Differential expression of lppA (black) 
and lppB (red) mRNAs over the indicated conditions 
(relative to the DMEM reference control). 
 
a b 
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2.7.3 Salmonella encounters various stresses inside its host cell niche, which are reflected in its gene 
expression profile 
The obtained Dual RNA-seq data can further provide information on the different types of 
stresses Salmonella faces within its host cell niche. For instance, after infection of both HeLa-S3 
and THP-1 cells, changes in the expression of genes involved in the response to iron (e.g. 
induction of iro mRNAs as well as RyhB and IsrE sRNAs (Masse and Gottesman, 2002)) and 
magnesium limitation (mgtB) were observed (Fig. 2.22a). This correlates with previous findings 
(Hautefort et al., 2008; Ortega et al., 2012) and indicates that iron and magnesium deficiency are 
generic sources of stress that intracellular Salmonella has to cope with irrespective of the host 
cell type.  
 
 
Figure 2.22|Metal ion scarcity and membrane stress are reflected in the transcriptome of 
intracellular Salmonella. a, Expression of genes involved in iron or magnesium uptake. Undetected genes in 
the THP-1 infection experiment are grey-shaded. b, Regulation of genes implicated in the σE response to cell 
surface stress. 
 
Besides metal ion deficiency, hallmarks of the envelope stress response were observed in the 
Dual RNA-seq data – predominantly inside monocytic cells (Fig. 2.22b): For example, the σE-
encoding rpoE mRNA itself, the σE-dependent rse operon and σE-dependent sRNAs such as RybB, 
a b 
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MicA and MicL (Guo et al., 2014; Hobbs et al., 2010; Papenfort et al., 2006) were induced upon 
THP-1 invasion. At the same time numerous omp mRNAs, which are major targets of σE-
activated sRNAs (Rhodius et al., 2006), were rapidly down-regulated. It is tempting to speculate 
that activation of the σE response and the resulting suppression of multiple outer membrane 
proteins might represent another immune evasion strategy of Salmonella. Moreover, this type of 
adaptation seems predominantly important inside monocytes, which express a wide range of 
cytosolic PRRs (Takeshita et al., 2004; Zhao et al., 2007). 
At the late time point of infection, invading Salmonella no longer proliferated (Fig. 2.4b). This 
was reflected in the composition of their transcriptome (Fig. 2.14). For instance, 24 h after HeLa-
S3 infection (but not that of THP-1; not shown) a massive increase in the fraction of reads 
mapped to tRNAs was observed, whereas rRNAs were lowly abundant (Fig. 2.14). Closer 
inspection of the most abundantly detected transcripts revealed the three initiator tRNAs-fMet 
(tRNA051, -052 and -056) to be the source of the increase. The coverage plots of these RNAs 
revealed a sharp decline in the profiles near the center of the annotated tRNA gene (indicated by 
red arrows in Fig. 2.23a), pointing at a processing event. Interestingly, cleavage was found to be 
specific to initiator tRNAs since elongator tRNAs were not affected as validated by Northern blot 
(Fig. 2.23b). tRNA-fMet processing seems not to be specific to Salmonella growing inside HeLa-
S3. Rather extracellular Salmonella growing to stationary phase in LB likewise displayed tRNA 
cleavage (Fig. 2.23c), suggesting it might be a generic feature of bacteria reaching a certain cell 
density. In addition, cleavage was also observed for Salmonella that had been treated for 4 h 
with high concentrations of gentamicin (Fig. 2.23d). As this antibiotic acts by targeting the 30S 
subunit of bacterial ribosomes to prevent mRNA translation, the observed effect might indicate 
that at the late infection time point traces of the antibiotic reached the host cell cytosol. 
Initiator tRNA cleavage has previously been described in Salmonella and shown to be in part 
mediated via the toxin/anti-toxin system (TA system) VapB/C (Winther and Gerdes, 2011). 
Here, while the abundance of vapC mRNA increased over time (Fig. 2.23e), in the present case 
deletion of vapB/C from the Salmonella genome did not significantly affect tRNA-fMet cleaving 
(Fig. 2.23f, g). Together this indicates that initiator tRNA processing in intracellular Salmonella 
during the late infection stages might be caused by diverse bacterial stresses, such as a high cell 
density or gentamicin traces reaching the host cell’s cytosol. However, as processing was still 
seen for the respective deletion mutant, VapB/C is unlikely to be the major player in this context. 
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Figure 2.23|High bacterial cell densities and gentamicin concentrations are accompanied by initiator 
tRNA cleavage. a, Coverage plots for individual tRNA loci in the Salmonella genome. tRNA0051, -52 and -56 
encode initiator tRNA (tRNA-fMet) and tRNA0020 is an elongator tRNA (tRNA-Ser). Transcript annotations 
are depicted below the coverage plots. Red box: Magnification of one of the tRNA-fMet and the tRNA-Ser loci. 
Red arrows indicate the position of a cleavage event for tRNA-fMet. b, Northern blot analysis of RNA samples 
isolated from Salmonella-infected HeLa-S3 cells at different time points using a radio-labeled DNA probe 
against the 5’ end of initiator tRNA-fMet or elongator tRNA-Ser. Salmonella 5S rRNA serves as loading 
control. c, Analogous Northern analysis of RNA samples from in vitro-grown Salmonella (in LB). d, In vitro-
growing Salmonella were treated for 4 h with gentamicin in the indicated final concentrations prior to RNA 
isolation and Northern analysis as before. e, Dual RNA-seq data reveals an induction of Salmonella vapC 
mRNA at 24 h p.i. Shown is the mean +/- SD from the triplicate experiment. f, g, Wild-type Salmonella (WT) 
or a vapB/C deletion mutant were grown overnight in LB medium (f) or treated for 4 h with 50 µg/mL of 
gentamicin (g) prior to RNA extraction and Northern blot analysis. 
 
 
 
a 
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2.7.4 sRNA expression profile of intracellular Salmonella 
Many sRNAs were identified to be strongly regulated during infection (Fig. 2.24a,b). To confirm 
Dual RNA-seq-based gene expression profiling of intracellular Salmonella by unrelated methods, 
four of the induced sRNAs were selected for independent qRT-PCR experiments: The well-
characterized Salmonella sRNAs RyhB (Masse and Gottesman, 2002) and RybB (Balbontin et al., 
2010; Papenfort et al., 2006) were chosen as representative for a highly (>100 fold) or slightly 
(~2 fold) induced sRNA. In addition, STnc440 – a previously validated (Sittka et al., 2008) but 
poorly characterized sRNA – was included as was a computationally predicted candidate sRNA, 
STnc510. The latter two showed very similar expression patterns with ~100-150 fold induction 
at 4 h p.i. in HeLa-S3 and ~30-50 fold induction in THP-1. These sRNAs were well covered with 
sequencing reads (Fig. 2.24c), and qRT-PCR measurements validated their observed up-
regulation (Fig. 2.24d). Importantly, the approximate fold-changes of induction were very 
similar among the two methods (Fig. 2.24d). In the qRT-PCR data, STnc440 was induced by 
~139 fold at 4 h p.i. (compared to ~143 fold in Dual RNA-seq) and RybB by ~5 fold (compared 
to 2 fold). One of the largest discrepancies between the two methods (39 vs. 119 fold) was 
observed for RyhB. This over-estimation by deep-sequencing might be due to the low abundance 
of the RyhB sRNA in the extracellular control (i.e. only 22 or 50 cumulated reads for the replicate 
LB or DMEM libraries, respectively) (Fig. 2.24c). If this would be the reason then such obstacles 
may be solved simply by increasing the sequencing depth. Indeed, when sequencing deeper the 
resulting fold-change in RyhB induction was similar to that deduced from qRT-PCR experiments 
(see the third chapter of this study). 
Besides these validated sRNAs, bioinformatically predicted sRNA candidates are also included in 
our annotation (Förstner et al., unpublished). The latter, however, have not yet been manually 
confirmed as bona fide sRNAs. One such candidate that was strongly induced after invasion was 
STnc510 (Fig. 2.24). However, closer inspection of STnc510 indicated that it may represent a 
non-annotated 5’ UTR of the downstream pagC coding gene rather than a true sRNA (Fig. 2.24c). 
In fact, STnc510 was always co-expressed with pagC and with a size of 810 nt it would be 
atypically long for a bona fide sRNA. Thus, STnc510 was discarded from the list of Salmonella 
sRNAs for the following analyses.  
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Figure 2.24|Intracellular sRNA expression profiles. a,b, Dual RNA-seq-based sRNA expression changes 
during infection of HeLa-S3 (a) or THP-1 cells (b). Depicted are sRNAs which are referred to in the main text. 
Note that not all of the sRNAs depicted in panel a were detected inside THP-1 cells and thus, some genes are 
missing in panel b. c, Coverage plots for the four selected sRNAs. Annotated transcripts are shown at the 
bottom of the coverage plots. Depicted are the read distributions from a representative replicate experiment. 
d, Independent validation of Dual RNA-seq results (left panel) by qRT-PCR (right) for the expression of the 
same four sRNAs inside HeLa-S3. The data represent the mean +/- SD from biological triplicates. 
a b 
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2.7.5 Global overlap between Salmonella gene expression inside epithelial and monocytic cells 
The above described results revealed several specific differences between Salmonella gene 
expression inside epithelial and monocytic cells. For instance, the opposing expression of the 
virulence gene avrA (Fig. 2.19), the exclusive tRNA cleavage inside HeLa-S3 (Fig. 2.23) or a full σE 
response only within THP-1 (Fig. 2.22b) are prominent host cell type-specific differences. 
Overall, however, there seemed to be a surprisingly huge overlap in Salmonella gene expression 
profiles between the infections of epithelial and monocytic cells. To address whether these 
similarities reach beyond the manually inspected cases, a global overlap between differentially 
(≥2 fold) regulated mRNAs or sRNAs after HeLa-S3 or THP-1 infection was determined (Fig. 
2.25). This revealed a slightly greater overlap in sRNA (38-55%) than in mRNA expression (15-
49%). Interestingly, gene expression of intra-epithelial and intra-monocytic Salmonella was 
more similar at the later time point than early after invasion, and this was true both for mRNAs 
(4 h: 15%; 24 h: 33-49%) and sRNAs (4h: 38-41%; 24h: 55%). This may indicate that more 
specific gene sets are expressed to initially adapt to the respective host environment, whereas 
during the late infectious stages relatively similar expression programs are elicited in either cell 
type. In general, however, the commonalities between Salmonella inside epithelial and 
monocytic cells indicate that a core set of genes is required to establish and maintain the 
intracellular lifestyle. 
 
Figure 2.25|Overlap in Salmonella gene expression between the infection of epithelial and monocytic 
cells. Shown are all detected mRNAs and sRNAs that were regulated (≥2 fold) under at least one condition. 
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In summary, using the Dual RNA-seq approach previously reported gene expression programs 
could readily be recapitulated. In addition, global communalities as well as host cell type-specific 
changes in Salmonella gene expression were revealed. This broadens our understanding of the 
diverse types of stresses Salmonella faces when entering its host cell environment. Finally, 
several previously under-characterized sRNAs were found to be regulated during infection – a 
striking example being STnc440. Its strong intracellular induction inside both cell types suggests 
a general role for this sRNA in virulence (see chapter 3). 
 
2.8  Changes in the host transcriptome 
2.8.1 Comparison of invaded host cells and non-infected bystanders 
Due to the low sequencing depth and lack of replicates for the THP-1 infection, analysis of the 
host response was restricted to HeLa-S3. In the following, the main findings from the pilot 
experiment about the host response will be described. Importantly, all major human RNA classes 
were detected by Dual RNA-seq (Fig. 2.14) allowing for the calling of differentially expressed 
genes from all relevant classes. Due to the overall subtler expression changes in the host, a 
different cut-off for differential expression was set (≥1.5 fold) than had been used for the 
pathogen (≥2 fold). 
Global expression profiles were compared between invaded and bystander cells. This unveiled 
substantial differences in the expression programs, e.g. that of mRNAs (Fig. 2.26), between the 
two sub-populations. As expected, generally more changes in gene expression were observed in 
the fraction of GFP-positive host cells that carry replicating pathogens than in non-infected 
bystander cells. Although the dataset cannot discriminate between changes induced following 
bacterial sensing by host PRRs and those elicited by the active manipulation of the host by the 
pathogen, it suggests the two host sub-populations to have fundamentally different physiological 
states. This highlights the importance of the FACS-based separation step. 
Since the infection of epithelial cells with Salmonella represents a well-studied system, at least 
for the expression of coding genes, existing microarray datasets are available and compared 
with the host subset of the Dual RNA-seq data. There was an overall good agreement between 
these datasets, e.g. the two most strongly induced mRNAs in infected cells at 4 h – SERPINB3 and 
Coagulation factor II receptor (F2R) – (Fig. 2.27) were found to be up-regulated also in previous 
studies (e.g. Bruno et al., 2009; Hannemann et al., 2013). Other early induced mRNAs such as IL6 
and TNFAIP3 (Fig. 2.27) have been defined as an integral part of the “common host response” of 
mammalian cells to diverse pathogen species (Jenner and Young, 2005). Strikingly, expression 
data indicated a general transcriptional shut-down in invaded host cells at 24 h. For example, of 
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the 13,126 detected mRNAs, 7,858 (60%) were down-regulated (≥1.5 fold) under these 
conditions (Fig. 2.26).  
 
Figure 2.26|Overlap of differentially regulated human mRNAs between invaded and bystander cells. 
Shown are all detected mRNAs that were regulated (≥1.5 fold) under at least one condition. 
 
 
 
Figure 2.27|Immune genes are strongly induced after invasive infection. a, The ten most strongly 
induced genes in invaded HeLa-S3 cells at 4 h (upper panel) or 24 h p.i. (lower panel) are depicted. b, Several 
genes involved in metabolic pathways are down-regulated at 4 h p.i. in both invaded and bystander cells. At 
the same time many immune genes are strongly up-regulated, predominantly in invaded cells. All data reflect 
biological triplicates. 
a b 
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2.8.2 Expression changes of NFκB-responsive and mitochondrial genes 
Among the common features displayed by pathogen-infected mammalian cells is the decreased 
expression of many metabolic genes and an activation of immune factors. For instance, a recent 
study described a general repression of metabolic genes in cells of the murine colon upon S. 
Typhimurium infection (Liu et al., 2010). In the present study, a down-regulation of several 
metabolic enzymes was observed at 4 h p.i. in both host cell sub-populations (Fig. 2.27b). In 
addition, certain immune-associated genes including IL6, IL8 and IL24 as well as chemokine 
ligand 2 (CXCL2) and TNFAIP3 were rapidly induced in invaded HeLa cells at 4 h p.i. (Fig. 2.27b). 
Cell surface receptors such as the LPS-sensing TLR4 or bacterial lipoprotein-responsive TLR2 
are involved in the detection of extracellular pathogens. Thus, due to the lack of functional TLR2 
and TLR4 signaling (Wyllie et al., 2000), HeLa cells are commonly considered unresponsive to 
external PAMP stimulation. Indeed, the non-infected bystander cells did not trigger an obvious 
immune response. It appears thus likely, that the innate anti-microbial response in HeLa cells is 
primarily mediated by intracellular stimuli, e.g. through NOD1 which is expressed in HeLa cells 
(Buchholz and Stephens, 2008). As non-infected bystanders, however, represent by far the 
major population in the culture (≥95%; Fig. 2.3a) inflammatory responses triggered by the few 
invaded cells would be difficult to detect without the FACS enrichment step. 
The immediate-early response transcription factor NFκB is a central activator of the innate 
immune response (Naumann, 2000). Bacterial endotoxins as well as cytokine stimulation can 
activate cellular signal transduction pathways that converge at the phosphorylation and nuclear 
import of NFκB. Once in the nucleus, NFκB initiates a global response by regulating the 
transcription of its target genes which often encode cytokines, anti-apoptotic proteins, or 
additional transcription factors (Oeckinghaus and Ghosh, 2009). Since HeLa-S3 cells were found 
to be non-responsive to extracellular PAMP stimulation (see above) early NFκB activation can be 
expected to be an exclusive feature of invaded cells. Indeed, as shown in Figure 2.28a at 4 h p.i. a 
set of known NFκB target genes were selectively activated in GFP-positive but not -negative 
cells. At the late stage of infection, however, NFκB-responsive genes such as IL8 or TNFAIP3 
were also induced in bystanders. This can be explained by the release of inflammatory cytokines 
by invaded cells that would spread in the culture and eventually elicit activation of the NFκB 
cascade also in non-infected neighboring cells. 
The unbiased nature of Dual RNA-seq not only enables the quantification of expression of 
nuclear but also organellar genes. At the late stage of infection mitochondrial transcripts were 
abundantly detected in invaded hosts (Fig. 2.14 and 2.28b). While the underlying molecular 
mechanisms remain to be determined, this finding might place Salmonella on the emerging list of 
intracellular pathogens that alter mitochondrial activity of their host (Rudel et al., 2010). 
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Figure 2.28|NFκB targets and mitochondrial genes are induced in invaded HeLa-S3 cells. a, At 4 h p.i. 
NFκB activation was limited to invaded host cells, whereas at 24 h p.i. NFκB-responsive genes were induced 
also in non-infected bystanders. b, Mitochondrial mRNAs accumulated at 24 h p.i. in invaded HeLa-S3 cells. 
 
2.8.3 The non-coding response 
This study provides the first global map of both polyadenylated and non-polyadenylated 
lncRNAs that respond to bacterial infection. Typically, a properly set RPKM-based selection filter 
allows for the discrimination between reliably detected transcripts and background noise. As 
lncRNAs, however, only recently emerged as a major subject of research their annotations are 
sometimes of poor quality and might inflate the RPKM calculation. As a consequence, for 
lncRNAs it is eminently important to inspect the read distribution along the annotated transcript 
to check for a good coverage. For instance, two lncRNA candidates that were both differentially 
regulated and well-covered with reads in the IGB profiles were uc002pec.2 and RP11-255B23.3 
(Fig. 2.29a). The read distribution for the former revealed the presence of a 14 kb-long RNA and 
thus matched well to the annotated transcript structure. In contrast reads exceeded the 
annotation of RP11-255B23.3 at both ends, suggesting the existence of a continuous transcript of 
a 
b 
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~120 kb. Both lncRNA candidates were identified as being repressed during the late infection 
stage. However, while RP11-255B23.3 was down-regulated specifically in invaded cells and 
might thus reflect the general transcriptional shut-down observed under that condition (see 
above), uc002pec.2 expression was suppressed in both sub-populations. qRT-PCR validation 
measurements correlated well with the Dual RNA-seq-based expression values (Fig. 2.29b). 
Mechanistic and functional implications of these lncRNA candidates were not further addressed. 
However, the data highlights that Dual RNA-seq profiling is not restricted to mRNAs but 
captures also non-coding expression changes of the host during bacterial infection. 
 
 
Figure 2.29|Differential expression of human lncRNAs after Salmonella infection. a, Coverage plots for 
two human lncRNAs that were down-regulated after 24 h of infection. Transcript annotations are indicated. 
Shown are the read distributions from a representative replicate experiment. b, Confirmation of the 
regulation by qRT-PCR. Mean +/- SD from biological triplicates are shown. 
a 
b 
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Besides lncRNAs, also miRNAs can be detected using the Dual RNA-seq approach, albeit with 
only a minor read fraction (see Fig. 2.14). Previously, Salmonella-infected HeLa cells have been 
reported to repress various members of the let-7 family of miRNAs with important implications 
on the expression of specific pro- and anti-inflammatory cytokines (Schulte et al., 2011). In 
addition, members of the miR-15 family were shown recently to be suppressed by invading 
Salmonella to trap the host cell in an invasion-favoring cell cycle stage (Maudet et al., 2014). 
Here, both let-7 and miR-15 family members appeared to be down-regulated in invaded HeLa-S3 
cells (not shown). However, despite the possibility to detect (abundant) cellular miRNAs and to 
quantify their expression changes using Dual RNA-seq, the approach is not tailored for an in-
depth miRNA expression profiling. In particular, due to the fragmentation of total RNA samples 
prior to cDNA synthesis (Fig. 2.1) and the computational removal of short reads (Fig. 2.9) the 
established protocol counter-selects against short transcripts. Thus, for a more comprehensive 
miRNA expression screen, library construction following classical protocols dedicated to 
miRNAs (e.g. size fractionation and enrichment of short RNA species) remains the strategy of 
choice. 
 
2.9  Concluding remarks 
In summary, Dual RNA-seq has been established for a Salmonella infection model of different 
human cell lines. Parameters that have been evaluated for this system include time points after 
infection to be sampled, different fixation protocols, sequencing depth requirements, read 
mapping, reproducibility, and the minimal number of cells needed. The pilot Dual RNA-seq 
experiment demonstrates that the simultaneous detection of all major transcript classes from 
two fundamentally different transcriptomes can be achieved and used to reliably profile gene 
expression in both organisms. Organellar RNA such as mitochondrial transcripts and non-coding 
genes can be also analyzed using this approach. However, as is true for conventional RNA-seq 
the accuracy depends largely on the abundance (the RPKM) and the coverage of a given 
transcript.  
Findings obtained from the pilot experiment are promising, especially with respect to 
intracellular Salmonella sRNA profiles which unveiled several poorly characterized yet strongly 
activated candidates. Their induction inside the host cell suggests that these sRNAs could serve 
important functions for Salmonella virulence. The third chapter of this work is therefore 
dedicated to the functional characterization of one of such intracellularly induced sRNAs, 
STnc440, and its role in Salmonella-host interplay. 
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3. The STnc440 sRNA regulates Salmonella virulence gene expression 
with impact on the host response 
 
Bacteria possess many regulatory sRNAs, several of which have been suggested to be important 
for virulence. However, standard infection assays or virulence screens provide little mechanistic 
insight into how the identified genes contribute to pathogenesis. Here – combining whole-
transcriptome studies with classical bacterial genetics and biochemical approaches – the 
function of the post-invasion induced STnc440 sRNA was characterized, suggesting it to be a 
novel riboregulator of Salmonella’s virulence programs. 
 
3.1  STnc440 inhibition coincides with a fitness defect in different infection models  
The pilot Dual RNA-seq experiment identified Salmonella STnc440 as the strongest induced 
sRNA inside HeLa-S3 cells (Fig. 2.24a). Importantly, STnc440 was also activated in human 
monocyte-like THP-1 cells (second most up-regulated sRNA at both time points; Fig. 2.24b), 
suggesting its induction is a generic feature of Salmonella’s intracellular lifestyle. 
STnc440 is a conserved ~80 nt-long Salmonella-specific sRNA that is absent from the genome of 
other Gram-negative bacteria. Within the genus Salmonella, however, its primary sequence is 
highly conserved pointing to a functional sRNA (Fig. 3.1). STnc440 has previously been 
predicted to be a sRNA in a bioinformatics screen (Pfeiffer et al., 2007) and was validated by 
Northern blot analysis (Sittka et al., 2008), but has not yet been functionally characterized. 
Recent data from the lab indicated that STnc440 gets activated through the key regulatory 
system of intracellular virulence, PhoQ/P, and represses the important invasion factors SopE 
and SopE2 in vitro (Y. Chao, personal communication). However, the role played by this sRNA 
during Salmonella’s interaction with host cells – i.e. the conditions when maximum expression is 
reached – remained elusive. 
In a previous genome-wide mutagenesis screen for Salmonella virulence genes (Chaudhuri et al., 
2013), disruption of STnc440 expression was found to result in a virulence defect in pig and 
cattle models of Salmonella infection (Fig. 3.2). Several classical proteinaceous virulence factors 
from the two major pathogenicity islands gave rise to a stronger phenotype when deleted (e.g. 
SsrB, SopE, SopB). Nevertheless, the effect of STnc440 inhibition was comparable to that of 
several well-established SPI-2 effectors such as SopD2 (Brumell et al., 2003; Schroeder et al., 
2010). As a negative control, disrupting the locus of the conjugal transfer regulator FinO – that 
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has not been related to infection and virulence – had no effect on Salmonella pathogenicity. 
Interestingly, the IsrC sRNA, which has recently been shown to be activated during macrophage 
infection (Padalon-Brauch et al., 2008), did not compromise Salmonella virulence in these 
models.  
 
 
Figure 3.1|The STnc440 locus. a, STnc440 is a Salmonella-specific sRNA on an AT-rich pathogenicity island. 
b, Sequence alignment of the STnc440 loci of different Salmonella species and serovars. “STY”: S. Typhi, 
“SEN”: S. enteritidis, “SGA”: S. gallinarum, “SAR”: S. arizonae, “SBG”: S. bongori. Conserved ribonucleobases 
are labeled in red, non-conserved bases are written in blue. The numbers indicate the position relative to the 
5’ end of STnc440 (+1 position). c, Secondary structure prediction of STnc440. Color-coding and numbering 
as in panel b. 
 
In standard cell culture infection experiments, deleting (strain ΔSTnc440) or complementing 
STnc440 (strain ΔSTnc440+) in the Salmonella chromosome had almost no effect on 
invasiveness (Fig. 3.3a). However, Salmonella mutants devoid of STnc440 expression displayed a 
slight proliferation defect during the late stage of infection of HeLa-S3 cells (Fig. 3.3b). Milder 
effects of the inhibition of STnc440 in cell culture models compared to its in vivo phenotype 
exemplify the limitations of in vitro infection systems to identify virulence genes: These 
simplistic, two-dimensional models that are typically based on a single cell type cannot fully 
recapitulate the complex environment that a pathogen would normally encounter in vivo. In 
combination with the phenotype of STnc440 disruption in animal models, however, the findings 
suggest this sRNA to contribute to Salmonella pathogenesis via a yet unknown mechanism. 
 
b 
a c 
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Figure 3.2|The STnc440 locus contributes to virulence in pig and cattle models of Salmonellosis. 
Visualization of TraDIS (transposon directed insertion-site sequencing) data for the STnc440 locus and those 
of several known virulence genes (data extracted from Chaudhuri et al., 2013). For genes that were hit by 
multiple transposons, the mean effect and deviation bars are shown. Statistically significant (p <0.05) 
virulence defects compared to wild-type Salmonella are labeled in red. In the screen in mouse, sopE was not 
hit by a transposon insertion (not detected: ‘n.d.’). 
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Figure 3.3|Mild effect of STnc440 deletion on intracellular replication within HeLa-S3 cells. a, 
Standard invasion assays for wild-type, ΔSTnc440 and ΔSTnc440+ Salmonella with human HeLa-S3 (m.o.i. 5), 
CaCo-2, undifferentiated THP-1 and murine RAW264.7 cells (all m.o.i. 10). Invasion was measured 10 min p.i. 
by flow cytometry. b, Intracellular replication kinetics for the same strains and host cell types. The increase in 
the GFP intensity of infected cells over time was monitored by flow cytometry and is expressed as fold-change 
compared to the 0 h time point (as explained in Fig. 2.4). The data represent the mean +/- SD from three 
independent biological replicates. 
 
3.2  STnc440 expression is rapidly induced after invasion of various host cell types 
To comprehensively profile gene expression in intracellular Salmonella, a temporally highly 
resolved Dual RNA-seq experiment was performed (~100-150 M reads per sample; biological 
triplicates). Samples were taken prior to and 2, 4, 8 and 16 h after infection of HeLa-S3 cells with 
wild-type Salmonella at a m.o.i. of 5 (Fig. 3.4; Tab. 3.1).  
Using a cut-off RPKM of ≥20, 106 known (i.e. sRNAs that have previously been detected by 
Northern blot) and 74 candidate Salmonella sRNAs (i.e. sRNAs that have been computationally 
predicted) were detected (Fig. 3.5). Overall, intracellular sRNA expression levels matched well to 
the findings obtained from the pilot study (chapter 2). For example, an activation of the FUR-
regulated sRNA RyhB (Masse and Gottesman, 2002; Padalon-Brauch et al., 2008) shows again 
how intracellular Salmonella encounter iron limitation and induction of OmrA/B indicates the 
presence of bacterial surface stress (Beisel and Storz, 2010). In addition, sRNAs known to be 
controlled by the master regulators of virulence followed the expected kinetics (see Fig. 2.19). 
a 
b 
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For example, InvR and DapZ sRNAs, which are activated by the major SPI-1 activator HilD (Chao 
et al., 2012; Pfeiffer et al., 2007), were repressed rapidly after host cell invasion (Fig. 3.5).  
 
Table 3.1|cDNA libraries generated for the temporally resolved Dual RNA-seq experiment. 
# library name Salmonella strain host cell type 
time 
point 
total 
reads 
replicates 
1 0 h WT HeLa-S3 (as carrier RNA) 0 h ~100 M 3 
2 2 h mock GFP- - HeLa-S3 2 h ~150 M 3 
3 2 h WT GFP+ WT HeLa-S3 2 h ~150 M 3 
4 4 h mock GFP- - HeLa-S3 4 h ~150 M 3 
5 4 h WT GFP+ WT HeLa-S3 4 h ~150 M 3 
6 8 h mock GFP- - HeLa-S3 8 h ~100 M 3 
7 8 h WT GFP+ WT HeLa-S3 8 h ~100 M 3 
8 16 h mock GFP- - HeLa-S3 16 h ~100 M 3 
9 16 h WT GFP+ WT HeLa-S3 16 h ~100 M 3 
 
 
 
Figure 3.4|Overview of the high-resolution Dual RNA-seq time-course of HeLa-S3 infection. Four 
individual time points post-invasion of HeLa-S3 cells were sampled (three replicates). Each time point 
analyzes invaded host cells only, but not the non-infected bystanders (in contrast to the pilot experiment 
described in chapter 2). Mock-treated cells were used as reference controls for each time point. As a bacterial 
reference, extracellular Salmonella were included (0 h).  
 
Importantly, STnc440 remained the most activated sRNA in intracellular Salmonella. Its 
induction kinetics detected by Dual RNA-seq was independently confirmed by qRT-PCR on RNA 
samples from intracellular Salmonella (Fig. 3.6a). Northern blot analysis revealed that full 
activation of STnc440 as seen for intracellular Salmonella can be recapitulated by growing the 
bacteria in synthetic SPI-2-inducing medium (Lober et al., 2006) in vitro (Fig. 3.6b). 
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Figure 3.5|Intracellular sRNA expression profile of wild-type S. Typhimurium during the time-course 
of infection of HeLa-S3 cells. All sRNAs detected with a RPKM ≥20 at all time points are shown. sRNAs 
referred to in the main text are labeled in color, the rest are shown as grey lines (dark grey: confirmed sRNAs; 
light grey: predicted candidates). Data shown comprise three replicates. 
 
 
 
Figure 3.6|STnc440 expression is strongly induced during infection. a, STnc440 activation after invasion 
of HeLa-S3 cells as revealed by Dual RNA-seq (red graph; three replicates; see Fig. 3.5) can be reproduced by 
qRT-PCR measurements (black dots; each dot represents a single out of four to six biological replicate 
experiments). qRT-PCR normalization was performed using the constitutively expressed GFP mRNA as a 
reference. b, Northern blot detection of STnc440 under defined in vitro conditions or 4 h after HeLa-S3 
infection. Salmonella 5S rRNA and human U6 snRNA serve as loading controls. ‘Input’ refers to bacteria 
grown in LB to OD600 of 2 and then shifted to host cell medium DMEM. 
 
We aimed to assess the expression levels of STnc440 in different cell types. Besides its induction 
inside HeLa-S3 cells, Dual RNA-seq at a lower depth (1-5 M reads) indicated STnc440 to be 
amongst the strongest induced sRNAs in all further tested cell types (Fig. 3.7). These included 
primary murine bone marrow-derived macrophages (BMDMs), in vitro-differentiated THP-1 
cells, and human epithelial colorectal adenocarcinoma (CaCo-2) cells. Although the levels of full 
induction differed between individual cell types, the collective data strongly supports the rapid 
up-regulation of STnc440 to be a generic feature of the intracellular lifestyle of Salmonella. 
a b 
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Figure 3.7|STnc440 is strongly induced after the invasion of diverse human and mouse cell types. Cells 
were infected with wild-type Salmonella for the indicated time points, invaded host cells were FACS-sorted 
and their total RNA was sequenced on Illumina’s MiSeq platform to each 1-5 M reads. THP-1 cells either were 
(‘differentiated’) or were not (‘monocytic’) differentiated by phorbol 12-myristate 13-acetate (PMA) 
treatment for 3 d prior to infection. For all cell types, infection was established at a m.o.i. of 10 and the 
indicated time points were taken. Expression profiles of all detected sRNAs are plotted (grey) and STnc440 
kinetics are labeled red. Fold-changes in expression are relative to extracellular Salmonella. In each case, 
data were derived from a single experiment. 
 
Together, STnc440 represents a paradigm example of a potential, novel virulence-related sRNA: 
The strong sequence conservation after its horizontal acquisition (Fig. 3.1), its high activation 
inside various host cell types (Fig. 3.7), and importantly its selection in previous transposon 
screens for intestinal colonization factors in pig and calf (Chaudhuri et al., 2013) (Fig. 3.2), 
collectively support a role of STnc440 in bacterial pathogenesis.  
 
3.3  Regulation of Salmonella virulence genes by STnc440 
Preliminary work in the lab suggested STnc440 to suppress the SPI-1 invasion effectors SopE 
and SopE2 in a direct manner (Y. Chao, personal communication). However, standard infection 
screens with diverse cell culture models of Salmonella infection did not reveal a defect in host 
cell invasion in the absence of STnc440 (Fig. 3.3a). In contrast, we detected a mild replication 
defect of ΔSTnc440 mutants at 20 h after HeLa-S3 invasion (Fig. 3.4b). This rather points at an 
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effect that this sRNA might exert in its intracellular state, e.g. by acting on SPI-2. Indeed, 
inhibition of STnc440 expression in previous transposon mutagenesis screens (Chaudhuri et al., 
2013) mirrored the outcome of the disruption of classical SPI-2 effectors such as SopD2 or PipB2 
(Fig. 3.2). Lastly, a preliminary Dual RNA-seq time-course experiment of the infection of HeLa-S3 
cells with the ΔSTnc440 strain hinted at a potential influence of this sRNA on SPI-2 expression 
(not shown). 
3.3.1 De-repression of SPI-2 genes in the absence of STnc440 
For the purpose of profiling global gene expression comparatively between wild-type and 
ΔSTnc440 Salmonella with moderate sequencing power, an in vitro transition experiment was 
designed wherein Salmonella was shifted from SPI-1-inducing to SPI-2-inducing conditions. This 
was intended to reconstitute the early stages of host cell invasion and intracellular proliferation 
in vitro. The two Salmonella strains were thus grown in LB medium to an OD600 of 2, a condition 
under which SPI-1 is strongly activated (Kroger et al., 2012, 2013). Subsequently the bacteria 
were pelleted and shifted to SPI-2 medium that mimics the intracellular environment (Lober et 
al., 2006). Total RNA samples were taken at 0 h (i.e. prior to the shift) or 1 h and 2 h after the 
medium shift and used to prepare cDNA libraries for RNA-seq. 
A functional analysis for enriched pathways compiled from the KEGG database and the literature 
suggested SPI-2 and the co-regulated SPI-5 (see Fig. 2.20) virulence locus to become gradually 
hyper-activated over time in Salmonella lacking STnc440 (Fig. 3.8). In addition, SPI-1 activation 
was slightly increased in the sRNA deletion mutant; mostly due to a de-repression of the 
STnc440 targets SopE/E2 (Y. Chao, personal communication). The pathways “Salmonella 
infection” and “bacterial invasion of epithelial cells” comprise many virulence genes included in 
the above-mentioned virulence programs and consequenctly, were also over-activated. Besides 
these virulence pathways, metabolism-associated GO-terms (such as histidine metabolism) were 
enriched. 
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To test whether the STnc440-dependent SPI-2 repression observed in vitro would be detectable 
also in Salmonella growing inside their host, HeLa-S3 cells were infected with wild-type, 
STnc440 deletion or trans-complementation strains. Host-pathogen lysates were prepared prior 
to or 2 and 4 h after infection, total RNA was isolated and the expression of individual SPI-2 
genes was measured by qRT-PCR (Fig. 3.9). The repressive effect of STnc440 on the selected SPI-
2 mRNAs, including that of the secreted effector SteC, was subtle but significant also in vivo. 
Importantly, trans-complementation of the sRNA gene restored wild-type expression profiles. 
This supports the notion that STnc440 acts to repress SPI-2 induction during the early phases 
after invasion. Further qRT-PCR measurements suggested that STnc440 may act upstream of the 
SPI-2 master transcription factor, SsrB, without affecting its own activator, PhoP, or the master 
regulator of SPI-1 genes, HilD (Fig. 3.9). 
To assess whether the STnc440-mediated influence on SPI-2 expression manifests itself also on 
protein level, the abundance of the representative SPI-2 effector SteC was monitored in vitro at 
five different time points after the SPI-1 to SPI-2 shift by Western blot analysis (Fig. 3.10). In line 
with the transcriptomic data, ΔSTnc440 bacteria displayed a pre-mature accumulation of this 
effector, as compared to wild-type and trans-complemented Salmonella. 
 
Figure 3.8|Salmonella pathway analysis 
for the comparative RNA-seq experiment 
between wild-type and ΔSTnc440 mutants 
in vitro. Pathways enriched in differentially 
expressed genes at any given time point after 
the medium shift from SPI-1- to SPI-2-inducing 
conditions are displayed. Red: pathway over-
activated in the mutant vs. wild-type; blue: 
under-activated. Color intensity increases with 
increased significance (hyper-geometric test). 
Pathways analyzed were compiled from the 
KEGG database and the literature. The 
analysis comprises two replicate experiments. 
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Figure 3.9|Influence of STnc440 on SPI-2 expression in vivo. qRT-PCR measurements during the early 
stages of HeLa-S3 infection support the de-repression of SPI-2 genes in the ΔSTnc440 background (red) as 
compared to both wild-type (black) and ΔSTnc440+ (grey) strains. Normalization was performed using GFP 
mRNA as a reference. Dots represent individual biological replicate experiments (n) and the solid lines 
indicate their mean. A Mann-Whitney U test was performed to test for significance (*: p <0.05; n.s.: p >0.05 
between wild-type and ΔSTnc440 strains). 
 
 
 
 
3.3.2 Pulse-expression experiments identify STnc440 targets 
Since STnc440 associates with Hfq (Chao et al., 2012; Sittka et al., 2008), it is likely to regulate 
mRNAs by base pairing (Vogel and Luisi, 2011). Thus, in order to identify direct targets of this 
sRNA, a previously described pulse-expression approach was applied (Masse et al., 2005; Papen-
fort et al., 2006). Briefly, the sRNA of interest is transiently over-expressed for a short time 
period (5-10 min) from an arabinose-inducible promoter and the global abundance of mRNAs is 
monitored in the presence or absence of the sRNA. The expression of direct mRNA targets is 
expected to change while indirect effects are minimized due to the short time frame of induction.  
Figure 3.10|STnc440 affects the accumulation 
of the SPI-2 effector protein SteC in vitro. 
Western blot analysis of a tagged steC::flag 
Salmonella strain shifted from SPI-1- to SPI-2-
inducing conditions. SteC levels were normalized to 
GroEL. Graphs and error bars represent the mean 
+/- SD from three independent time-course 
experiments. 
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To identify STnc440 targets in conditions mimicking the host cell milieu (i.e. conditions when 
STnc440 is maximally expressed), the sRNA was transiently over-expressed in Salmonella 
growing in synthetic SPI-2-inducing medium (Lober et al., 2006). However, to take into account 
that an artificial medium might not perfectly reflect the conditions found intracellularly (Ortega 
et al., 2012), an experiment was also designed to transiently induce STnc440 expression in 
bacteria within their host cell niche. Previous work suggested that supplementing the host cell 
medium with L-arabinose would be sufficient for the inducer to traverse the host’s plasma 
membrane and diffuse into the cytosol (Loessner et al., 2007). We thus added L-arabinose into 
the supernatant of HeLa-S3 cultures which had been infected for 4 h with GFP-expressing 
Salmonella containing the STnc440 over-expression plasmid. At 2, 5, 10 and 20 min post-
induction, total RNA samples were taken and STnc440 expression was monitored by qRT-PCR 
(Fig. 3.11a). This revealed that in wild-type or ΔSTnc440 Salmonella transformed with the empty 
control plasmid, STnc440 levels were as expected: A ~100 fold induction was measured in the 
wild-type background at 4 h p.i. compared to the levels in extracellular bacteria prior to 
infection (Fig. 3.11a, black graph), in line with previous findings (Fig. 2.24, Fig. 3.6a). Conversely, 
the sRNA was not detected in the ΔSTnc440 background (Fig. 3.11a, grey graph). In a ΔSTnc440 
strain transformed with the STnc440-containing expression plasmid, however, the sRNA was 
lowly expressed in the absence of the inducer (0 min), but rapidly up-regulated to up to ~500 
fold as soon as 5 min post-induction (Fig. 3.11a, red curve). 
 
 
Figure 3.11|In vivo sRNA pulse-expression establishment. a, 4 h after the infection of HeLa-S3 cells, 
STnc440 over-expression was induced from the pBAD plasmid by the addition of L-arabinose into the host cell 
medium. Up-regulation of STnc440 (red) was monitored by qRT-PCR and compared to its expression in the 
wild-type (black) or ΔSTnc440 strain (red) containing the empty pBAD vector. b, Work-flow for the 
enrichment of bacterial RNA after in vivo pulse-expression. 
a b 
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Therefore, ΔSTnc440 strains either harboring the empty control or the STnc440 expression 
plasmid were used to infect HeLa-S3 cells for 4 h and subsequently L-arabinose was added into 
the medium for 5 min (Fig. 3.11b). Infected host cells were harvested and lysed by detergent 
treatment on ice. The released bacteria were pelleted by centrifugation. To freeze their 
transcriptome, Salmonella cells were fixed in RNAlater (see section 2.2). In order to further 
reduce the host RNA background, fixed Salmonella were enriched via FACS by gating for the 
GFP-positive population of released bacteria. RNA was isolated from the collected samples and 
analyzed by RNA-seq. The in vivo data was used to complement the results from pulse-
expression in SPI-2 medium (Fig. 3.12). The combined datasets predicted the mRNAs of the 
enzyme glutaredoxin 1 (GrxA) and the transcriptional regulator cyclic AMP receptor protein 
(CRP) as high-confidence repressed targets of STnc440. Furthermore, the mRNA of the 
bacteriolytic toxin entericidin B (EcnB) was included in the downstream analyses, as strong 
repression was detected in SPI-2 medium (Fig. 3.12). Note that the mRNAs for the two SPI-1 
effectors SopE/E2 – which are direct STnc440 targets under SPI-1 conditions (Y. Chao, personal 
communication) – were lowly abundant under the in vivo-like conditions sampled and 
consequently not identified here as targets. 
 
 
 
Western blot analysis was used to assess whether STnc440 expression affected the protein 
levels of these three putative targets (Fig. 3.13). Under SPI-2 conditions, a time-course of protein 
abundance revealed a rapid clearance of GrxA, CRP and EcnB following the expression of 
STnc440 from a plasmid under its native promoter. The level of the unrelated GroEL protein 
remained unaffected.  
 
Figure 3.12|Pulse-expression experiments to identify 
target genes of STnc440. The sRNA was over-expressed 
under SPI-2-inducing conditions in vitro or 4 h after 
HeLa-S3 infection. In each case, total RNA samples were 
taken 5 min after induction and analyzed by RNA-seq 
(two independent replicates per condition). Axes 
represent the fold-changes in mRNA abundance between 
strains harboring the empty control plasmid and the 
STnc440-containing plasmid. The mRNAs that were 
confirmed to be directly targeted by STnc440 (see Fig. 
3.13 and 3.14) are labeled blue.  
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Figure 3.13|Western blot analysis for STnc440 targets. Protein levels upon the expression of STnc440 
from a plasmid containing the sRNA under its native promoter (pOWN-STnc440) in strains with FLAG-tagged 
grxA or ecnB that were shifted from LB to SPI-2 medium. At defined time points after the shift total protein 
samples were taken and analyzed by Western blot for the high-confidence STnc440 targets identified in Fig. 
3.12. GroEL served as a loading control. 
 
In silico approaches were used to search for potential target sites within the grxA, crp and ecnB 
mRNAs (Rehmsmeier et al., 2004). In the case of grxA a high confidence interaction site between 
the region around the start codon of the mRNA and STnc440 could be predicted (Fig. 3.14a). As 
validated using a translational GFP reporter construct, targeting of grxA by STnc440 is direct 
(Fig. 3.14b). Intriguingly, regulation was diminished for a point mutant of STnc440, in which two 
bases within the seed region (see Fig. 3.1) were exchanged (variant STnc440*). Probably due to 
the extensive RNA-RNA interactions predicted to form between the two transcripts, exchanging 
a single ribonucleobase within the seed (STnc440**) was insufficient to abolish regulation. 
Two crp mRNA isoforms have been reported (Kroger et al., 2012) that differ with respect to their 
5’ UTR: The primary TSS gives rise to a mRNA with a shorter 5’ UTR, while an isoform with a 5’ 
UTR extended by 76 nt is produced from the secondary TSS (Fig. 3.14c). For both crp isoforms 
suitable GFP reporter constructs were generated and the effect of STnc440 over-expression on 
them was analyzed (Fig. 3.14d). This indicated that primarily the long isoform is regulated by 
STnc440 (but not STnc440*), even though slight repression was also observed for the shorter 
transcript. This suggests that the primary target site is located in the region exclusive to the long 
crp mRNA variant. Indeed a weak but possible interaction site with the STnc440 seed region 
could be identified within the respective 76 nt window (Fig. 3.14c). Additionally, there might be 
(a) further targeting site(s) shared by both crp isoforms. For ecnB mRNA several but weak 
interaction sites were predicted, however, these were not further addressed here. 
Western blot analysis supported that efficient clearance of GrxA and CRP proteins depends on an 
intact seed region of STnc440 (Fig. 3.14e). The ectopic expression of the wild-type sRNA in 
bacteria grown under SPI-2 conditions decreased GrxA and CRP levels, whereas over-expression 
of the point-mutated version of STnc440 (variant STnc440*) had little effect on target protein 
levels.  
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Figure 3.14|Direct targeting of grxA and crp mRNAs by STnc440. a, Predicted RNA duplex formation 
between STnc440 and the 5’ part of grxA. Point mutants analyzed in panel b are indicated. The ribosome 
binding site and start codon of grxA are marked in blue and red, respectively. b, Validation of direct targeting 
of the grxA mRNA by the seed region of STnc440 using translational grxA::gfp reporter gene fusions. For 
these reporters, the region -34 to +90 of grxA (relative to the position of the start codon) was fused to the 
coding sequence of gfp. Salmonella strains containing both a GFP reporter plasmid and a sRNA over-
expression vector were grown overnight in LB and analyzed by flow cytometry. The error bars indicate 
standard deviation from the mean based on triplicate measurements. c, Putative RNA duplex formation 
between STnc440 and crp. Two isoforms of crp mRNA exist that differ with respect to their 5’ UTR. Point 
mutations introduced in the STnc440 seed (panel d) are indicated. d, Validation of direct targeting of the 
long crp mRNA isoform by the seed region of STnc440 using suitable translational crp::gfp reporter fusions 
(as in panel b). e, Western blot analysis for GrxA and CRP proteins upon the over-expression of either wild-
type STnc440 or the point-mutated sRNA variant (STnc440*). 
 
In summary, STnc440 seems to have widespread regulatory effects that are mediated in either a 
direct or indirect fashion: Under SPI-2 conditions (in vivo and in vitro-reconstituted), STnc440 
targets and represses grxA and crp mRNAs. Also the bacteriolytic toxin EcnB appears to be 
amongst STnc440’s targets although no validation experiments were performed for this factor. 
In addition, STnc440 seems to exert a global repressive effect on the SPI-2 locus, likely via an 
indirect mechanism. Since GrxA and CRP affect intracellular replication by activating Salmonella 
virulence genes (Bjur et al., 2006; Chen et al., 2010; Yoon et al., 2009), they are considered 
putative factors through which STnc440 might signal to SPI-2. Likewise, EcnB levels have 
recently been shown to be regulated between proliferating and resting Salmonella in vivo (Claudi 
et al., 2014). 
a 
c 
b 
d 
e 
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Thus, to address if GrxA, CRP or EcnB were involved in the effect of STnc440 on SPI-2 activity, 
appropriate Salmonella strains were subjected to the in vitro SPI-1 to SPI-2 transition assay 
described above. As a proxy for SPI-2 activity, induction of a transcriptional reporter fusion 
comprising the SsrB-activated SPI-2 promoter of ssaG fused to the coding sequence of gfp was 
monitored (Fig. 3.15). Again, the medium-switch assay recapitulated the premature activation of 
SPI-2 transcription in the absence of STnc440 (red curve in Fig. 3.15). Reciprocally, the presence 
of STnc440 on a multi-copy plasmid impaired SPI-2 gene activation (grey curve in Fig. 3.15). 
Importantly, genomic deletion of crp (but not grxA) abrogated and ecnB deletion weakened the 
STnc440 effect on the ssaG::gfp fusion, suggesting that STnc440 might signal to SPI-2 through 
CRP, possibly involving EcnB. 
 
 
Figure 3.15|STnc440 counter-acts SPI-2 activation through CRP in vitro. Salmonella strains with 
endogenous STnc440 expression (black), strains over-expressing (grey) or lacking STnc440 (red) in either the 
wild-type or a defined deletion mutant background were shifted from SPI-1 to SPI-2 conditions. A 
transcriptional reporter fusion of the SPI-2 gene ssaG to gfp was used as a proxy for SPI-2 induction. Time 
point 0 h refers to the time of the medium shift and the induction of ectopic sRNA expression. Fold-changes 
are expressed relative to the maximum activation levels of ssaG reached in the presence of wild-type STnc440 
expression (black curves). The error bars indicate SD from the mean from triplicate measurements. 
 
3.4 JAK/STAT and cytokine signaling are STnc440-affected host pathways  
Secreted bacterial effector proteins are directly exposed to the surveillance machinery of the 
host. Therefore, observations that STnc440 affects the level of Salmonella virulence effectors 
from SPI-1 (Y. Chao, personal communication) and SPI-2 (see above), implied that also the host 
response to infection could be influenced by the action of this sRNA (Bruno et al., 2009; 
Hannemann et al., 2013; Uchiya and Nikai, 2005, 2008).  
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For example, the JAK/STAT (Janus kinase/Signal transducer and activator of transcription) 
signaling cascade is well known to be a major host cellular target process of many intracellular 
pathogens, including Salmonella (reviewed in Carey et al., 2012). Indeed, preliminary data from 
a Dual RNA-seq time-course with ΔSTnc440 Salmonella suggested that this pathway might be 
differentially affected in the absence of STnc440 (not shown). Within the JAK/STAT pathway 
members of the Suppressor of cytokine signaling (SOCS) family play a key role as mediators of 
downstream signaling events. Their expression is typically controlled transcriptionally and thus 
changes are reflected already on the mRNA level (Yoshimura et al., 2007). Intriguingly, previous 
studies reported differential SOCS expression in a SPI-2 effector-dependent manner (Uchiya and 
Nikai, 2005, 2008). Here, to assess whether the JAK/STAT pathway was affected by STnc440, 
expression of key members of the SOCS family was profiled by qRT-PCR (Fig. 3.16). SOCS 
activation was almost exclusively observed in the invaded cells but not the non-infected 
bystanders (solid vs. dashed lines in Fig. 3.16). Changes in the expression kinetics between wild-
type- or mutant-infected cells were observed for all the addressed factors. Most prominently, 
however, SOCS3 mRNA was prematurely induced upon the invasion with ΔSTnc440 as compared 
to wild-type bacteria. 
 
 
Figure 3.16|Infection with ΔSTnc440 Salmonella impacts on SOCS3 induction of the host. qRT-PCR 
measurements on total RNA samples isolated from FACS-sorted HeLa-S3 cells at the indicated time points 
after wild-type, ΔSTnc440 or ΔSTnc440+ infection. U6 snRNA was used for normalization. The data represent 
the mean +/- SD from three independent biological replicates. 
 
SOCS3 has previously been shown to inhibit tyrosine phosphorylation of the transcription factor 
STAT3, thereby preventing its activation and nuclear import (Li et al., 2012a). In agreement with 
this, reduced STAT3 tyrosine phosphorylation in cells infected with ΔSTnc440 Salmonella 
compared to wild-type infection was observed by means of Western blot analysis using a Tyr705-
phospho-specific antibody (Fig. 3.17). As a control, a second, non-canonical phosphoralytion site 
at residue Ser727 (Gough et al., 2009) was unaffected by STnc440. 
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A classical readout in profiling inflammatory responses of stimulated cells is to measure 
cytokine/chemokine levels. As revealed in the pilot Dual RNA-seq experiment (chapter 2) 
infected HeLa-S3 cells strongly up-regulated the mRNAs for the pro-inflammatory chemokine IL-
8 and the IL-10-like, anti-inflammatory cytokine IL-24 (a.k.a. MDA-7) (e.g. Fig. 2.27). Thus, to 
address whether the STnc440 genotype of invading Salmonella would affect the inflammatory 
response of its corresponding host, qRT-PCR measurements of IL8 and IL24 mRNAs at 16 h after 
infection (i.e. at the maximal height of their expression) were performed (Fig. 3.18a). These data 
indicate that HeLa-S3 cells infected with mutant Salmonella lacking STnc440 hyper-expressed 
IL8 while IL24 induction was reduced as compared to wild-type infection. Of note, these 
alterations in gene expression were not caused by a differential bacterial load of the individual 
strains at 16 h p.i. as indicated by a similar GFP mRNA to U6 snRNA ratio for all conditions (Fig. 
3.18b). Enzyme-linked immunosorbent assay (ELISA) at 20 h p.i. demonstrated increased IL8 
mRNA expression after ΔSTnc440 infection resulted in elevated levels of IL-8 protein in the 
culture supernatant (Fig. 3.18c). All reported alterations reverted to levels seen in wild-type-
infected cells upon trans-complementation of the sRNA (Fig. 3.16, 3.17 and 3.18). 
 
 
Figure 3.18|STnc440-dependent changes in host cytokine/chemokine levels. a, qRT-PCR on RNA from 
FACS-sorted HeLa-S3 cells at 16 h p.i. with the indicated strains. U6 snRNA was used for normalization. b, 
Differential gene expression events in panel a were not caused by bacterial load variations as judged from the 
qRT-PCR detection ratio of bacterial GFP mRNA to human U6. c, ELISA detected elevated concentrations of 
secreted IL-8 protein in the culture supernatant at 20 h after ΔSTnc440 infection. All data represent the 
mean +/- SD from at least three independent biological replicates. 
Figure 3.17|STnc440 affects host STAT3 phospho-
rylation. The phosphorylation status of STAT3 was 
assessed by Western blot analysis of unsorted HeLa-
S3 cells at 16 h p.i. using Tyr705- or Ser727-phospho-
specific antibodies against STAT3. Salmonella GroEL 
served as a bacterial and tubulin as a human control. 
 
a b c 
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3.5  Concluding remarks 
Based on the results from the pilot Dual RNA-seq screen, STnc440, a strongly induced but poorly 
studied Salmonella sRNA was selected for in-depth characterization. A preliminary Dual RNA-
seq screen with the ΔSTnc440 mutant was used to pinpoint putative Salmonella and host 
processes affected by this sRNA. In combination with the observed growth defect of the sRNA 
mutant, this led us to globally profile gene expression during the onset of intracellular 
proliferation. Under the defined conditions of an in vitro-reconstituted growth experiment that 
mimicked the intracellular milieu, pathway analysis revealed SPI-2 genes to be de-repressed in 
the absence of STnc440. In parallel, based on the body of previous work on Salmonella effectors 
we monitored whether STnc440 expression would influence important branches of the immune 
response in the host. The combined data illustrate how STnc440 may orchestrate a complex 
regulatory network of Salmonella virulence gene expression, likely to shape the transition from 
an invasive to an intracellularly replicating lifestyle. The function of STnc440 in pathogen-host 
interplay further manifests itself in changes in important signaling cascades of the host. 
Differences in the activity of the here-assessed (and possibly further) immune pathways 
between wild-type- and ΔSTnc440-infected cells suggest STnc440 might act to indirectly 
modulate the inflammatory host response.  
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4. Discussion 
 
4.1  Dual RNA-seq: potential and scope for future improvements 
Infection is one of the most intricate interactions between two organisms from different species 
– especially in a scenario where the pathogen invades its host. Thus, rather than laboriously 
separating the interaction partners post infection, methods are required that enable the 
simultaneous analysis of both organisms. In the case of proteins, in silico separation of mixed 
bacterial/eukaryotic peptide samples is routinely performed (reviewed in Rodland et al., 2008 
for the example of Salmonella infection models). Even dynamic analyses are feasable using stable 
isotope labeling of amino acids. These approaches are capable of revealing how intracellular 
pathogens reprogram their proteome from inside the host cell (Rechavi et al., 2010) or 
identifying secreted bacterial effectors and their cognate host targets (Auweter et al., 2011). 
However, as our perception of gene expression shifts from a protein-centric to a more RNA-
centric view both in pro- (Papenfort and Vogel, 2010) and eukaryotes (Dunham et al., 2012), 
such parallel techniques need to be transferred to nucleic acids. 
On the RNA level, joint analyses have proven more challenging, mostly due to the dramatic 
differences concerning host and pathogen transcriptomes (Westermann et al., 2012). Recently 
several studies have reported the application of joint RNA-seq to infection models (Kawahara et 
al., 2012; Petre et al., 2012; Tierney et al., 2012; Yazawa et al., 2013), however, due to the 
fundamental differences between bacterial and eukaryotic transcriptomes such analyses have 
been restricted to hosts infected with eukaryotic parasites. The ubiquitous polyadenylation of 
eukaryotic mRNAs and the sequence similarity of ribosomal transcripts facilitates the 
experimental protocol as it enables the poly(A) enrichment or ribosomal depletion for host and 
pathogen in a single step. Recently a few publications have reported the application of RNA-seq 
to a model of bacterial infection of plant leaves (Asai et al., 2014; Socquet-Juglard et al., 2013), 
porcine enterocytes (Vannucci et al., 2013), or human epithelial carcinoma cells (Humphrys et 
al., 2013). However, these suffered from the lack of an enrichment of invaded cells, resulting in a 
low bacterial transcriptome coverage, and/or from a shallow sequencing depth, hampering an 
in-depth profiling of the host response.  
Here, a generic protocol for Dual RNA-seq was established that should be transferable to any 
infection system, eventually even to tissue or animal models. Samples were fixed directly after 
harvesting; this means that the transcriptome composition will be maintained during all down-
stream processes such as the enrichment of infected cells. Note, however, that the here 
described RNAlater-based fixation method was optimized for the analysis of robust, 
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immortalized cell lines. For other sample types – especially primary cells or tissue samples – this 
treatment might turn out to be too harsh. Thus, further fixatives and protocols should be 
evaluated in the future. The current protocol for Dual-RNAseq requires as little as 10,000 
infected cells. However, as the sensitivity of library construction continues to increase, the time 
required for cell sorting will decrease and fixation might then be omitted. This strategy is 
typically used for single-cell RNA-seq studies (Saliba et al., 2014). 
Using Dual RNA-seq, sample preparation is simpler than for previous microarray-based 
approaches as the interacting organisms can be analyzed together and mixed RNA samples are 
directly converted into cDNA in the absence of further enrichment or depletion steps. As a result, 
little starting material is required which accelerates sampling and allows for the design of 
larger-scale experiments (e.g. different host cell types or pathogen strains could be handled in 
parallel). The many advantages over probe- or tag-based techniques (see Introduction) have 
rendered conventional RNA-seq the gold standard for single-organism transcriptomics (Wang et 
al., 2009). As the same advantages are inherent to the parallel analysis of host and pathogen 
transcriptomes by Dual RNA-seq, it might eventually become an important technique for 
microbial infection biology. 
Here, Dual RNA-seq was performed on Illumina’s HiSeq 2000 platform. Assigning up to one lane 
of a flow cell (~150 M reads) to a single library was found to be reasonable for a Dual RNA-seq 
experiment that starts from total RNA. The resulting ~0.5-5 M bacterial non-ribosomal reads 
(depending on the time p.i.) and the ~50 M human non-ribosomal reads appear sufficient for the 
characterization of both pathogen and host transcriptomes. Differential gene expression studies 
were possible on both sides and the calculated expression changes were in good accordance 
with results obtained from independent qRT-PCR or Northern blot experiments. Note, however, 
that it was initially intended to complement the temporally resolved time-course of Salmonella 
wild-type infection with that of the ΔSTnc440 mutant strain. The high degree of reproducibility 
of strong expression changes between infectious and non-infectious conditions notwithstanding, 
the subtle changes between wild-type and ΔSTnc440 infection were not consistently detected in 
the sequencing datasets from multiple biological replicates. As a result, the differences did not 
withstand rigorous significance assessment using state-of-the-art analysis tools. One explanation 
could be that the HeLa-S3 cell culture model used here might impede such a comparative 
analysis. That is, we initially selected HeLa-S3 cells as a robust in vitro model of infection for the 
purpose of establishing the Dual RNA-seq technique. However, as a consequence of its simplicity, 
subtle but potentially meaningful changes might be mitigated or even entirely masked in this 
model system. In addition, the high degree of variability that accompanies the infection process 
would probably require more replicates to accurately quantify slight expression changes. Lastly, 
with the current sequencing depth the Dual RNA-seq method might not be sufficiently sensitive 
81 
 
to quantitatively assess the subtle differences in gene expression between wild-type bacteria 
and a single sRNA mutant or their respective hosts. Indeed, for a more comprehensive 
characterization of mammalian transcriptomes ~700 M non-rRNA reads (Blencowe et al., 2009) 
and for saturated bacterial transcriptomics >10 M non-rRNA reads (Haas et al., 2013) were 
recently suggested. As an alternative to the sequencing of total cDNA, rRNA may be depleted 
from the samples prior to library construction in the future. That is, recently a ribosomal 
depletion kit was launched that enables the joint removal of bacterial and eukaryotic rRNA in a 
single step (Ribo-Zero Magnetic Gold kit from epicenter). Such an approach promises to reduce 
sequencing depth requirements for future Dual RNA-seq studies.  
 
4.2  Rewiring the regulatory network of virulence gene expression in Salmonella 
Making use of ENCODE-compatible HeLa-S3 or THP-1 cells challenged with S. Typhimurium as a 
robust cell culture model of infection, has enabled us to provide deeper insight into the 
expression programs triggered in pathogen and host during the course of infection. For example, 
inspecting the bacterial data subset informed about the various types of stresses that the 
pathogen experiences inside its different host cell niches. Also information about the expression 
of virulence genes from different programs could be obtained. Intriguingly a previously poorly 
characterized Salmonella sRNA was found to be highly induced inside all host cell types tested. 
Using global transcriptomics complemented with standard genetics and biochemical techniques, 
evidence was collected that this trans-acting sRNA operates at the transition of SPI-1 to SPI-2 
expression and thus, at the heart of Salmonella virulence (Fig. 4.1). In particular, STnc440 is 
encoded within a pathogenicity island and genomically adjacent to the rtsA gene, which encodes 
a known regulator of SPI-1 genes (Ellermeier and Slauch, 2003). RtsA, however, was dismissed 
as a transcriptional activator of STnc440 due to the opposing expression patterns of this sRNA 
and SPI-1 invasion genes. Rather STnc440 may be activated through the major regulatory 
system of intracellular virulence gene expression, PhoQ/PhoP (Y. Chao, personal 
communication). In turn, STnc440 regulates specific effectors from SPI-1 by direct base-pair 
interaction with the respective mRNAs (Y. Chao, personal communication) as well as expression 
of the bulk of SPI-2 genes via an indirect mechanism, possibly involving CRP. 
The STnc440 deletion mutant displayed a replication defect during the late stages of HeLa-S3 
infection and genome-wide transposon mutagenesis screens have previously identified insertion 
mutants with impaired STnc440 expression to have a fitness defect in diverse animal models of 
Salmonellosis. To some extent, this may be linked to the mis-regulation of SPI-2 expression in 
the absence of STnc440. It has been reported before that premature SPI-2 induction has an 
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adverse effect on Salmonella growth within its host cell niche and therefore negative regulators 
of SPI-2, such as YdgT (Coombes et al., 2005) or PmrA (Choi and Groisman, 2013), are required 
for the contextual activation of virulence factors from this island (Fig. 1.2). The present data 
suggest that STnc440 contributes to the modulation of SPI-2 activity. 
CRP was identified as a possible mediator of this regulation. This factor has previously been 
suggested to impact Salmonella virulence by affecting both SPI-1 (Chen et al., 2010) and SPI-2 
(Yoon et al., 2009), via unknown mechanisms. Whereas the presented data also cannot provide a 
mechanistic link between CRP expression and SPI activity, it suggests that the CRP hub in the 
regulatory network would provide a temporal gap between PhoP-dependent SPI-2 induction 
and its indirect, STnc440-mediated repression (Fig. 4.1). This way, virulence effector expression 
inside the host would be restricted to within a narrow time window – sufficient for optimal host 
manipulation but avoiding hyper-production of bacterial effectors, thereby potentially 
minimizing recognition by host cell sensors. Future efforts – using cell culture but also animal 
models of Salmonella infection – should aim to evaluate the here proposed role of STnc440 in 
Salmonella virulence. 
The transcriptional regulator CRP senses intracellular glucose levels by means of cyclic AMP 
binding and controls the expression of several hundred of target genes in the Enterobacteriaceae 
(Xu and Su, 2009; Zheng et al., 2004). Besides its emerging role in virulence (see above), CRP is 
involved in carbon catabolite repression, flagellum synthesis and toxin production (Botsford and 
Harman, 1992). Indeed, pathway analysis during the in vitro-reconstituted SPI-1 to SPI-2 switch 
revealed potential footprints of STnc440-mediated crp repression beyond its effect on virulence 
genes (e.g. histidine metabolism was affected). As the experimental conditions, however, were 
selected specifically for the purpose of monitoring virulence gene expression it appears likely 
that STnc440’s effect on CRP may be more prominently reflected in the transcriptome of 
Salmonella grown under different conditions. While the exact role of this sRNA for Salmonella’s 
metabolism remains to be elucidated in the future, the obtained data suggest STnc440 could be 
an example of the emerging theme of sRNAs acting at the interface of bacterial metabolism and 
virulence (Papenfort and Vogel, 2014). 
The results from ectopically expressing STnc440 under in vivo conditions hint at an extensive 
targetome for this sRNA. Besides CRP, glutaredoxin and entericidin were found to be additional 
high-confidence STnc440 targets. Salmonella and E. coli have two major redox systems to repair 
oxidized sulfhydryl groups in cytosolic proteins, namely the thioredoxin and glutathione/ 
glutaredoxin systems (Stewart et al., 1998). Previous studies have uncovered a link between the 
expression of thioredoxin 1 (TrxA) and Salmonella virulence, as a trxA deletion strain displayed 
a virulence defect in BALB/c mice and a cell culture model of murine macrophage-like cells (Bjur 
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et al., 2006; Negrea et al., 2009). In the same work deletion of grxA was found to increase fitness 
of Salmonella in the macrophage model (Bjur et al., 2006).  
Recently slowly growing, persistent Salmonella within host tissues have been reported to 
contain elevated levels of EcnB protein compared to actively replicating bacterial cells (Claudi et 
al., 2014). The fact that the bacteriolytic toxin EcnB is part of a toxin/anti-toxin (TA) system 
(Bishop et al., 1998) would thus fit to the emerging theme of TA systems playing major roles in 
persistence formation (Gerdes and Maisonneuve, 2012; Helaine et al., 2014). At the moment, 
however, it is still unclear whether increased EcnB expression is a cause or consequence of the 
persistent lifestyle. If the former holds true, one could speculate that STnc440 – by regulating 
EcnB expression – is involved in persister cell formation. (See section 5.5.3. for further 
information.) Future studies need to address the biological relevance of the regulation of GrxA 
and EcnB by STnc440 and whether they contribute to Salmonella’s virulence state. 
 
 
Figure 4.1|Preliminary working model for the role of STnc440 in host-pathogen interplay. A balanced 
expression of SPI-2 effectors that may be adjusted by STnc440 would prevent the premature induction of 
SOCS3, thereby enabling the activation and nuclear import of STAT3. This is accompanied by induced mRNA 
levels of anti-inflammatory IL-24 while pro-inflammatory IL-8 expression is appeased, presumably protecting 
the pathogen from an exaggerated host response. Black: findings reported in the present study; grey: Y. Chao, 
personal communication. 
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In summary, the presented data support a role for STnc440 in controlling far-reaching 
regulatory networks that enable Salmonella to adopt its specific intracellular state. In this 
respect, STnc440 appears reminiscent of the recently described E. coli sRNA McaS (Jorgensen et 
al., 2013) that regulates various targets via different mechanisms that converge to control 
biofilm formation. Similarly, several Vibrio harveyi sRNAs were shown to coordinate the quorum 
sensing response (Tu et al., 2010) and the RsaA sRNA has recently been reported to control 
persistence in Staphylococcus aureus (Romilly et al., 2014). These examples might eventually 
turn out to represent just the tip of the iceberg of a novel class of “lifestyle-regulating sRNAs”. 
 
4.3 The STnc440 regulon may modulate the host response towards an appeased 
state 
As described in the second chapter of this study, although HeLa cells are generally considered a 
host infection model of restricted immune pathway activity, it was capable of mounting a 
defined response against invading bacteria. This comprised both coding and non-coding 
transcript expression changes. Major differences were detected for the two sub-populations of 
invaded hosts and non-infected bystanders. This appears reasonable as HeLa cells neither 
express TLR2 nor MD2 (a critical co-receptor of TLR4) and thus, the two major cell surface PRR 
signaling cascades are inhibited in this cell type (Wyllie et al., 2000). Accordingly, the early stage 
of infection was characterized by the induction of a NFκB response specifically in intracellularly 
stimulated, GFP-positive cells but not in extracellularly exposed bystanders. In fact, several of 
the most strongly induced mRNAs at 4 h p.i. were found to be derived from NFκB-dependent 
immune genes. This indicates that intracellular PAMP sensing – e.g. via NOD1 (Buchholz and 
Stephens, 2008) – would be required for efficient NFκB activation in this cell type, similar to 
what has been shown for THP-1 (Tukhvatulin et al., 2013). During the late infectious stage, 
mitochondrial genes were strongly activated – again specifically in the invaded host cell fraction. 
This was accompanied by the general down-regulation of the majority of other cellular 
transcripts. Collectively, these data might hint at a substantial degree of host cellular stress 
during the late stages of invasive infection. Importantly, these effects are very likely to be 
mitigated – and thus overseen – without the FACS-based separation step as the non-infected 
bystanders form by far the majority of cells in the culture. As revealed in the third chapter of this 
study, STnc440 expression seems to contribute significantly to certain modules of this 
characteristic host response, since HeLa-S3 cells containing intracellular ΔSTnc440 bacteria 
differed from wild-type-infected cells in several aspects. 
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For example, host mRNAs of factors involved in JAK/STAT signaling were differentially 
expressed between wild-type and mutant infections. In particular, SOCS3 induction was 
accelerated in ΔSTnc440- compared to wild-type-infected cells. Interestingly, effectors from the 
SPI-2 locus have previously been suggested to influence SOCS and STAT signaling (Uchiya and 
Nikai, 2005, 2008). Therefore, the here-described observations would favor a model wherein 
balancing virulence gene expression by the STnc440 sRNA helps Salmonella to adjust the 
magnitude and/or timing kinetics of the host’s immune response in a way that is ideal to 
establish and maintain its intracellular lifestyle (Fig. 4.1). Intriguingly, due to the fact that 
eventually the levels of secreted cytokines are affected in a STnc440-dependent manner, 
alterations will be communicated to the non-infected bystander cells and influence the entire 
cell population. Such a self-amplifying effect might explain how the deletion of this single 
bacterial sRNA could result in a fitness defect in diverse models of Salmonella infection.  
 
4.4  The concept of “molecular phenotypes” of bacterial sRNAs 
Data collected over the past decades has revealed an ever increasing number of bacterial sRNAs, 
many of which could be shown to serve key functions in orchestrating responses to changing 
environmental conditions and various stresses (Benjamin et al., 2010; Bobrovskyy and 
Vanderpool, 2014; Repoila et al., 2003; Vogel and Papenfort, 2006). For bacterial model 
organisms growing under diverse conditions in culture flasks, genetics and diverse biochemical 
assays are routinely applied to provide insight into the mechanistic aspects and cellular roles of 
individual sRNAs. Conversely, as infection constitutes a tight interplay of two different 
organisms, methods to investigate the pathogen in isolation from its host can never provide the 
full picture and are thus unsuited to profile virulence-associated sRNAs. Techniques, however, 
are lacking for the functional study of sRNAs during infection of host cells. Even though global 
mutant screens in animal models of infection have recently been introduced as an invaluable 
tool to identify bacterial genes that contribute to pathogenesis, functional analyses to uncover 
the underlying mechanisms have largely lagged behind. In other words, while transposon 
screens can address if a given sRNA (or any other gene) contributes to pathogenicity, methods 
are needed to assess how it would do so. 
In theory, Dual RNA-seq has the potential to close this gap: Its universal character to detect and 
quantify all expressed transcript classes, irrespective of their kingdom affiliation, enables the 
simultaneous analysis of gene expression in pathogen and host. In the present study, however, a 
preliminary comparative Dual RNA-seq time-course of infection between wild-type and a 
mutant strain devoid of STnc440 did not reveal consistent changes (see above). Nevertheless, 
future efforts should attempt to profile STnc440-dependent gene expression changes in the 
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pathogen and its host by Dual RNA-seq, probably in physiologically more relevant models (e.g. 
primary cells or in animal models) and/or in greater depth and resolution. Furthermore, as 
infection is a highly variable biological process it is desirable to further decrease the material 
constraints for cDNA library construction to allow gene expression to be monitored in more 
defined sub-populations of infected cells (see sections 5.5.3 and 5.5.4). This way, it might 
eventually become possible to resolve the “footprint” of a given bacterial sRNA (or any other 
virulence factor) on both the pathogen and host transcriptomes during infection. 
Traditional techniques to profile the phenotypes of individual sRNA mutants (e.g. c.f.u. assays or 
host cell death measurements) can be considered end-point determinations as the net outcome 
of infection is assessed. Dual RNA-seq would in principle allow effects to be appreciated much 
earlier as the transcriptome rapidly adapts to changing conditions and therefore mirrors the 
physiological state of the cells at any given time point after infection. Such a “molecular 
phenotype” might or might not eventually lead to a “macroscopic phenotype” (i.e. a virulence 
defect). In the long run Dual RNA-seq is proposed as a method to complement macroscopic with 
molecular phenotypes for virulence genes during bacterial infections of eukaryotic cells, to 
provide a new angle on host-pathogen interaction studies. 
 
4.5  Future applications 
The HeLa-S3 infection model proved suitable for the purpose of evaluating the general feasibility 
of Dual RNA-seq and revealed new aspects of Salmonella infection. Future studies should aim at 
transferring the method to model systems closer to physiological conditions of the infection with 
Salmonella and other pathogens. In the following, a selection of scientific questions are listed, for 
which to answer Dual RNA-seq is envisaged to be helpful in the future. 
4.5.1 Molecular phenotyping of deletion mutants of entire sRNA regulons during infection 
STnc440 was one of the most induced Salmonella genes during infection of both epithelial and 
monocytic host cells and gave rise to virulence defects when inhibited. In contrast, several 
further host-induced sRNAs identified in the present work did not produce a positive hit in 
global transposon screens for Salmonella virulence genes (Barquist et al., 2013; Chaudhuri et al., 
2013; Santiviago et al., 2009). This means that the mere intracellular induction of a given sRNA 
cannot be considered strict evidence for it giving rise to a virulence phenotype when deleted. To 
some extent this may be due to functional redundancy, as several sRNAs have been shown to 
regulate the same mRNA target. Additionally sRNAs generally do not function as on/off switches 
but rather as timers or fine-tuners of target gene expression. The present Dual RNA-seq data 
provides a resource for the identification of co-regulated sRNAs and the prediction of their 
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corresponding activator. Deleting functionally related sRNA pairs (see Appendix) or entire sRNA 
regulons, rather than individual sRNAs alone, combined with profiling the in vivo performance of 
the resulting mutants could inform about the joint contribution of functionally redundant or co-
regulated sRNAs to bacterial virulence. 
For example, several sRNAs are known to be induced together with major virulence programs 
under infection conditions in Salmonella or pathogenic E. coli. Previous work on IsrM 
demonstrated that this sRNA is activated under conditions of low pH and increased osmolarity 
and to regulate the expression of hilE, encoding a negative regulator of SPI-1 (Gong et al., 2011). 
Furthermore, there are currently three confirmed HilD/HilA-responsive sRNAs, InvR (Pfeiffer et 
al., 2007), DapZ (Chao et al., 2012) and IsrJ (Padalon-Brauch et al., 2008), and two PhoP-
dependent sRNAs, MgrR (Moon et al., 2013) and STnc440 (Y. Chao, personal communication). 
However, intracellular sRNA expression kinetics derived from temporal Dual RNA-seq profiling 
of wild-type Salmonella revealed further sRNAs to have similar expression patterns and suggest 
that their production might be also HilD- or PhoP-driven. An assessment of multi-mutant strains 
devoid of these putative regulons of SPI-1- or SPI-2-associated sRNAs might help solve the 
current controversy concerning the fact that ∆hfq mutants of many pathogens are highly 
attenuated while individual sRNA deletion strains display only modest (if any) virulence 
phenotypes (Chao and Vogel, 2010). 
4.5.2 Towards in vivo Dual RNA-seq 
As was shown for infected BMDMs in the present work, Dual RNA-seq can be applied to isolated 
and in vitro-infected primary cells. However, primary cells appeared to be more sensitive to 
RNAlater fixation and/or the mechanical stress applied during cell sorting than immortalized 
cell types. Therefore, for the design of larger-scale experiments in the future, the current 
protocol will have to be optimized for primary cells. Future attempts should also include the 
transfer of the Dual RNA-seq technique to three-dimensional tissue models (e.g. Pusch et al., 
2011) or to animal models such as the streptomycin-treated mouse (Barthel et al., 2003).  
4.5.3 Intra-species pathogen heterogeneity: transcriptomics for bacterial persisters and their hosts 
Genetically identical cells do not necessarily behave alike. Instead, many bacterial species are 
known to display extensive phenotypic variation, e.g. with respect to their division rate or 
susceptibility to antibiotics. A prominent example is bacterial persistence (Balaban et al., 2013). 
Persisters are defined as multidrug-tolerant bacterial cells causing relapsing, chronic infections. 
Moreover, persistence usually comprises a non-replicating, dormant cell state. Recently novel 
tools have emerged that foster the study of bacterial persisters (Helaine and Kugelberg, 2014). 
For instance, fluorescence-based techniques have been successfully used both in vitro and in vivo 
88 
 
to demonstrate how host tissues and sub-cellular micro-environments diversify Salmonella 
phenotypic heterogeneity with consequences for disease progression and the development of 
therapeutics to eradicate persisting individuals (Claudi et al., 2014; Helaine et al., 2014). The 
combination of these techniques with Dual RNA-seq could permit unprecedented insight into the 
molecular mechanisms underlying the persistence phenotype as well as into the host response 
to persistent pathogens.  
4.5.4 Single-cell Dual RNA-seq 
Not only bacterial but also eukaryotic cells occasionally vary dramatically with respect to their 
behavior despite an identical genetic background (examples are reviewed in Saliba et al., 2014). 
This cell-to-cell variability is known to be reflected in the transcriptomic composition between 
individuals. As infection comprises two organisms, that both may display a certain extent of 
heterogeneity, the total variability between two infected cells is expected to exceed the variation 
between two uninfected host cells or between extracellular bacteria. In other words, variability 
potentiates with the number of different organisms involved in a biological process. 
In recent years, ever-increasing sensitivity of research instruments together with the 
automation of many experimental steps from single-cell isolation to sample preparation and 
data analysis have facilitated single-cell studies, including single-cell transcriptomics. The major 
challenge the field of single-cell RNA-seq currently faces is to broaden the range of detectable 
transcripts from polyadenylated-only to all types of cellular RNA classes. In parallel, sensitivity 
will have to increase to make the method eventually compatible with the minute RNA amounts 
of a single prokaryotic cell. Once these prerequisites have been attained, Dual RNA-seq on single 
infected cells should become feasible and provide unprecedented resolution to infection biology.  
4.5.5 Bacterial/viral co-infections 
Viruses hijack the transcription machinery of their host, meaning that a virus-infected cell will 
produce only a single transcriptome (even if the resulting reads from a RNA-seq experiment 
map to two different genomes). For example, in line with viral mRNAs being transcribed by the 
host machinery, they become capped and polyadenylated. In addition, viral transcripts will 
usually be produced at very high amounts. Consequently, RNA-seq-based transcriptome analysis 
of virus-infected host cells is straight-forward (Lisnic et al., 2013). 
It is known that infection by a pathogen may heighten the likelihood of a secondary infection 
with a different pathogenic species. Such co-infections occur frequently between several 
bacterial pathogens and certain viruses, such as Streptococcus spp. and influenza virus (Chertow 
and Memoli, 2013), Trichomonas vaginalis and human immunodeficiency virus (Kissinger and 
Adamski, 2013) or Chlamydia trachomatis and human herpes virus (Prusty et al., 2013). The 
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genome-independent nature of RNA-seq again bears great potential to analyze gene expression 
changes of the host together with those of its multiple pathogens. 
 
4.6  Conclusions and perspectives 
Compared to traditional methods, RNA-seq provides unprecedented access to the 
transcriptomes of potential hosts or pathogens, it improves the annotation of genomes and 
enables the detection of novel genes. This has caused a shift from hypothesis-based to unbiased, 
discovery-driven approaches, thereby increasing the likelihood of identifying novel principles. 
The described Dual RNA-seq technique comprises many of the advantages associated with 
classical RNA-seq but profiles gene expression in host and pathogen simultaneously while they 
physically interact. It can therefore provide new insights into the infection process that could not 
be obtained before by sequencing the individual partners in isolation. The present work focuses 
largely on the contribution of Salmonella sRNAs to the adoption of the pathogen’s intracellular 
state and the contextual manipulation of its host. However, similar analyses appear feasible for 
other bacterial virulence genes or host factors that define susceptibility or contribute to defense 
mechanisms towards bacterial infection. 
Furthermore, future research may shift from the analysis of ‘average’ cellular responses to the 
detection of more specific expression programs in defined sub-populations of host cells 
challenged with pathogens (e.g. bystanders, invaded hosts containing bacterial loads in varying 
amounts). Likewise, there is variability within the bacterial population, e.g. with respect to the 
pathogenicity of individual members (i.e. replicating vs. persisting bacteria). The synchronized 
detection of host and pathogen expression by Dual RNA-seq can be applied to assess the role of 
stochasticity and cell type-specificity for the development of such phenotypes; features that 
would not be addressable by sequencing the transcriptome of either host or pathogen alone. 
Ongoing advances in ‘third-generation’ sequencing methods are expected to further boost multi-
transcriptomics approaches. In particular, recent improvements in nanopore sequencing 
(Loman and Quinlan, 2014; Mattei, 2014; Rosenstein, 2014; Ying et al., 2014) appear highly 
promising, as this technology is potentially compatible with direct RNA sequencing (i.e. without 
a cDNA intermediate) and without read length limitation. The expected increase in throughput 
and sensitivity might enable scientists to resolve gene expression events during infection in finer 
detail by scaling down the number of cells – potentially down to the single-cell level.  
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5. Material and methods 
 
5.1  Material 
5.1.1 Technical instruments 
Table 5.1|List of instruments and devices used.  
Instrument/device Manufacturer 
analytical balances TE64, TE601 Sartorius 
Bio-Link BLX 254 UV-Crosslinker PeqLab 
centrifuge Eppendorf 5415R Eppendorf 
centrifuge Eppendorf 5424 Eppendorf 
centrifuge Hereaus Multifuge X3R Thermo Scientific 
eraser for imaging screens Molecular Dynamics 
FACSAria III BD Biosciences 
FACSCalibur BD Biosciences 
gel documentation system Gel iX Imager INTAS UV Systeme 
heat block Thermomixer comfort Eppendorf 
horizontal electrophoresis system Perfect Blue Mini S, M, L PeqLab 
hybridization oven HP-1000 UVP 
imaging system Image Quant LAS 4000 GE 
incubator for bacterial plates Memmert 
incubator for cell culture flasks HERAcell 150i Thermo Scientific 
Infinite F200 PRO plate reader TECAN 
Innova 44 shaker New Brunswick Scientific 
LEICA SP5 confocal microscope  Leica 
light microscope Eclipse TS100 Nikon 
MACSQuant Analyzer  Miltenyi Biotec 
MicroPulser electroporator BioRad 
MiSeq Illumina 
Multiskan Ascent  Thermo Electron Corporation 
PCR cycler MJ Mini BioRad 
phosphoimager Typhoon FLA 7000 GE 
photometer Ultraspec 10 Cell Density Meter Amersham Biosciences 
power supplies peqPOWER E300 PeqLab 
Qubit 2.0 Fluorometer Life Technologies 
real time PCR cycler CFX96 Real-Time System BioRad 
Refrigerated Incubator Shaker C24KC PeqLab 
Safe 2020 cell culture hood Thermo Scientific 
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Table 5.1|continued. 
Instrument/device Manufacturer 
semi-dry electroblotter Perfect Blue SEDEC M PeqLab 
shaking water bath incubator 1092 GFL 
spectrophotometer NanoDrop 2000 Thermo Scientific 
VacuSafe pump IBS Integra Biosciences 
vertical electrophoresis system Perfect Blue Twin S, ExW S, L PeqLab 
Victor3 1420 Multilabel Counter PerkinElmer 
Vortex-Genie 2 Scientific Industries 
water bath HAAKE A10 Thermo Scientific 
 
5.1.2 Glass/plastic ware and consumables  
Table 5.2|List of lab ware used.  
Labware Manufacturer 
12-well plates Corning 
24-well plates Corning 
50 mL syringe BD Plastipak 
6-well plates Corning 
96-well microtiter plates Nunc 
cell scraper 25 cm Sarstedt 
Cellstar serological pipets 5 mL, 10 mL, 25 mL (plastic) Greiner bio-one 
cover slips Hartenstein 
electroporation cuvettes (2 mm) Cell projects 
G-25, G-50 MicroSpin columns GE Healthcare 
Gilson pipets 10 µL, 20 µL, 200 µL, 1,000 µL Gilson 
glass beads (0.1 mm) Roth 
glass bottles Schott 
glass test tubes and lids Roth 
glass tips (for pump) Geyer 
Hard-shell PCR plates 96-well WHT/WHT BioRad 
Hybond-XL Membrane for nucleic acid transfer GE Healthcare 
imaging cassettes Fujifilm 
imaging screens Fujifilm 
inoculation loops (10 µL) VWR 
L-shape bacteriology loops VWR 
MACS pre-separation filters  (30 μm pore size) Miltenyi Biotec 
Multidispenser combitips (5 mL) Eppendorf 
Multidispenser Repeater Plus Eppendorf 
Neubauer counting chamber HBG Henneberg-Sander 
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 Table 5.2|continued. 
Labware Manufacturer 
object slides Hartenstein 
PCR tubes (8 x 0.5 mL stripes) Thermo Scientific 
petri dishes Corning 
phase-lock gel (PLG) tubes 1.5 mL, 2 mL 5 PRIME 
Pipetboy acu-jet pro BRAND 
Pipetman P10, P20, P200, P1000 pipet tips Sarstedt 
PolyScreen PVDF transfer membrane PerkinElmer 
reaction tubes 15 mL, 50 mL Sarstedt 
safe-lock tubes 1.5 mL, 2 mL Eppendorf 
spectrophotometer cuvettes Sarstedt 
Sterile filters (0.2 μm pore size) Sarstedt 
T-150 flasks Corning 
T-25 flasks Corning 
T-75 flasks Corning 
TC Microwell 96F Thermo Scientific 
 
5.1.3 Chemicals, reagents, proteins and size markers 
Table 5.3|List of chemicals, reagents and proteins used.  
Chemicals/reagents/proteins/size markers Manufacturer 
6x DNA loading buffer Fermentas 
Albumin Fraktion V Roth 
ampicillin sodium salt Roth 
Annexin V-APC BD Pharmingen 
chloramphenicol Roth 
D(+)-glucose Merck 
dimethyl dulfoxide (DMSO) Roth 
DMEM Gibco 
EDTA Roth 
ethanol Roth 
ethanol (absolute) Merck 
Gel loading buffer II Ambion 
GeneRuler 1 kb DNA Ladder Fermentas 
gentamicin sulfate salt  Sigma 
GlycoBlue Ambion 
GlycoBlue Ambion 
H2O2 (30%) AppliChem 
Igpal Sigma 
isopropanol Roth 
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Table 5.3|continued. 
Chemicals/reagents/proteins/size markers Manufacturer 
kanamycin sulfate Roth 
L(+)-arabinose Roth 
methanol Roth 
milk powder Roth 
PBS Gibco 
Prestained Protein Marker Broad Range New England Biolabs 
propidium idodide Sigma 
pUC Mix Marker, 8 Fermentas 
random hexamers Invitrogen 
RedSafe ChemBio 
RedSafe ABC Scientific 
RNA Ladder High Range Fermentas 
RNA Ladder Low Range Fermentas 
RNAlater Qiagen 
Roti-Aqua P/C/I Roth 
Roti-Free Roth 
Roti-Hybri-Quick Roth 
Rotiphorese gel 40 (19:1) Roth 
Rotiphorese gel 40 (37.5:1) Roth 
RPMI Gibco 
SUPERaseIN RNase Inhibitor Ambion 
tetracycline Roth 
Triton X-100 Sigma 
TRIzol reagent Invitrogen 
Western Lightning chemiluminescence reagent PerkinElmer 
 
5.1.4 Commercial kits 
Table 5.4|Commercial kits used.  
Kit Manufacturer 
CytoTox 96(R) Non-Radioactive Cytotoxicity Assay Promega 
Human CXCL8/IL-8 DuoSet R&D Systems 
MAXIscript T7 Kit Ambion 
MEGAscript T7 Kit Ambion 
mirVana miRNA isolation kit Life technologies 
NucleoSpin Extract II Macherey-Nagel 
NucleoSpin Plasmid QuickPure Macherey-Nagel 
Power SYBR Green RNA-to-CT 1-Step Kit Life technologies 
P-STAT sampler kit Cell Signaling Technology 
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 Table 5.4|continued. 
Kit Manufacturer 
Rediprime II DNA Labeling System GE Healthcare 
SV40 Total RNA Isolation System Promega 
TOPO TA Cloning Kit Invitrogen 
 
5.1.5 Enzymes 
Table 5.5|List of enzymes used.  
Enzyme Manufacturer 
Calf Intestine Alkaline Phosphatase (CIP, 10 U/µL) New England Biolabs 
Deoxyribonuclease I (DNase I, 1 U/µL) Fermentas 
DpnI (20 U/µL) New England Biolabs 
Pfu DNA Polymerase (2.5 U/µL) Fermentas 
Phusion High-Fidelity DNA Polymerase (2 U/µL) New England Biolabs 
Shrimp Alkaline Phosphatase (SAP, 1 U/µL) Fermentas 
SuperScript II Reverse Transcriptase Invitrogen 
SuperScript III Reverse Transcriptase Invitrogen 
T4 DNA Ligase (5 U/µL) Fermentas 
Taq DNA polymerase (5 U/µL) New England Biolabs 
Tobacco Acid Pyrophosphatase (TAP, 10 U/µL) Epicentre 
Trypsin-EDTA (0.25%), phenol red Gibco 
Various restriction enzymes from New England Biolabs or Fermentas 
  
5.1.6 Antibodies 
Table 5.6|List of primary and secondary antibodies and -sera used.  
Antibody/antiserum Source Dilution Provider 
anti-FLAG mouse (1:1,000 in 3% BSA) Sigma 
anti-GroEL  rabbit (1:10,000 in 3% BSA) Sigma 
anti-CRP  rabbit (1:500 in 3% BSA) Hiroji Aiba (Nagoya, Japan) 
anti-phospho-Stat3 (Tyr705) rabbit (1:1,000 in 3% BSA) Cell Signaling Technology 
anti-phospho-Stat3 (Ser727) rabbit (1:1,000 in 3% BSA) Cell Signaling Technology 
anti-tubulin mouse (1:10,000 in 3% BSA) Ana Eulalio (Würzburg, Germany) 
anti-mouse  goat (1:10,000 in 3% BSA) Thermo Scientific 
anti-rabbit  goat (1:10,000 in 3% BSA) Thermo Scientific 
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5.1.7 Synthetic oligonucleotides 
Table 5.7|List of synthetic oligonucleotides used.  
name target purpose nucleotide sequence 
Salmonella-directed oligonucleotides 
JVO-1117 Salmonella rfaH qRT-PCR sense primer 5'-TCAGCCATTTTGTGCGCTT-3' 
JVO-1118 Salmonella rfaH qRT-PCR antisense primer 5'-TTCAGGATCGACAACGCCTT-3' 
AE-1 gfp qRT-PCR sense primer 5'-ATGCTTTTCCCGTTATCCGG-3' 
AE-2 gfp qRT-PCR antisense primer 5'-GCGTCTTGTAGTTCCCGTCATC-3' 
JVO-4621 Salmonella STnc440 qRT-PCR sense primer 5'-AGTAACGGATTACTTTGTGGTG-3' 
JVO-9040 Salmonella STnc440 qRT-PCR antisense primer 5'-ACTACGCTGCCGCAAATAT-3' 
JVO-9804 Salmonella RyhB qRT-PCR sense primer 5'-GCATCCAGGGGAACCC-3' 
JVO-9805 Salmonella RyhB qRT-PCR antisense primer 5'-CAGCAAAAGCTGGCCAA-3' 
JVO-8216 Salmonella RybB qRT-PCR sense primer 5'-GCCACTGCTTTTCTTTGATGT-3' 
JVO-8217 Salmonella RybB qRT-PCR antisense primer 5'-AACCCACCAACCTTGAACC-3' 
JVO-10198 Salmonella STnc510 qRT-PCR sense primer 5'-TAAATCGGAGCGGGAATAAAG-3' 
JVO-10199 Salmonella STnc510 qRT-PCR antisense primer 5'-GCTTCACAGTCCTCACGTGAC-3' 
JVO-322 Salmonella 5S rRNA Northern probe 5'-CTACGGCGTTTCACTTCTGAGTTC-3' 
JVO-9982 Salmonella tRNA-fMet Northern probe 5'-GACGAGCTACCAGGCTGCT-3' 
JVO-10085 Salmonella tRNA-Ser Northern probe 5'-TCAAGACCGGTGCCTTCAA-3' 
JVO-2408 Salmonella STnc440 Northern probe 5'-TATGAGGAGGACAATTACCG-3' 
JVO-10254 Salmonella sseA qRT-PCR sense primer 5'-CTTGCTGAAAGGGCAGAGAG-3' 
JVO-10255 Salmonella sseA qRT-PCR antisense primer 5'-TTCTTTAAATCCTTCTCGGCC-3' 
JVO-10250 Salmonella sseC qRT-PCR sense primer 5'-GAGGTGCAAAATGCATTACGTA-3' 
JVO-10251 Salmonella sseC qRT-PCR antisense primer 5'-CTTTACGCGCTTTATCCTCCT-3' 
JVO-11545 Salmonella steC qRT-PCR sense primer 5'-GACGGATGCATCACAACCAG-3' 
JVO-11546 Salmonella steC qRT-PCR antisense primer 5'-CATGTAACCGATAGACTGTCCCA-3' 
JVO-10290 Salmonella ssrB qRT-PCR sense primer 5'-GGAAGCTATCCTGGCTGAATTA-3' 
JVO-10291 Salmonella ssrB qRT-PCR antisense primer 5'-ATTCATCCGGTGTGTTTCG-3' 
JVO-10398 Salmonella phoP qRT-PCR sense primer 5'-AAGAGGTAATGGCGCGTATG-3' 
JVO-10399 Salmonella phoP qRT-PCR antisense primer 5'-GATGACCTCTTCATTGACGGA-3' 
JVO-5528 Salmonella hilD qRT-PCR sense primer 5'-GTACGTCAACGCTCAAACG-3' 
JVO-566 Salmonella hilD qRT-PCR antisense primer 5'-GAAACATTGAATGAAGTAGGACG-3' 
JVO-9805 Salmonella RyhB Northern probe 5'-CAGCAAAAGCTGGCCAA-3' 
JVO-9807 Salmonella IsrE Northern probe 5'-AGGCGGGCAAATAATACTG-3' 
JVO-1001 Salmonella OmrA Northern probe 5'-GAGACAGGTACGAAGAGCGTAC-3' 
JVO-1000 Salmonella OmrB Northern probe 5'-TGTGATCAACAATGACGTTGA-3' 
JVO-12151 Salmonella YrlA Northern probe 5'-ATTGAGCTACAGAGCCGGG-3' 
JVO-12152 Salmonella YrlB Northern probe 5'-TCATAGCCGGGATGATACG-3' 
JVO-10705 Salmonella grxA 
sense oligo to add 3xFLAG to grxA in 
SL1344 
5'-TTTTGAAGCATGGGCAAAAGAAAATCTGAATCTTTTCGCC 
GACTACAAAGACCATGACGG-3' 
JVO-10706 Salmonella grxA 
antisense oligo to add 3xFLAG to grxA and 
antisense deletion primer of grxA in SL1344 
5'-CGCCGATAGCGCCCTCCGTCAGAGGGCGTTGCCAGAGC 
AACCATATGAATATCCTCCTTAG-3' 
JVO-11247 Salmonella grxA 
sense deletion primer of grxA in SL1344 (-40 
to -1 upstream of AUG) 
5'-ACCTGTTCGCCGTCTGGCTTTATGTTCGAGGAGAGATATG 
GACTACAAAGACCATGACGG-3' 
JVO-11657 Salmonella steC 
sense oligo to add 3xFLAG to steC in 
SL1344 
5'-GACTCTTGTGGCTAAGGTATTAAAGGATGAATTAAAAAAA 
GACTACAAAGACCATGACGG-3' 
JVO-11658 Salmonella steC 
antisense oligo to add 3xFLAG to steC in 
SL1344 
5'-TGTGCCCCCGGCGATTCGCAGAAAAGAACGGAACTAAAT 
GCCATATGAATATCCTCCTTA-3' 
JVO-11657 Salmonella steC 
sense oligo to add 3xFLAG to steC in 
SL1344 
5'-GACTCTTGTGGCTAAGGTATTAAAGGATGAATTAAAAAAA 
GACTACAAAGACCATGACGG-3' 
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Table 5.7|continued. 
 
name target purpose nucleotide sequence 
JVO-11658 Salmonella steC 
antisense oligo to add 3xFLAG to steC in 
SL1344 
5'-TGTGCCCCCGGCGATTCGCAGAAAAGAACGGAACTAAAT 
GCCATATGAATATCCTCCTTA-3' 
JVO-10703 Salmonella grxA sense oligo to generate grxA::gfp fusion 5'-GTTTATGCATGTTCGCCGTCTGGCTTTA-3' 
JVO-10704 Salmonella grxA antisense oligo to generate grxA::gfp fusion 5'-GTTTTGCTAGCATCGTCGCGTTCTTTGCTC-3' 
JVO-11991 Salmonella grxA 
sense mutagenesis primer to generate grxA** 
construct 
5'-TTCGAGGAGAGATATGTTTAGTGTTATTTTTGGCCGTCCA 
GG-3' 
JVO-11759 Salmonella grxA antisense primer to generate grxA** construct 5'-TCTCCTCGAACATAAAGCCAGAC-3' 
JVO-4224 Salmonella crp 
sense oligo to generate crp::gfp fusion 
(1°TSS) 
5'-GTTTTTTATGCATTTCCCAGGTAGCGGGAAGT-3' 
JVO-4225 Salmonella crp 
antisense oligo to generate crp::gfp fusion 
(1°TSS) 
5'-GTTTTTTCTAGAAAACCGCAAACAGACCCG-3' 
JVO-5850 Salmonella crp 
sense oligo to generate crp::gfp fusion 
(2°TSS) 
5'-GTTTTTTATGCATGATGCTACAGTAATACATTGACGTAC-3' 
JVO-5851 Salmonella crp 
antisense oligo to generate crp::gfp fusion 
(2°TSS) 
5'-GTTTTTTGCTAGCACGGGTGCCGTAGACGAC-3' 
JVO-4621 Salmonella STnc440 sense oligo to clone STnc440 5'-p~AGTAACGGATTACTTTGTGGTG-3' 
JVO-4724 Salmonella STnc440 antisense oligo to clone STnc440 5'-GTTTTTTTCTAGATTGTCTGTTAATTATTACAGAGAGAG-3' 
JVO-5853 Salmonella STnc440 sense oligo to clone pOWN-STnc440 5'-GTTTTTTCTAGACTGTCACAGTATGCTAAAACAG-3' 
JVO-5473 Salmonella STnc440 sense oligo to introduce STnc440* mutation 5'-CGTAACCCTAATTGTCCTCCTCATATTTGC-3' 
JVO-5474 Salmonella STnc440 
antisense oligo to introduce STnc440* 
mutation 
5'-CAATTAGGGTTACGCTACACCACAAAGTAAT-3' 
JVO-8695 Salmonella ssaG sense oligo to clone ssaG promoter 5'-GTTTTGACGTCGAGTGGTAGTTTGGGACTAC-3' 
JVO-8696 Salmonella ssaG antisense oligo to clone ssaG promoter 5'-GTTTTGCTAGCTTTAATCATCGATTCTGG-3' 
JVO-4726 Salmonella STnc440 sense oligo to disrupt STnc440 
5'-AATCTATTTTTACTGTCACAGTATGCTAAAACAGAACAAG 
GTGTAGGCTGGAGCTGCTTC-3' 
JVO-8070 Salmonella STnc440 antisense oligo to disrupt STnc440 
5'-GAGTTAATTTATAAAAAAAAGCGGCAGACTACGCTGCCGC 
GGTCCATATGAATATCCTCC-3' 
JVO-8739 Salmonella STnc440 
sense oligo to introduce trans-complemented 
STnc440::Cm in put locus 
5'-GCAGGTCACATTTAACGCGGTTGCACAAGTTGCAACATG 
CCGTCTTACTGTCCCTAGTG-3' 
JVO-8740 Salmonella STnc440 
antisense oligo to introduce trans-
complemented STnc440::Cm in put locus 
5'-GACCCGGATAGTAATTTTGCCCGGCCAGATGATAAATCG 
CGATGTCCTACTCAGGAGAG-3' 
JVO-5796 Salmonella STnc440 sense oligo to exchange Cm to dfhr 
5'-GTTCTGAGGTCATTACTGGATCTATCAACAGGAGTCCAA 
GTACACATCTCAACCATCAT-3' 
JVO-5797 Salmonella STnc440 sense oligo to exchange Cm to dfhr 
5'-TATCTGGCGAAAATGAGACGTTGATCGGCACGTAAGAGG 
TTTATACACATCTCAACCCT-3' 
JVO-9313 Salmonella STnc440 
sense oligo to introduce trans-complemented 
STnc440::dhfr in trg locus 
5'-TTAACGCTTATATGTCCAGAGCGGTGAAAACACCCGCCG 
ACTTACTGTCCCTAGTGCTTGG-3' 
JVO-9314 Salmonella STnc440 
antisense oligo to introduce trans-
complemented STnc440::dhfr in trg locus 
5'-CGTTCAGCGCCAGGATGTTGGTCTGGAAAGCGATACTGT 
TCGGATTTGTCCTACTCAGGA-3' 
human-directed oligonucleotides 
JVO-7673 human U6 snRNA qRT-PCR sense primer 5'-GCTTCGGCAGCACATATACTAAAAT-3' 
JVO-7672 human U6 snRNA qRT-PCR antisense primer 5'-ATATGGAACGCTTCACGAATTTG-3' 
JVO-5409 human β-actin  qRT-PCR sense primer 5'-CCTGTACGCCAACACAGTGC-3' 
JVO-5410 human β-actin  qRT-PCR antisense primer 5'-ATACTCCTGCTTGCTGATCC-3' 
JVO-12865 human SOCS1  qRT-PCR sense primer 5'-GACTGCCTCTTCGAGCTGC-3' 
JVO-12866 human SOCS1  qRT-PCR antisense primer 5'-CTGGAAGGGGAAGGAGCTC-3' 
JVO-11432 human SOCS2 qRT-PCR sense primer 5'-GCCAAAGAGAAATTAAAAGAGGCA-3' 
JVO-11433 human SOCS2 qRT-PCR antisense primer 5'-GAAGATTAGTTGGTCCAGCTGATG-3' 
JVO-12867 human SOCS3 qRT-PCR sense primer 5'-TGGTCACCCACAGCAAGTTT-3' 
JVO-12868 human SOCS3 qRT-PCR antisense primer 5'-GGCACTGAGCAGCAGGTTC-3' 
JVO-10352 human IL24 qRT-PCR sense primer 5'-TCCCTTGCCTGGGTTTTAC-3' 
JVO-10353 human IL24 qRT-PCR antisense primer 5'-CCAGAAGGCTTCCCACAGT-3' 
JVO-8832 human IL8 qRT-PCR sense primer 5'-CTGGCCGTGGCTCTCTTG-3' 
JVO-8833 human IL8 qRT-PCR antisense primer 5'-CCTTGGCAAAACTGCACCTT-3' 
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5.1.8 Plasmids 
Table 5.8|List of plasmids used.  
trivial 
name 
stock 
number 
relevant 
insert 
comment parental 
plasmid 
resistance 
marker 
reference 
pBAD-ctrl. pKP8-35 
 
empty control plasmid 
 
Amp 
 
pBAD-
STnc440 
pYC5-34 STnc440 
wild-type STnc440 under arabinose-inducible 
promoter 
pBAD Amp this study 
pBAD-
STnc440* 
pYC60 STnc440* 
double point-mutated STnc440 under 
arabinose-inducible promoter 
pBAD Amp this study 
FLP helper 
plasmid  
pCP20 
 
used to heal genetically modified SL1344 
derivates   
Datsenko and 
Wanner, 2000 
pOWN-ctrl. pJV300  
 
empty control plasmid pZE12 Amp this study 
pOWN-
STnc440 
pYC55  STnc440 wild-type STnc440 under native promoter pZE12 Amp this study 
pXG-10 
  
empty control plasmid 
 
Cm 
 
grxA::gfp pYC213 grxA::gfp grxA-30aa translational GFP fusion pXG-10 Cm this study 
crp(1°TSS)::
gfp 
pYC53 
crp::gfp 
(1°TSS) 
crp-10aa translational GFP fusion pXG-10 Cm this study 
crp(2°TSS)::
gfp 
pYC51 
crp::gfp 
(2°TSS) 
crp-50aa translational GFP fusion fusion pXG-10 Cm this study 
pXG-0 
  
negative control vector 
 
Cm 
 
pXG-1 
 
gfp positive control vector 
 
Cm 
 
ssaG::gfp pYC104 
ssaG 
promoter 
ssaG promoter fused to gfp pAS093 Cm this study 
 
5.1.9 Bacterial strains 
Table 5.9|List of Salmonella strains used.  
trivial name stock 
name 
resistance 
marker 
comments reference 
WT JVS-3858 Str, Cm 
constitutively GFP-expressing SL1344 strain (GFP 
integrated in the chromosome; ptet-GFP) 
Papenfort et al., 2009 
ΔSTnc440 JVS-10038 Str, Cm 
deletion of STnc440 (terminator was kept) in the 
ptet-GFP background backgound 
this study 
ΔSTnc440+ JVS-10039 Str, Cm, dhfr 
trans-complementation of STnc440 in the ptet-GFP 
background (complementation in in trg locus) 
this study 
grxA::3xflag JVS-11005 Str 
epitope-tagged endogenous grxA on the 
chromosome in the wild-type background 
this study 
ΔSTnc440/grxA::3xflag JVS-11006 Str 
epitope-tagged endogenous grxA on the 
chromosome in the ΔSTnc440 background 
this study 
ΔSTnc440/ΔgrxA JVS-11019 Str 
deletions of STnc440 and grxA from the 
chromosome 
this study 
ecnB::3xflag JVS-11071 Km, Str 
epitope-tagged endogenous ecnB on the 
chromosome in the wild-type background 
this study 
ΔSTnc440/ecnB::3xflag JVS-11072 Km, Str 
epitope-tagged endogenous ecnB on the 
chromosome in the ΔSTnc440 background 
this study 
ΔgrxA JVS-11074 Str deletion of grxA this study 
ΔSTnc440/Δcrp JVS-11011 Str, Tet 
deletion of STnc440 and Tn10 insertion into crp 
gene locus 
this study 
Δcrp JVS-1626  Str, Tet Tn10 insertion into crp gene locus 
P22 lysate was 
obtained from M. 
Teplitski (University of 
Florida); originally 
generated by J. Roth 
sopE::3xflag/steC::3xflag JVS-10981 Str, Kan 
epitope-tagged endogenous sopE and steC on the 
chromosome in the wild-type background 
this study 
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Table 5.9|continued. 
 
trivial name stock 
name 
resistance 
marker 
comments reference 
ΔSTnc440_sopE::3xflag/steC::3xflag JVS-11009 Str 
epitope-tagged endogenous sopE and steC on the 
chromosome in the ΔSTnc440 background 
this study 
ΔSTnc440+_sopE::3xflag/steC::3xflag JVS-10983 Str, Kan 
epitope-tagged endogenous sopE and steC on the 
chromosome in the ΔSTnc440+ background 
this study 
ΔryhB/ΔisrE JVS-10996 Str, Kan 
deletions of ryhB and isrE from the chromosome in 
the ptet-GFP background 
this study 
ΔomrA/ΔomrB JVS-10792 Str, Cm 
deletions of omrA and omrB from the chromosome 
in the ptet-GFP background 
this study 
ΔyrlA/ΔyrlB JVS-10977 Str, Cm 
deletions of yrlA and yrlB from the chromosome in 
the ptet-GFP background 
this study 
 
5.1.10 Media and supplements 
Lennox Broth (LB) liquid medium: 1% (w/v) tryptone 
0.5% (w/v) yeast extract 
85.6 mM NaCl 
SPI-2 MES liquid medium (pH 5.8): 1x MES buffer 
1x phosphate buffer 
0.4% (w/v) glucose 
15 mM NH4Cl 
1 mM MgSO4 
10 µM CaCl2 
0.04% (w/v) L-histidine 
0.001% (w/v) thiamine 
10x Micronutrients 
SOCS liquid medium:   2% (w/v) tryptone 
0.5% yeast extract 
85.6 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
20 mM glucose 
Lennox agar:    LB medium (see above) 
1.2% (w/v) agar 
TOP agar:    1% (w/v) tryptone 
1% (w/v) agar 
10 mM MgSO4 
5 mM CaCl2 
86 mM NaCl 
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DMEM complete:   DMEM (Gibco) 
      10% fetal calf serum (FCS; Biochrom) 
      2 mM L-glutamine (Gibco) 
      1 mM sodium pyruvate (Gibco) 
DMEM complete + Pen/Strep:  DMEM complete 
      1% penicillin/streptomycin 
DMEM complete + gentamicin (low): DMEM complete 
      10 µg/mL gentamicin 
DMEM complete + gentamicin (high): DMEM complete 
      50 µg/mL gentamicin 
RPMI complete:    RPMI (Gibco) 
      10% fetal calf serum (FCS; Biochrom) 
      2 mM L-glutamine (Gibco) 
      1 mM sodium pyruvate (Gibco) 
      0.5% β-mercaptoethanol 
RPMI complete + Pen/Strep:  RPMI complete 
      1% penicillin/streptomycin 
RPMI complete + gentamicin (low): RPMI complete 
      10 µg/mL gentamicin 
RPMI complete + gentamicin (high): RPMI complete 
      50 µg/mL gentamicin 
X-vivo-15 complete:   X-vivo-15 medium (Lonza) 
      10% FCS 
      10% L929-conditioned DMEM (composition as above) 
X-vivo-15 + gentamicin (low):  X-vivo-15 complete 
      10 µg/mL gentamicin 
X-vivo-15 + gentamicin (high):  X-vivo-15 complete 
50 g/mL gentamicin 
 
5.1.11 Buffers and solutions 
30:1 ethanol/sodium acetate:  30 parts of 100% ethanol 
(for RNA precipitation)   1 part of 3M sodium acetate (pH 6.5) 
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Agarose gel electrophoresis solution: X% (w/v) agarose in 1x TAE buffer 
Chemiluminescence solution A:  0.1 M Tris-HCl (pH 8.6) 
     0.025% (w/v) luminol 
Chemiluminescence solution B:  0.11% (w/v) p-coumaric acid (in DMSO) 
DNA loading dye (5x stock):  10 mM Tris-HCl (pH 7.6) 
     60% (v/v) glycerol 
     60 mM EDTA (pH 8.0) 
     0.025% (w/v) bromphenol blue 
PAA gel electrophoresis solution (6%): 100 mL 10x TBE 
(for Northern blots)   420 g 7M Urea 
     150 mL Rotiphorese Gel 40 (19:1) 
     H2O ad 1 L 
PAA stacking gel solution (4%):  1.25 mL Tris solution (“upper buffer”) 
(for Western blots)   1 mL Rotiphorese Gel 40 (37.5:1) 
     7.5 mL H2O 
     75 µL 10% (w/v) APS 
     7.5 µL TEMED 
PAA separation gel solution (12%): 3.75 mL Tris solution (“lower buffer”) 
(for Western blots)   3 mL Rotiphorese Gel 40 (37.5:1 ) 
     3.25 mL H2O 
     150 µL 10% (w/v) APS 
     15 µL TEMED 
Protein loading dye RPA (2x stock): 98% (v/v) formamid 
     2 mM EDTA (pH 8.0) 
0.02% (w/v) bromphenol blue  
0.02% (w/v) xylene cyanol 
RNA loading dye GL-II (2x stock): 0.13% (w/v) SDS 
     18 µM EDTA (pH 8.0) 
     95% formamid 
0.025% (w/v) bromphenol blue  
0.025% (w/v) xylene cyanol 
 SDS running buffer (10x stock):  30.275 g Tris base 
      144 g glycin 
      10 g SDS 
      H2O ad 1 L 
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SSC buffer (20x stock):   3 M NaCl 
      0.3 M sodium citrate 
      titrate to pH 7.0 (using HCl) 
TAE buffer (50x stock):   242 g Tris base 
      51.7 mL acetic acid 
      10 mM EDTA (pH 8.0) 
      H2O ad 1 L 
TBE buffer (10x stock):   108 g Tris base 
      55 g boric acid 
      20 mM EDTA (pH 8.0) 
      H2O ad 1 L 
TBS buffer (10x stock):   24.11 g Tris base 
      72.6 g NaCl 
      titrate to pH 7.4 (using HCl) 
      H2O ad 1 L 
TBST buffer (10x stock):   1x TBS 
      0.1% (v/v) Tween-20 
Transfer buffer (10x stock):  30 g Tris base 
      144 g glycin 
      H2O ad 1 L 
Tris “lower buffer” solution:  1.5 M Tris-HCl (pH 8.8) 
      0.4% (w/v) SDS 
Tris “upper buffer” solution:  0.5 M Tris-HCl (pH 6.8) 
      0.4% (w/v) SDS 
Western development solution:  2 mL chemiluminescence solution A 
200  chemiluminescence solution B 
5 µL 3% (v/v) H2O2 
 
5.2  Methods 
5.2.1 Microbiological methods  
Standard growth conditions: Salmonella enterica serovar Typhimurium strain SL1344 
constitutively expressing GFP from a chromosomal locus (strain JVS-3858) was previously 
described (Papenfort et al., 2009) and is referred to as wild-type throughout this study. The 
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complete list of bacterial strains used in this study is provided in Table 5.9. Bacteria were grown 
in Lennox broth (LB) medium at 37°C with shaking at 220 rpm. When appropriate, 100 μg/mL 
ampicillin (Amp), 50 μg/mL kanamycin (Kan) or 20 μg/mL chloramphenicol (Cm) (final 
concentrations) were added to the liquid medium or agar plates. 
Growth under SPI-2 conditions: To grow Salmonella under SPI-2-inducing conditions, 1 mL of a 
LB overnight cultures was washed 2x in PBS and 1x in synthetic SPI-2 medium (Lober et al., 
2006). The resulting pellet was resuspended in 1 mL of SPI-2 medium and diluted 1:50 in fresh, 
pre-warmed SPI-2 medium (10 mL total culture volume) in 100 mL Erlenmeyer flasks. The 
culture was grown at 37°C, 220 rpm until it reached an OD600 of 0.3 (takes approximately 3 h). 
In vitro SPI-1 to SPI-2 switch assay: To mimic the early stages of the infection of a host cell in 
vitro, the indicated Salmonella strains were grown in LB overnight, diluted 1:100 in LB and 
grown to an OD600 of 2 (i.e. a condition under which SPI-1 is highly induced (Kroger et al., 2013; 
Sittka et al., 2007)), washed 2x with PBS and 1x with SPI-2 medium, diluted 1:50 in pre-warmed 
SPI-2 medium and transferred to either an Erlenmeyer flask (10 mL culture volume; for Western 
blotting) or each three wells of a 96-well plate (150 µL culture volume; for measuring GFP 
intensity). In SPI-2 medium the bacteria were kept growing for the indicated time periods. At the 
respective time points total protein samples were taken for Western blotting or GFP 
fluorescence was measured. 
Transformation of chemically competent E. coli: 10 μl of chemically competent E. coli TOP10 cells 
(Invitrogen) were mixed with 2 µL of a ligation reaction or 10-50 ng of plasmid DNA. The 
mixture was pre-incubated for 30 min on ice. Subsequently cells were heat-shocked for 30 s at 
42°C and chilled for 1 min on ice. Then 900 μl of LB medium was added and cells were recovered 
for 1 h at 37°C, 220 rpm. 100 µL of the culture and the residual volume were plated on LB agar 
supplemented with the appropriate selection antibiotics. 
Preparation and transformation of electro-competent Salmonella: In order to prepare electro-
competent Salmonella cells, LB cultures were inoculated with bacteria from an overnight culture 
(1:100 dilution) and grown at 37°C, 220 rpm to an OD600 of 0.5. Subsequently, the cells were 
chilled for 30 min on ice and centrifuged (20 min; 4,000 rpm; 4°C). The cell pellets were next 
washed once with ice-cold H2O and twice with 10% (v/v) glycerol. The pellets were 
resuspended in 1 OD600/100 µL of ice-cold H2O and each 100 µL were distributed in pre-cooled 
electroporation cuvettes (2 mm gap size) and mixed with ~10 ng of the respective plasmid DNA. 
Transformation was achieved by electroporation (200 Ω; 25 µF; 2.5 kV). Transformed bacteria 
were resuspended in 900 µL of SOC medium and recovered by shaking at 220 rpm and 37°C for 
1 h. 
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One-step modification of genes in the chromosome: Chromosomal mutagenesis of Salmonella 
SL1344 was performed as previously described (Datsenko and Wanner, 2000). To construct the 
STnc440 deletion strain (JVS-10038), the first ~60 nt of the gene were removed while keeping 
the Rho-independent terminator intact. The respective resistance cassette was eliminated using 
the FLP helper plasmid pCP20 at 42°C (Datsenko and Wanner, 2000). All mutations were 
transduced into the wild-type background using phage P22 (Sternberg and Maurer, 1991).  
Phage P22 transduction: For the transfer of chromosomal mutations to different strain 
backgrounds, P22 phage lysates were prepared using soft agar plates as previously described 
(Sternberg and Maurer, 1991). Briefly, 100 µl of the culture of the respective donor strain (OD600 
of 1.0) were added to 3 mL of TOP agar containing 20 mM MgSO4, 10 mM CaCl2 and the mixture 
was poured onto a pre-warmed LB agar plate. 100 µL of the P22 lysate from wild-type bacteria 
were plated on top of the TOP agar. Plates were incubated at 37°C overnight. The next day, the 
TOP agar layer was scraped off, transferred to a glass tube and resuspended in 5 mL of liquid 
LB/10 mM MgSO4/5 mM CaCl2 and supplemented with 400 µL of chloroform. The resulting 
suspension was mixed thoroughly, incubated overnight at 4°C, and subsequently centrifuged for 
10 min at 4,000 rpm (4°C). The resulting supernatant fraction was transferred to a fresh glass 
tube containing 400 µL of chloroform for storage at 4°C. 
For transduction, 100 µL of a culture of the recipient strain (OD600 of 1.0) were mixed with 1-50 
µL of the phage lysate (see above) and incubated for 20 min at room temperature. Addition of 
EGTA to a final concentration of 10 mM was used to stop the transduction. The sample was then 
plated on pre-warmed LB agar plates supplemented with appropriate antibiotics to select the 
positive transductants, which were subsequently verified by PCR. 
sRNA pulse-expression (in vitro and in vivo): For the in vitro experiment in SPI-2 medium, 
arabinose-induced over-expression of STnc440 from the pBAD plasmid was achieved using the 
previously described protocol (Papenfort et al., 2006; Papenfort et al., 2012; Papenfort et al., 
2009) with minor modifications. Briefly, wild-type Salmonella that had been transformed with 
pKP8-35 (pBAD control), pYC5-34 (pBAD-STnc440) or pYC60 (pBAD-STnc440*) were grown 
overnight in LB. The next day, the cultures were washed 2x with PBS and 1x with SPI-2 medium, 
diluted 1:50 in SPI-2 medium and grown to an OD600 of 0.3. Then L-arabinose (Sigma) was added 
to the culture in a final concentration of 0.2%. 5 min after induction, total RNA was extracted 
using the TRIzol LS reagent (Invitrogen). cDNA libraries were prepared as explained below and 
analyzed by RNA-seq on Illumina’s MiSeq machine (~3-5 M reads/library).  
For the pulse-expression of STnc440 inside host cells, HeLa-S3 cells were infected (m.o.i. of 5) 
with the same three strains and 4 h after infection, 0.2% L-arabinose was supplemented into the 
DMEM medium. Activation of inducible sRNA expression in intracellular bacteria was confirmed 
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by qRT-PCR over a time-course of 20 min, demonstrating full induction levels to be reached at 5 
min. Thus, 5 min after induction the host cells were lysed with ice-cold 1% Triton X-100/PBS 
and further incubated for 30 min on ice with pipetting up and down from time to time to 
improve lysis efficiency. Then the intact bacterial cells were pelleted by centrifugation for 2 min 
at 16,100 g (4°C) and resuspended in RNAlater (Qiagen). The thus fixed bacterial cells were 
further enriched against the host background via cell-sorting (FACSAria III, BD Biosciences) and 
selective gating for the fraction of GFP+ bacterial cells released from their hosts. Total RNA was 
isolated and analyzed by RNA-seq as above except that sequencing was on the HiSeq platform to 
~20 M reads/library as despite the enrichment of bacterial cells the majority of sequence reads 
were still host-derived. 
EGFP fusion assays (flow cytometry, plate reader): For sRNA target validation, the CDS of EGFP 
was fused downstream of and in frame with the respective target sequence (5’ UTR plus early 
coding sequence) and inserted into plasmid pXG-10. Salmonella transformed with either the 
empty plasmid or the target gene reporter construct in combination with the pBAD-ctrl., pBAD-
STnc440 or pBAD-STnc440* were grown in LB (Amp + Cm) overnight. The next day, 50 µL of the 
culture were diluted into 2 mL LB (Amp + Cm + 0.2% L-arabinose) and grown for 3 h to ~OD600 
of 2. Then, 1 OD600 bacteria were collected for measurement of GFP fluorescence (FACSCalibur, 
BD Biosciences). 
To measure SPI-2 activation, a transcriptional fusion of the ssaG promoter to the CDS of EGFP 
was inserted into plasmid pAS046 via AatII/NheI sites as previously described (Pfeiffer et al., 
2007). The resulting reporter construct or the empty control plasmid pXG1 were co-transformed 
with expression plasmids pBAD-ctrl., pBAD-STnc440 or pBAD-STnc440* into the indicated 
strain backgrounds. The resulting strains were grown overnight in LB (Amp + Cm) and then 
diluted 1:100 and further in LB to an OD600 of 2. Each 1 mL of the cultures was pelleted and cells 
shifted to SPI-2 medium (defined as t0) as described above, except that the growth experiment 
was conducted in 96-well plates (TC Microwell 96F, Thermo Scientific). After measuring the 
OD600 and GFP intensity at t0, L-arabinose was added to each well to final concentration of 0.2% 
and bacteria were grown for 20 h at 37°C (shaking) with measurements of both the OD600 and 
GFP fluorescence in 10 min intervals using the Infinite F200 PRO plate reader (TECAN). For each 
technical triplicate the ratios of GFP intensity and OD600-value were calculated, normalized 
against strains carrying the empty vector control (pXG1) and are expressed relative to the 
maximum reached in the wild-type background. 
5.2.2 Cell culture methods  
Passaging and seeding: The following cell lines were used in this study: Human cervix carcinoma 
(HeLa-S3; ATCC CCL-2.2), human epithelial colorectal adenocarcinoma cells (CaCo-2; ATCC HTB-
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37), human stomach adenocarcinoma cells (AGS; ATCC CRL-1739), human embryonic kidney 
293 cells (HEK 293; ATCC CRL-1573), human monocytic cells (THP-1; ATCC TIB-202), murine 
embryonic fibroblast cells (MEF; ATCC SCRC-1040), mouse leukaemic monocyte/macrophage 
cell line (RAW264.7; ATCC TIB-71). All cell lines except for AGS cells were obtained from the 
group of Thomas Rudel (Biocenter Würzburg). AGS cells were provided by Cynthia Sharma 
(ZINF Würzburg). HeLa-S3 cells were cultured according the guidelines provided by the 
ENCODE consortium (genome.ucsc.edu/encode/protocols/cell/human/Stam_15_protocols.pdf). 
Briefly, cells were grown in DMEM (Gibco) supplemented with 10% fetal calf serum (FCS; 
Biochrom), 2 mM L-glutamine (Gibco) and 1 mM sodium pyruvate (Gibco) in T-75 flasks 
(Corning) in a 5% CO2, humidified atmosphere at 37°C. All further cell lines used in this study 
(THP-1, CaCo-2, AGS, HEK 293, MEF and RAW264.7) were cultured in RPMI (Gibco) 
supplemented with 10% FCS, 2 mM L-glutamine, 1 mM sodium pyruvate in a 5% CO2, humidified 
atmosphere at 37°C. To differentiate THP-1 monocytes, seeded cells (1x106 cells/well; six-well 
format) were treated with 50 ng/mL (final concentration) of phorbol 12-myristate 13-acetate 
(PMA) (Sigma) for 72 h (after 48 h fresh PMA in the same concentration was added to the 
culture). For the differentiation of bone marrow derived macrophages (BMDMs) the marrow of 
femur and tibia was isolated from 8-12 week old female C57BL/6 wild-type mice and stored in 
RPMI supplemented with 10% FCS. The cell suspension was centrifuged for 5 min at 250 g and 
the leukocyte pellet was resuspended in differentiation medium consisting of X-vivo-15 medium 
(Lonza) supplemented with 10% FCS and 10% L929 conditioned DMEM medium (same 
composition as above). Cells were cultured for 3 days at 3x106 cells per 10 mL in a T-75 flask. At 
day 3 another 3 mL of differentiation medium were added and cells were further cultured until 
day 5. Successful macrophage differentiation was validated by microscopy on day 5 upon which 
the cells were detached using a rubber scraper (Sarstedt) and seeded into six-well plates at 105 
cells per well in fresh differentiation medium. Infection was carried out on day 7 as described 
below. 
Apoptosis assay: To detect apoptotic cells, HeLa-S3 were washed twice with PBS and 
resuspended in 1x binding buffer (BD Pharmingen) in a concentration of 106 cells/mL. 100 µL of 
this cell suspension were then mixed with 5 µL of APC-labeled Annexin V (BD Pharmingen) and 
1 µL of 500 mg/mL propidium iodide (PI; lyophilized stock from Sigma). Upon incubation for 15 
min at room temperature (light-protected) cells were subjected to flow cytometry (see below).  
LDH release assay: Necrosis was evaluated by quantifying released lactate dehydrogenase (LDH) 
via the Cytotox96 assay (Promega) according to the manufacturer’s instructions. The 
absorbance at 490 nm was measured using a Multiskan Ascent instrument (Thermo Fisher). In 
order to convert the measured absorbance values into the relative proportion of dead cells, the 
maximal absorbance was determined by using 1x Lysis Solution (Promega) following the 
106 
 
manufacturer’s instructions and referred to as 100% cytotoxicity. For both apoptosis and 
cytotoxicity measurements at least three biological replicates were analyzed, each of which 
comprised three technical replicates. 
5.2.3 Infection assays 
In vitro Salmonella infection assay: Infection of HeLa-S3 cells was carried out following the 
protocol of (Schulte et al., 2011) with slight modifications. Two days prior to infection 2x105 
HeLa-S3 cells were seeded in 2 mL complete DMEM (six-well format). Overnight cultures of 
Salmonella were diluted 1:100 in fresh LB medium and grown aerobically to an OD600 of 2. 
Bacterial cells were harvested by centrifugation (2 min at 12,000 rpm, room temperature) and 
resuspended in complete DMEM medium. Infection of HeLa-S3 cells was carried out by adding 
the bacterial suspension directly to each well. If not mentioned otherwise, infections were 
performed at a multiplicity of infection (m.o.i.) of 5. Immediately after addition of bacteria, the 
plates were centrifuged for 10 min at 250 g, room temperature followed by 30 min incubation in 
5% CO2, humidified atmosphere, at 37°C. Medium was then replaced for gentamicin-containing 
complete DMEM (final concentration: 50 mg/mL) to kill extracellular bacteria. After a further 30 
min incubation step, medium was again replaced by 10 mg/mL gentamicin/DMEM and 
incubated for the remainder of the experiment. Time point 0 h was defined as the time when 
gentamicin was first added to the cells.  
Further cell types (THP-1, CaCo-2, AGS, HEK 293, MEF and RAW264.7) were infected as 
described for Hela-S3 cells except that infection was carried out in RPMI complete medium 
instead of DMEM and that infection was with a m.o.i. of 10 instead of m.o.i. 5. Infection of BMDMs 
was carried with a m.o.i. of 10 and using X-vivo-15 medium (10% fetal calf serum, 10% L929 
conditioned medium). 
Quantification of intracellular replication: Infected HeLa-S3 cells were analyzed by flow 
cytometry as described below. Alternatively, infected HeLa-S3 cultures were solubilized with 
PBS containing 0.1% Triton X-100 (Gibco) at the respective time points. Cell lysates were 
serially diluted in PBS, plated onto LB plates and incubated at 37°C overnight. The number of 
colony forming units (c.f.u.) recovered was compared to that obtained from the bacterial input 
solution used for infection. In all cases, at least three biological replicates were analyzed, each of 
which comprised three technical replicates. 
5.2.4 Basic molecular biological methods  
Preparation of plasmid DNA: Plasmid DNA was extracted from transformed TOP10 cells using 
the NucleoSpin Plasmid QuickPure kit (Macherey-Nagel) following the manufacturer’s 
instructions. 
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Preparation of genomic DNA: Salmonella genomic DNA was prepared using the Masterpure DNA 
purification Kit (Epicentre) according to the manufacturer’s recommendations. 
Polymerase chain reaction (PCR): To amplify DNA fragments of interest different protocols were 
performed. For simple PCR-based validation screens a Taq-based protocol was applied: 
PCR reaction (1x): 10-100 ng template DNA (in 1-2 µL) or single colony 
   5 µL HotStart reaction buffer (10x) 
   dNTPs (100 µM each) 
   sense primer (1 µM) 
   anti-sense primer (1 µM) 
   1.25 U Taq DNA polymerase 
   H2O ad 50 µL 
PCR program:  95°C  2 min (for colony-PCR: 10 min) 
   95°C  30 sec 
   55-60°C 30 sec   35x 
   68°C  1 min/1 kb 
   68°C  10 min 
   15°C  ∞ 
For cloning purposes or analysis by Sanger sequencing a Phusion-based protocol was applied: 
PCR reaction (1x): 10-100 ng template DNA (in 1-2 µL) or single colony 
   10 µL Phusion reaction buffer (5x) 
   dNTPs (200 µM each) 
   sense primer (0.5 µM) 
   anti-sense primer (0.5 µM) 
   0.5 U Phusion DNA polymerase 
   H2O ad 50 µL 
PCR program:  98°C  2 min (for colony-PCR: 10 min) 
   98°C  30 sec 
   55-60°C 30 sec   35x 
   72°C  30 sec/1 kb 
   72°C  5 min 
   15°C  ∞ 
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Resulting PCR products were either purified directly using the QIAquick PCR Purification kit 
(Qiagen) following the manufacturer's instructions or separated by AGE, excised from the gel 
and purified using the QIAquick Gel Extraction Kit (Qiagen). 
Restriction digestion, DpnI digestion and DNA ligation: Restriction digestions were performed 
using restriction enzymes and buffers from NEB and Fermentas according to the instructions 
given by the manufacturers. Plasmid products from mutagenesis PCR were treated for 1 h at 
37°C with DpnI (NEB) to remove remnants of the template plasmid. Blunt and sticky end ligation 
of DNA fragments was achieved using the T4 DNA ligase (NEB) according to the manufacturer’s 
recommendations.  
Agarose gel electrophoresis (AGE): After PCR or restriction digestion, individual DNA fragments 
were separated by AGE. Gels were prepared by dissolving pure agarose in 1×TAE buffer to the 
desired concentration (typically 1-2% (w/v)). The solution was boiled until all agarose was 
dissolved, supplemented with 0.02% (v/v) of the RedSafe dye (ABC Scientific) and casted. 
Samples were supplemented with ¼ volume of 5x DNA loading buffer, mixed and loaded on the 
gel. The GeneRuler 1 kb DNA Ladder (Fermentas) was loaded as a size marker. Separation was at 
100-150 V. 
Denaturing polyacrylamide gel electrophoresis (PAGE): To size-separate individual RNA species, 
denaturing polyacrylamide (PAA) gels were used. Prior to casting the gels, all glass ware and 
equipment was cleaned with 70% ethanol. The 40% PAA solution (19:1 acrylamide/bis-
acrylamide) was diluted in water to the desired concentration and supplemented with urea to a 
final concentration of 8.3M. The addition of 0.01 volumes of 10% APS and 0.001 volumes of 
TEMED polymerized the PAA solution. RNA samples were supplemented with 1 volume of 2x 
GL-II loading dye, denatured by boiling for 5 min at 100°C and chilled on ice for 5 min. 1x TBE 
was used as a running buffer. PAGE was performed at 300 V and room temperature. 
5.2.5 RNA techniques  
Total RNA extraction: For Dual RNA-seq, RNA was extracted from cells using the mirVana kit 
(Ambion) following the manufacturer’s instructions for total RNA isolation. This method had 
been optimized to recover transcripts of all sizes, including short RNA fractions (in particular 
miRNAs and sRNAs) in addition to larger transcripts, and in this respect may surpass traditional 
column-based RNA isolation techniques (Stead et al., 2012). To this end, infected cells at a given 
time point were trypsinized, collected and directly lysed in 600 µL of Lysis/Binding buffer of the 
mirVana kit (Ambion). As a reference for gene expression changes in HeLa-S3 upon infection, a 
non-infected yet mock-treated control was included. The bacterial reference samples were 
derived from Salmonella grown in LB to an OD600 of 2, which either were then shifted to 
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complete DMEM for 15 min, pelleted and fixed in RNAlater (see below) or were fixed directly 
(i.e. without a medium exchange step). Fixed Salmonella cells were pelleted and lysed in 
Lysis/Binding buffer. In order to maintain the approximate ratio of bacterial to human 
transcripts during RNA isolation, Salmonella lysates were mixed with HeLa-S3 lysate in a way 
that the calculated proportion of individual Salmonella cells per infected host cell at the 
respective time points was matched. The resulting mixture was then processed collectively. 
For qRT-PCR or Northern blot experiments as well as for RNA-seq-based analysis of pulse-
expression experiments, total RNA was extracted using the TRIzol LS reagent (Invitrogen) 
according to the manufacturer’s recommendations. 
DNase I treatment: To get rid of contaminating genomic DNA, RNA samples supposed to be 
analyzed by RNA-seq or qRT-PCR were treated with 1 U of DNase I (Fermentas) per 4 µg of RNA 
for 45 min at 37°C. If applicable, RNA quality was checked on the Agilent 2100 Bioanalyzer 
(Agilent Technologies).  
qRT-PCR analysis: qRT-PCR experiments were performed with the Power SYBR Green RNA-to-CT 
1-Step kit (Applied Biosystems) according to the manufacturer’s instructions. Fold-changes were 
determined using the 2(-ΔΔCt)-method (Livak and Schmittgen, 2001). Primer sequences are given 
in Table 5.7 and their specificity had been confirmed using Primer-BLAST (NCBI). For the 
estimation of Salmonella RNA within infection samples (Fig. 2.8), a dilution series of separately 
isolated Salmonella and HeLa-S3 total RNA was set up and in each case the ratio of rfaH/β-actin 
mRNAs was determined. The same was done for biological samples from infected cells (with or 
without sorting) as well as for the Salmonella reference controls (see above). From the resulting 
trend-line equation the approximate proportion of the Salmonella transcriptome within mixed 
pro-/eukaryotic total RNA samples could be deduced. 
Northern blotting: Total RNA was prepared using the TRIzol LS reagent and separated in 
denaturing PAA gels as described above. 5-10 μg of RNA per lane were loaded for bacteria only 
samples and 2 µg (sorted samples) to 50 µg (unsorted) per lane for mixed human/Salmonella 
RNA samples. Northern blotting was as described (Sittka et al., 2007). For detection, Hybond XL 
membranes (Amersham) were hybridized at 42°C with gene-specific [32P] end-labeled DNA 
oligonucleotides (see Table 5.7 for sequences) in Rapid-hyb buffer (GE Healthcare). 
5.2.6 Protein techniques 
Western blotting: Immunoblotting of Salmonella proteins was done as previously described 
(Urban and Vogel, 2007). Briefly, samples from Salmonella in vitro cultures were taken according 
to 0.4 OD600, centrifuged for 4 min at 16,100 g at 4°C, and pellets resuspended in protein loading 
buffer to a final concentration of 0.01 OD/μL. After denaturation for 5 min at 95°C, 0.05-OD 
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equivalents of the sample were separated via SDS-PAGE. Gel-fractionated proteins were blotted 
for 90 min (0.2 mA/cm2; 4°C) in a semi-dry blotter (Peqlab) onto a PVDF membrane 
(PerkinElmer) in transfer buffer (25 mM Tris base, 190 mM glycin, 20% methanol). Blocking 
was for 1 h at room temperature in 10% dry milk/TBST. Appropriate primary antibodies were 
hybridized at 4°C overnight and – following 3x 5 min washing in TBST – secondary antibodies 
for 1 h at room temperature. Primary and secondary antibodies used and the respective dilution 
are listed in Table 5.6. For Western blotting of human proteins, infected cells were harvested in 
protein loading buffer (500 µL/well; six-well format), transferred to 1.5 mL reaction tubes, 
boiled for 5 min at 95°C and 20 µL/lane were loaded onto a 10% PAA gel for SDS-PAGE as above. 
After blotting and blocking, the membrane was probed with the respective primary antibody at 
4°C overnight and for 1 h at room temperature with the corresponding secondary antibodies. 
Blots were developed using Western Lightning solution (PerkinElmer) in a Fuji LAS-4000. 
Where indicated, intensities of bacterial protein bands were quantified using the AIDA software 
(Raytest, Germany) and normalized to GroEL levels. 
ELISA: HeLa-S3 cells were infected with wild-type Salmonella, ΔSTnc440 or ΔSTnc440+ mutant 
strains at a m.o.i. of 5 as described above. Culture supernatant samples were taken at 20 h p.i. 
and analyzed using the ELISA kit for human CXCL8/IL-8 (R&D Systems). 
5.2.7 Fixation techniques 
Infected cells were washed twice with PBS, trypsinized and pelleted. For ethanol fixations, cell 
pellets were re-dissolved in 0.1 volumes of ice-cold PBS and then 0.9 volumes of ice-cold ethanol 
(either 70% or 100%; as indicated) were added in single droplets during shaking (400 rpm, 4°C) 
to avoid cell clumping. Fixation using the stop solution (95% EtOH/5% water-saturated phenol; 
(Eriksson et al., 2003)) was performed by resuspending the cell pellet in PBS prior to the 
addition of 0.2 volumes of stop solution and mixing. When PFA was used, the pellet was 
resuspended in the respective PFA concentration (0.5% or 4% (w/v) PFA, pH 7.4, with or 
without 4% (w/v) sucrose) and shaken for 15 min at 400 rpm, room temperature. PFA-induced 
cross-links were reverted by an additional heating step for 15 min at 70°C (Hamatani et al., 
2006; Kuramochi et al., 2006). For fixation with RNAlater (Qiagen) cell pellets were directly 
resuspended in RNAlater (1 mL/5x106 cells) and incubated for 30 min at room temperature. For 
systematic evaluation of different fixation protocols (Fig. 2.5 and 2.6), fixed cells had not been 
sorted but were either directly analyzed upon fixation (30 min) or stored at -20°C (ethanol-
based fixatives) or 4°C (others), respectively, overnight. RNAlater-fixed samples that were to be 
analyzed by Dual RNA-seq were sorted. To this end, tubes containing ~5x106 fixed cells were 
filled up with 10 mL of ice-cold PBS, centrifuged (5 min, 500 g, 4°C) and cell pellets resuspended 
in 1 mL of cold PBS. This cell suspension was filtered and sorted. 
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5.2.8 Flow cytometry and FACS-based methods 
Flow cytometry-based analyses: To measure the infection rate, infected HeLa-S3 cultures were 
washed twice with PBS, detached from the bottom of the plate by trypsinization and 
resuspended in complete DMEM. Upon pelleting the cells (5 min at 250 g, room temperature) 
they were resuspended in PBS and analyzed by flow cytometry using a FACSCalibur instrument 
(BD Biosciences) and the Cyflogic software (CyFlo Ltd.). Selection of intact HeLa-S3 cells was 
achieved by gating based on cell diameter (forward-scatter) and granularity (side-scatter) 
(linear scale). Of those, infected (GFP-positive) and non-infected (GFP-negative) sub-fractions 
were defined based on GFP signal intensity (FITC channel) vs. auto-fluorescence (PE channel) 
(logarithmic scale). 
To quantify the relative amount of intracellular pathogens per host cell over time, the increase in 
GFP intensity (geometric mean) was measured in the GFP-positive sub-population and 
normalized to that of the non-infected population from the same sample as described above. 
To measure apoptosis, Annexin V-stained cells were analyzed by flow cytometry using the 
MACSQuant Analyzer (Miltenyi Biotec). Upon gating of the fraction of intact cells based on cell 
diameter (forward-scatter) and granularity (side-scatter), the Annexin-positive/PI-negative sub-
population was determined by comparison against the appropriate single-stained controls in the 
APC vs. PerCP channels and quantified. 
Cell sorting: RNAlater-fixed cells (see below) were first passed through MACS Pre-Separation 
Filters (30 µm exclusion size; Miltenyi Biotec.) and then analyzed and sorted using the FACSAria 
III device (BD Biosciences) under continuous cooling to 4°C (both the input tube holder and the 
collection tube rack) and at a medium flow rate (~4) using the same gating strategy as described 
above, except that the gates for GFP-positive and -negative fractions were more conservative in 
order to prevent cross contamination (as exemplified in Fig. 2.7a). Typically ~3x105 cells were 
collected in each fraction and subjected to RNA isolation. 
5.2.9 RNA-seq techniques 
Total RNA samples for Dual RNA-seq and pulse-expression were converted into cDNA libraries 
for Illumina sequencing by Vertis Biotechnologie AG, Freising-Weihenstephan, Germany 
(http://www.vertisbiotech.com). A minimal amount of ~100 ng of total RNA was required for 
cDNA library preparation. DNase I-treated total RNA samples were first sheared via ultra-sound 
sonication (4 pulses of 30 s at 4°C each) to generate on average ~200-400 bp fragmentation 
products. Then, fragments <20 nt were removed using the Agencourt RNAClean XP kit (Beckman 
Coulter Genomics). As an internal quality control for the pilot experiment, spike-in RNA (5’-
AAAUCCGUUCGUACGGGCCC-3’; 5’-monophosphorylated and gel-purified) was added to a final 
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concentration of 0.5%. The samples were then poly(A)-tailed using poly(A) polymerase and the 
5’ triphosphate (and eukaryotic cap) structures were removed using tobacco acid 
pyrophosphatase (TAP). Afterwards, a RNA adapter was ligated to the 5’ monophosphate of the 
RNA. First-strand cDNA synthesis was performed using an oligo(dT)-adapter primer and the M-
MLV reverse transcriptase (NEB). The resulting cDNA was PCR-amplified to about 20-30 ng/µL 
using a high fidelity DNA polymerase (barcode sequences for multiplexing were part of the 3’ 
primers). The cDNA library was purified using the Agencourt AMPure XP kit (Beckman Coulter 
Genomics) and analyzed by capillary electrophoresis (Shimadzu). Single-end sequencing (100 
cycles) was performed on an Illumina HiSeq 2000 machine at the Max Planck Genome Centre 
Cologne, Cologne, Germany or on the Illumina MiSeq platform at the Institute for Molecular 
Infection Biology, University of Würzburg, Würzburg, Germany.  
5.2.10 Microscopy techniques 
For microscopic analyses, infection was carried out as described above, except that HeLa-S3 cells 
were seeded onto coverslips (24-well format). At the respective time point coverslips with 
infected HeLa-S3 were washed twice with PBS (Gibco) and fixed in 4% (w/v) PFA for 15 min in a 
wet chamber. After two additional PBS washing steps, cells were stained with Hoechst 33342 
(Invitrogen; 1:5,000 diluted in PBS) for 15 min in a wet chamber and again washed twice with 
PBS. After coverslips had been air-dried, they were embedded in VECTASHIELD(R) Mounting 
Medium (Biozol) and analyzed using the LEICA SP5 confocal microscope (Leica) and the LAS AF 
Lite software (Leica). 
5.2.11 Bioinformatics analyses 
RNA-seq data processing: Illumina reads in FASTQ format were trimmed with a phred score cut-
off of 20 by the program fastq_quality_trimmer from the FASTX toolkit version 0.0.13 
(http://hannonlab.cshl.edu/fastx_toolkit/). For the high-resolution time-course experiment (as 
outlined in Figure 3.2), the FASTQ files were sub-sampled to have an equal number of 146 M 
total reads/library except for the 0 h bacterial reference samples which were sub-sampled to 10 
M reads mapping to the Salmonella genome. To compare the ΔSTnc440 data to that of other 
sRNA mutants (Fig. 4.3 and 4.4), the respective time points from the deeply sequenced 
experiment were sub-sampled to 30 M total reads to ensure an equal sequencing depth for all 
libraries that were compared. For read mapping, 5’ linker-clipped reads were aligned to the 
Salmonella enterica SL1344 genome (accession numbers: NC_016810.1, NC_017718.1, 
NC_017719.1, NC_017720.1) and the human (hg19 – hs37d5 retrieved from the 1000 Genome 
Project (Abecasis et al., 2012)) or the mouse genome sequence (GENCODE M2), respectively, in 
parallel using the READemption pipeline (Förstner et al., 2014) and the short read mapper 
segemehl (Otto et al., 2014) allowing for split reads (Hoffmann et al., 2014). Reads shorter than 
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20 nt after poly(A)-trimming were discarded prior to the mapping. Mapped reads with an 
alignment accuracy <90% as well as cross-mapped reads – i.e. reads which could be aligned 
equally well to both human and Salmonella reference sequences – were discarded. Based on the 
resulting BAM files, coverage files in wiggle format were generated by READemption and split by 
organism. Gene-wise quantifications for the human data subset were performed based on 
annotations from GENCODE (Harrow et al., 2012), NONCODE (Xie et al., 2014) and miRBase 
(Kozomara and Griffiths-Jones, 2014) after removing redundant entries and the annotation for 
Salmonella genes was retrieved from NCBI (under the above mentioned accession numbers) and 
manually extended by small RNA annotations (Förstner et al., unpublished). Based on gene 
quantifications provided by the READemption pipeline the calculation of RPKM values and all 
subsequent analysis steps were carried out separately for the host and the pathogen system. 
Different RPKM cut-off values did not alter the general trends observed. All differential 
expression analysis was performed using the DESeq R package (Anders and Huber, 2010) with 
method blind and sharing mode fit-only. 
Salmonella analyses: A database of pathways, regulons, and genomic islands was constructed 
using information obtained from the KEGG database (Kanehisa et al., 2014) (organism code sey), 
the SL1344 genome annotation (Kroger et al., 2012), and relevant literature sources. Spearman 
correlation coefficients between changes in STnc440 expression and changes in expression of 
each gene within each regulon over the time-course were plotted in Figure 3.6. To assess 
enrichment of differentially expressed transcripts in pathways (Figure 3.9), genes displaying an 
absolute fold-change of at least 2 and a RPKM value of at least 20 in both the wild-type and 
ΔSTnc440 were considered differentially expressed, and a hypergeometric test for enrichment 
was conducted for each pathway. To generate Figure 4.3a, aligned reads for the STnc440 
deletion and control libraries were subsampled to be comparable in depth to those of the other 
sRNA deletion libraries. Transcripts with a minimum count per million reads excluding 
ribosomal and tRNAs of at least 400 (approximately 20 reads) in either the wild type or deletion 
strain and a fold-change of at least 2 in at least one deletion:wild-type comparison are displayed. 
Human analyses: A transcript was considered to be detected if in at least one condition the 
observed RPKM was above 0.1 for lncRNA genes and 0.5 for all other human transcript classes, 
respectively. For a given comparison, all detected transcripts showing at least a 1.5 fold-change 
in abundance and a p-value below 0.01 were considered differentially expressed.  
Statistics: Tests for the evaluation of statistical significance in Figure 2.3 were performed using a 
one-tailed Student’s t-test. p-values <0.05 were considered statistical significant (*) and p-values 
<0.001 were considered very significant (***). The significance of differences in qRT-PCR results 
in Figure 3.10 was assessed using a one-tailed Mann-Whitney U test.  
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7. Appendix 
 
7.1 Intracellular sRNA expression profiles in diverse host cell types  
The functional insights obtained for the highly induced STnc440 sRNA in pathogen-host 
interaction (chapter 3) may prompt screens for the performance of additional Salmonella sRNA 
deletion mutants during infection in the future. Although an intracellular induction does not 
necessarily coincide with a virulence phenotype of the corresponding deletion mutant (Barquist 
et al., 2013), regulated sRNAs during infection are likely candidates for novel virulence-related 
riboregulators previously missed in mRNA-centric infection screens. Similarly to STnc440, many 
other sRNA loci are strongly induced upon host cell invasion (Fig. 3.5). Six of these sRNAs were 
selected for Northern blot validations and all six of them were induced also under SPI-2 
conditions in vitro (Fig. 7.1). Of note, with the exception of the Y-RNAs (YrlA/B) and IsrE that 
were not detected in these experiments due to the lower sequencing depth, the induction of the 
selected sRNAs was also observed in various additional host cell types (Fig. 7.2). 
 
 
 
The functionally related RyhB/IsrE are important regulators of iron homeostasis (Masse et al., 
2005) and OmrA/B are involved in curli synthesis and the regulation of outer membrane 
proteins (Guillier and Gottesman, 2008; Holmqvist et al., 2010). These sRNAs control multiple 
target mRNAs by Hfq-dependent base-pairing. In contrast, YrlA and YrlB act as a scaffold for the 
RNA degradation machinery composed of the Ro ortholog Rsr and the exoribonuclease poly-
nucleotide phosphorylase (PNPase), and serve an important function in rRNA maturation and 
decay (Chen et al., 2013). Importantly, while RyhB and IsrE have previously been suggested to 
play a role in Salmonella virulence – e.g. they were amongst the strongest induced Salmonella 
Figure 7.1|In vitro validation of intracellularly induced sRNAs. 
Northern blot analysis was used to confirm further Salmonella sRNAs 
that were induced upon host cell invasion (see Fig. 3.5). ‘ON’ refers to 
an overnight culture and ‘inoculum’ refers to bacteria grown in LB to 
an OD600 of 2 and then transferred to the host cell medium DMEM. 
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sRNAs and counter-acted intracellular growth in a fibroblast model (Ortega et al., 2012) – 
OmrA/B and YrlA/B have so far not been implicated in pathogenicity. Of these sRNA genes, only 
omrA was hit in the previous transposon screen for virulence factors, but its inhibition exhibited 
no growth defect compared to the wild-type (Chaudhuri et al., 2013).  
Pair-wise deletion of these functionally related sRNAs has been performed and the resulting 
mutants will subsequently be analyzed by comparative Dual RNA-seq. To increase sensitivity of 
the method, bacterial and host ribosomal transcripts will be removed prior to library 
construction using the Ribo-Zero Magnetic Gold kit (epicenter). With this strategy, even subtle 
changes in gene expression between mutant and wild-type infections might possibly become 
detectable. 
 
 
Figure 7.2|sRNA expression profile inside various host cell types. Relative expression of Salmonella 
sRNAs at an early or late time point after the infection of diverse cell types relative to their extracellular 
expression levels (in DMEM medium). Data are derived from a single replicate and each library was 
sequenced to 1-5 M reads (same as in Fig. 3.7). sRNAs selected for deletion experiments are labeled in red. 
Grey shaded boxes mean that the respective sRNA was not detected under this condition. 
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